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 Abbreviations 
Å angstrom EtOAc ethyl acetate 
Ac  acetyl g  gram(s) 
ACN acetonitrile GABA  γ-aminobutyric acid 
AIBN  aza-isobutyronitrile h  hour(s) 
Ar  aryl HPLC  high-performance liquid 
atm.  Atmosphere HRMS  high-resolution mass spectrometry 
Boc  tert-butoxycarbonyl Hz  Hertz 
brine  saturated NaCl solution iPr  iso-propyl 
Bu  butyl IR  infrared 
BuLi  butyl lithium L  liter; ligand 
°C  degrees Celsius M  molar 
calcd.  calculated μ  micro 
cm-1  wavenumber(s) max  maximum 
d  day(s) Me  methyl 
DBU  1,8-diazabicyclo [5.4.0] undec-7-ene MeOH  methanol 
DCM  dichloromethane MHz  megahertz 
DMF  dimethyl formamide min  minute(s) 
DMS  dimethyl sulfide mL  milliliter 
DMSO  dimethylsulfoxide mm  millimeter 
d.r.  diastereomeric ratio mmol  millimole(s) 
ed.  edition mp  melting point 
EDG  electron-donating group Ms  mesyl 
ee  enantiomeric excess NBS  N-bromosuccinimide 
e.g.  exempli gratia, for example NMR  nuclear magnetic resonance 
eq  equation Nu  nucleophile 
equiv  equivalent(s) n.d. not detected 
ESI  electrospray ionization PG  protection group 
Et  ethyl pH  proton log units 
et al.  and others (co-authors) Ph  phenyl 
etc.  etcetera ppm  part per million 
Et3N  trimethylamine Piv  pivaloyl 
EWG  electron-withdrawing group PE petroleum ether 
  
quant  quantitative    
rac  racemic    
Rf  retention factor (in chromatography)    
r.t  room temperature    
sat.  saturated    
tBu  tert-butyl    
Tf  triflate    
TFA  trifluoroacetic acid    
THF  tetrahydrofuran    
TIPS  triisopropylsilyl    
TLC  thin layer chromatography    
TON  turnover number    
TOF  turnover frequency    
tR  retention time    
Ts  tosyl    
vs  versus    
UV  ultraviolet    
wt%  weight percent   
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A. Introduction 
1. Introduction: Transition-metal-catalyzed ring-opening of non-activated 
vinyl cyclopropanes 
Vinylcyclopropanes (VCPs) are not only important structural elements that constitute 
the skeleton of many biologically active and drug-related compounds,1–4 but also one of the 
most versatile building blocks in organic synthesis.5–7 Over the past few decades, VCPs have 
been successfully employed to develop various synthetic methodologies and to access complex 
targets in total synthesis.8–15 
In general, VCPs can undergo different types of rearrangement processes: a) ring-
opening;16,17 b) cis–trans isomerization;18–23 c) ring-expansion to generate cyclopentenes or 
methylcyclobutenes.24–30 These transformations can proceed through thermal, photochemical, 
or catalytic pathways.7,31 The driving force for ring opening of VCPs is the strain relief 
associated with the three-membered ring fragmentation.32 The unique reactivities of VCPs also 
arise from both the high p-character of C–C σ-bonds of the cyclopropane ring and the overlap 
of these σ-bonds with the π-orbitals of the vinyl group.  
A donor-acceptor substitution pattern along the vinylcyclopropane moiety, i.e. activated 
VCPs, greatly facilitates the ring-opening of the cyclopropanes. This strategy was broadly 
exploited in organic synthesis.32 However, transition-metal catalysis33–36 offers a powerful 
technique to achieve ring opening chemistry also for non-activated VCPs.3–5 The development 
of transition-metal-catalyzed methodologies that allow highly selective C–H or C–C bond 
cleavage of VCPs is therefore a conceptually most intriguing, but underexplored area in 
synthetic organic chemistry.37 In this chapter, we will discuss the ring opening of non-activated 
vinylcyclopropanes catalyzed by transition metals, such as palladium,38–47 zirconium,48–50 
platinum,51 iron,52–55  gold,56–60 rhodium,61–81 ruthenium,61,82–86 nickel 37,87–89 and cobalt. 92 
The fundamental mechanistic pathways for ring-opening reactions catalyzed by metal 
complexes are illustrated in Scheme 1. Direct oxidative addition of a metal to the C-C 
cyclopropane bond constitutes the most direct approach for ring-opening (Scheme 1 a). This 
approach can deliver metalacyclobutanes 2 or σ-alkyl π-allyl complexes 3. Another approach 
to achieve such a C-C bond activation is via migratory insertion of a metal complex onto the 
VCP alkene moiety leading to 4, followed by a formal [1,3] metal migration with concurrent 
C-C-bond cleavage to give rise to an α-cyclopropyl organometallic species 5. In a similar 
 2 
fashion, the oxidative cyclization of an alkene alkyne complex 7 to a metallacyclopentene 8 
also sets the stage for cyclopropane bond cleave via a β-carbon elimination, which results in an 
intermediate 9 (Scheme 1 c). 
 
Scheme 1. Mechanistic pathways of transition-metal-catalyzed ring opening of non-
activated vinyl cyclopropanes. 
 
Palladium-Catalyzed Reactions. 
 
Selective ring opening of VCPs mediated by transition-metal “chain-walking” is mostly 
dominated by the utilization of palladium complexes.38–46 Pioneering work in this area was done 
by Heck and Fischetti who reported the synthesis of diene 14 via ring-opening 
carboesterification of non-activated VCP 10 (Scheme 2).38 The proposed mechanism for this 
reaction involves transmetalation of the methoxycarbonyl group of AcOHgCO2CH3 to a [Pd
II] 
species followed by migratory insertion with VCP 10. The resulting α-cyclopropyl-
organopalladium 11 undergoes a β-carbon elimination delivering a primary alkyl palladium 12 
which upon β-hydride elimination and hydride insertion to the terminal position rearranges to 
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the allyl palladium complex 13. Through a final β-hydride elimination of this complex the diene 
14 was obtained in 42% yield.  
 
 
 
Scheme 2. Early evidence of palladium-catalyzed ring-opening reactions of VCP and “chain-
walking”. 
Moving to a catalytic manifold, efforts have been subsequently devoted to exploit the 
ability of palladium to migrate over the hydrocarbon chain to build up complex structures.[38–
42] Marek and co-workers developed an elegant approach to access diverse open-chain 
molecules by palladium-catalyzed Mizoroki–Heck intermolecular arylation of vinyl substituted 
cyclopropanes 15. Notably, the homologues with a remote alkene moiety could also be 
employed (Scheme 3 a).42 Mechanistic studies suggested that the reaction is initiated by the 
migratory insertion of ArPdX to the terminal olefin upon which a series of β-hydride 
elimination and reinsertion events take place to arrive at the organopalladium complex 17, at 
which point the Pd-migration with concurrent C–C ring opening delivers 18. The chain walking 
process then resumes until the strategically placed hydroxyl group can terminate the reaction 
by -hydride elimination to yield thermodynamically favored carbonyl compound 19.  
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Scheme 3. The ring opening of VCPs triggered by palladium chain walk process. 
In 2018, the same group reported a related palladium-catalyzed oxidative Heck reaction. 
Hydroxyl directed migratory insertion arylpalladium intermediates into VCP 21 followed by β-
carbon elimination and chain walking mechanism afforded products 22 with high regio and 
diastereoselectivity (Scheme 3b).43 The reaction showed high functional group tolerance 
delivering desired products in moderate to good yields. 
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Stoichiometric Zirconium-mediated Reactions. 
 
The C–C combied with a C–H-bond activation of VCPs is possible through 
stoichiometric zirconocene complexes (Scheme 4).[48–50] One such example was reported by 
Marek and co-workers in 2013, in which the overall process involves a ring-opening 
difunctionalization of VCPs using two distinct electrophiles. The reaction is initiated via an 
allylic C–H-insertion by zirconocene, upon which a zirconium walk from 24 to 25 occurs. For 
here, a direct oxidative addition into the proximal cyclopropane C–C bond to give the 
zirconacyclobutane 26 takes place, which undergoes a sequential reaction with two 
electrophiles starting at the allylic position. Overall the products 27 are obtained with excellent 
regio and diastereoselectivity. 
 
 
Scheme 4. Zirconium-mediated selective C–C ring opening of cyclopropanes. 
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Platinum-Catalyzed Reactions. 
While studying platinum-catalyzed enantioselective diborylations of alkenes and, 
Moken and co-workers also investigated this reaction with VCP 10.51 After workup with 
hydrogen peroxide under basic conditions the diol 31 was obtained, suggesting the intermediacy 
of the α-cyclopropyl organoplatinum complex 29, which, analogous to palladium, undergoes a 
β-carbon elimination to afford the primary alkyl platinum complex 30. The latter undergoes a 
reductive elimination to afford the diborylated product which is subsequently oxidized to the 
corresponding diol 31. 
 
Scheme 5. Platinum-catalyzed enantioselective ring-opening of VCPs. 
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Stoichiometric Iron-Mediated Reactions. 
 
Schulze and co-workers presented iron-mediated ring-opening of non-activated VCPs 
leading to either α,β-unsaturated ketones or conjugated dienes (Scheme 6).52 The nature of this 
chemodivergent transformation was mainly influenced by the electronic properties of the alkene 
moiety of VCPs 32. Thus, when electron poor alkenes were employed the VCP ring opening 
led to conjugated dienes 36 (Scheme 6b). Conversely, electron neutral alkenes led to the 
formation of α, β-unsaturated ketones 39. The postulated mechanism for this reaction starts CO 
dissociation and direct oxidative addition to the cyclopropyl C–C bond leading to the σ-alkyl 
π-allyl complex 33. Depending upon on the electronic nature of the π-allyl moiety, the 
mechanism diverges to either one of the following two mechanisms: a) for electron withdrawing 
substituents at the π-allyl 35, the reaction proceed through β-hydride elimination affording the 
corresponding conjugated diene 36; b) for electron neutral substituents at the π-allyl, the 
reaction proceeds through a CO insertion and reductive elimination to afford a β,γ-unsaturated 
ketone which isomerizes in situ to the corresponding α,β-unsaturated one 39. 
 
Scheme 6. Iron-promoted ring-opening of non-activated VCPs. 
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Gold-Catalyzed Reactions. 
In 2011, Barluenga and co-workers reported a gold(I)-catalyzed, chemodivergent, ring-
opening reaction of alkynylcyclopropanes 40 (Scheme 7).58 In the absence of an alcohol as a 
cosolvent, the selective cleavage of the non-activated C–C bond resulted in the formation of 
alkynylcyclohexadienes 46 in 47–88% yield. On the other hand, when an alcohol was added 
the bicyclic compounds 44 were obtained instead. Curiously, the reaction led to scrambling 
between the substituents R1 and R2 employed in the starting material on both products 44 and 
46. The mechanistic rationale for this reaction started with the coordination of [AuI] species to 
form 41. This intermediate scrambles R1 and R2 via a reversible 6-endo-dig cyclisation and 
cation rearrangement (42 and 43). In the absence of an alcohol, the reaction proceeds through 
an irreversible 3-exo-dig nucleophilic attack of the σC–C bond connecting the two bridgehead 
carbons of the bicycle. The ring opening of non-activated C–C bond results on the formation of 
intermediate 45, which eliminates [AuI] leading to the dihidrobenzenes 46. If, however, an 
alcohol is used as cosolvent, the cationic intermediates 42 are trapped and, upon 
protodemetallation of the resulting alkenylgold(I) complex, lead to the formation of the bicyclic 
compounds 44.  
 
Scheme 7. Gold (I)-catalyzed ring-opening of VCPs. 
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Rhodium-, Ruthenium-, Nickel and Cobalt-Catalyzed Reactions. 
Perharps the most popular application of VCPs is on rhodium catalyzed formal 
cycloaddition reactions.90 In 1995, Wender and co-workers reported the first such rhodium 
catalyzed ring-opening [5+2]-intramolecular cycloaddition of VCPs and alkynes.61 This 
versatile strategy was since extended to other systems and found application in total synthesis 
of natural products.63 Some of these developments will be herein discussed to illustrate modern 
implementations thereof.62–64,66–70 The general mechanistic picture of ring opening and 
subsequent cycloaddition for these reactions is illustrated in Scheme 8. Coordination of VCPs 
and alkynes to the transition metal can lead to either direct C–C activation via oxidative addition 
(47) or oxidative cyclization leading to an α-cyclopropyl organometalic species (8). Regardless 
of the first step, the same metalacyclooctadiene 9 is achieved on the second step, through either 
β-carbon elimination in the case of 8 or migratory insertion in the case of 47. The 
metallacyclooctadiene 9 can then follow two mechanistic pathways: reductive elimination, 
affording cycloheptadienes 48, or β-hydride elimination affording an alkylmetalhydride 49 that 
delivers the corresponding triene 50 upon reductive elimination.  
 
Scheme 8. Different mechanistic routes of ring-opening processes delivering cycloadducts 
and dienes. 
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In 2002, Wender developed a general procedure for rhodium-catalyzed ring-opening 
and subsequent [5+2]-cycloaddition of non-activated VCPs delivering multifunctionalized 
hexahydroazulenes and heterocyclic derivatives thereof (Scheme 9a).64 In comparison with 
other rhodium catalysts like the Wilkinson’s catalyst ([RhCl(PPh3)3]), where longer time and  
 
Scheme 9. The inter- and intramolecular [5+2]-cycloadditions of VCPs with different π-
systems. 
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harsher reaction condition was required, 52 was found the most general and powerful rhodium 
complex for inter- and intramolecular [5+2]-transformations, providing the desired product 53 
in excellent yields. 
The same group reported the intermolecular [5+2]-transformation of non-activated 
VCPs with different alkynes in the presence of [Rh(CO)2Cl]2 providing cycloheptadiene 56 in 
49–93% yields (Scheme 9b).66 Curiously, unsubstituted VCPs required longer reaction time 
and delivered reduced yields in this transformation, when compared to VCPs containing a 
quaternary carbon. This was attributed to steric effects that destabilize conformation I over III 
(Scheme 9b). This facilitates the C–C bond cleavage that leads to the Z-allyl intermediate II, 
which, as opposed to the E-allyl intermediate IV, is able to deliver the desired cyclodienes 56. 
Wender and co-workers also presented intramolecular [5+2]-cycloadditions between 
vinyl cyclopropanes and allenes, using Wilkinson’s catalyst (Scheme 9c).67,68 The cis fused 
system 58 were formed as major in 68-93% yield. Moreover, cycloaddition of chiral allenes 
proceeded with complete axial to central chirality transfer. 
In 2007, Yu and co-workers presented the rhodium-catalyzed [5+2+1]-cycloaddition 
reaction of VCPs and CO (Scheme 10a).[72] The oxidative addition of the rhodium(I)-catalyst 
onto 59 generated rhodacyclohexene intermediate 60. The subsequent migratory insertion 
 
Scheme 10. Rhodium-catalyzed [5+2+1] and [5+1] cycloaddition of VCPs with CO. 
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into the alkene moiety led to 61. Next, the CO insertion process formed the intermediate 62. 
Finally, reductive elimination of 63 resulted on the 8-membered heterocyclic compound 63 in 
high diastereosselectivity (20:1). The reaction scope employed various substituted VCPs 
demonstrating high functional group tolerance. This two component rhodium-catalyzed 
reaction is now widely employed in total synthesis to deliver complex natural products like (+)-
asteriscanolide 64.77 
In 2011, the same group reported rhodium-catalyzed [5+1] cycloaddition of non-
activated VCP 65 and CO (Scheme 10b).[78] The cycloaddition of VCPs in the presence of 
[Rh(dppp)]OTf catalyst delivered a mixture of regioisomers 66 and 67, where 60 was identified 
as a major product in 41–68% yields. On the other hand, the selective ring-opening and [5+1]-
cycloaddition could also be employed on the synthesis of 67 when [Rh(dppp)]SbF6 was used 
as catalyst and the reaction was further treated with DBU. In this case, high yields and 
selectivities could be obtained.  
Ruthenium-catalyzed formal [5+2]-cycloadditions of VCPs are efficient routes for 
natural product synthesis offering short and atom-economical ways to deliver complex 
polycyclic structures with excellent yields and stereo and regiocontrol.[61,82,83,85,86]B. M  Trost and co-
workers reported one such reaction in high yields, regio- and diastereoselectivity (Scheme 
11a).82 The mechanistic proposal for this reaction involves oxidative cyclization followed by β-
carbon elimination (Scheme 8). Both electronic and steric factors influenced the selective ring-
opening of the cyclopropyl ring. Cis-cyclopropanes bearing electron-withdrawing substitution 
led to 69 as a single isomer. In contrast, trans-cyclopropanes delivered mixture of the two 
isomers 69 and 70.  
When different diastereoisomers were applied to the ruthenium-catalyzed [5+2]-
cycloaddition of Scheme 11 b, contrasting results have been observed. Cycloaddition product 
72 was obtained in 73% yield, when E isomer was employed. In contrast, the use of Z olefin 
provided diene 73 as a major product in 78% yield.  
The construction of fused tricyclic seven membered ring 75 was reported utilizing the 
same ruthenium catalyzed [5+2]-cycloaddition methodology (Scheme 11c). Despite of the 
steric hindrance on the cyclopropyl ring, the tryclyclic products were obtained in good to 
excellent yields and diastereoselectivity.82 
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Scheme 11. Ruthenium-catalyzed intramolecular [5+2]-cycloadditions of VCPs. 
 
In 2004, Louie reported the nickel-catalyzed ring-opening of non-activated VCPs 76 
furnishing various heterocyclic adducts (Scheme 12).87 The selective, high yielding, preparation 
of cyclopentadienes 77 was achieved in the presence of 1,3-di-tertbutylimidazolidene (ItBu). In 
addition, striking steric effects of the alkynyl substitution, R in 41, in the presence of bulky 
ligand (SIPr) were observed. Thus, if a sterically unhindered alkyne is employed, like when R 
= Me in 76, cyclopentane 77a was observed. On the other hand, a mixture of 77 and 78 was 
obtained after introducing more sterically hindered groups like Et or iPr in the substrate 76. 
Finally, a large group substitution on alkynyl led to sole bicyclic seven-membered ring 79.  
A plausible mechanism for this transformation is illustrated in Scheme 8. According to 
which, nickel-catalyzed transformation of cyclopropylenyne 8 would generate a 
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nickelacyclooctadiene 9 (see Scheme 8), much to the liken of the rhodium and ruthenium 
intermediates previously discussed. β-Hydride followed by reductive elimination would then 
lead to the triene 77 (49 in Scheme 8).88 In contrast, if both ligand and substituent R in 76 are 
bulky, β-Hydride would be unfavored, and reductive elimination would lead to the bicyclic 
seven-membered heterocycle 78, which isomerizes in situ to afford 79.  
 
Scheme 12: Nickel catalyzed ring opening and subsiqent cycloadiition of VCPs. 
 
The same group also reported nickel-catalyzed ring-opening and further isomerization 
of activated and non-activated VCPs.89 The resulting cyclopentene products are a core structure 
of many biological systems (Scheme 13 a).91 The ligand choice was crucial in performing the 
isomerization step and no reaction was observed in its absence. Thus, the combination of Ni(0) 
and a sterically hindered N-heterocyclic carbene (NHC) led to satisfactory results. Moreover, 
the substitution pattern of the alkene moiety of VCPs was crucial for the reaction rate. While 
1,1-disubstituted alkenes led to the desired products 83 in good yield, trisubstituted as well as 
1,2–dissubstituted olefins reacted sluggishly or not at all. The proposed mechanism starts with 
the oxidative addition of nickel complex to the VCP forming the nickelacyclobutane 81, a [1,3]-
metal-shift would then provide nickelacyclohexene 82, which in turn would undergo reductive 
elimination to generate the five-membered carbocycle 83.  
Suginome and Ito reported the nickel-catalyzed ring-opening silaboration of non-
activated VCP 80 yielding products 89 in high regio- and stereoselective (Scheme 13).37 The 
proposed mechanism involves coordination of cyclopropane into nickel complex 86 leading to 
intermediate 87. Subsequent migratory insertion and β-carbon elimination leads to the allyl 
nickel complex 88, which would then undergo reductive elimination to deliver the final product 
89 as the exclusive regioisomer.  
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Scheme 13. Nickel-catalyzed ring opening and cycloaddition. 
In 2018, Yoshikai and co-workers, reported a cobalt catalyzed intramolecular reaction 
between non-activated VCP and alkynes delivering bicyclic hexahydroazulenes and 
heterocyclic derivatives thereof with high chemo-, regio- and stereoselectivity (Scheme 14).92 
In the examples illustrated in Scheme 14, ligand- and substituent-controlled selective 
transformations of VCPs were achieved. In this work Yoshikai demonstrated that the choice of 
solvent and cobalt complex allows control over two competitive pathways, [5+2]-
cycloadditions and homo-ene reactions (Scheme 14). Thus, utilizing the noncoordinating 
solvent 1,2-dichloroethane in combination with diphosphine ligand led to cyclopentane 
products 91 in excellent yields and enantioselectivities. While, the weakly coordinating solvent 
dimethylacetamide resulted in [5+2]-cycloadducts 92 with high yields. 
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Scheme 14. Cobalt-catalyzed, solvent-controled, ring opening of VCPs. 
In summary, the unique ability of transition metals to cleave a non-activated C–C bond 
on a VCP ring is a valuable transformation in organic chemistry. Moreover, the selectivity in 
these reactions can be tuned by the appropriate selection of, metal complexes, ligands, substrate 
substituent patterns, and solvents. This flexibility allows for a richness of mechanistic pathways 
and, perhaps more importantly, synthetic applications. For this reason, the synthesis of VCP 
containing molecules and their further transformation are highly desirable in synthetic 
chemistry and natural product synthesis. 
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B. Main Part  
1- Heck cross-coupling arylation of monocyclopropanated heterocycles 
1.1 Introduction: The synthesis of cyclopropanes  
Cyclopropane subunit is one of the most occurring moieties in organic synthesis.1,2  
Cyclopropane-based molecules are widely utilized as versatile synthetic building blocks in 
organic transformations for the synthesis of complex structures. 2,3 Besides, they are a rather 
kinetically inert and resistant to bond cleavage unless activated. The substitution of three-
membered ring systems with donor and acceptor groups results in the tremendous increase 
of its reactivity.4a,4b In early 70s and 80s of last century, pioneering studies of Wenkert and 
Reissig demonstrated the first synthesis of donor–acceptor (D–A) cyclopropanes.4 
Generally, two possibilities of donor and acceptor groups substitution at the cyclopropane 
ring are known: vicinal I and geminal II. The highly polarized chemical bond between a 
vicinally substituted cyclopropane ring with donor and acceptor groups respectively 
promoted heterolytically cleavage giving rise to 1,3-zwitterion synthons: this process is 
known as “push-pull” effect. The positive charge in the resulting 1,3-zwitterionic structure 
is stabilized by the donor group and the negative charge is stabilized by the acceptor.4 d, 4e, 
4？-i On the contrary, a geminal substitution with donor and acceptor groups II is less popular 
in synthetic chemistry but very often utilized in medicinal chemistry since they display 
important structural motifs.5 
 
 
Figure 1. “Push–pull” effect on in vicinally positioned D-A cyclopropanes 
I and geminal cyclopropanes II. 
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Over the past few decades, the area of donor–acceptor cyclopropanes has been massively 
expanded leading to various transformations such as rearrangements, cycloadditions and ring-
opening reactions.6-15 The high importance of heterocyclic moieties in natural product synthesis 
attracted many synthetic chemists to develop a general methodology for cyclopropanated 
heterocycles construction. Among all reported methods,16-26 the transition-metal-catalyzed 
cyclopropanation of olefinic bonds using diazo compounds as a carbene source is one of the 
best developed and employed transformations.1a, 27, 28  
 
 
Scheme 15. Previous synthesis of enantioselective synthesis of monocyclopropanated 
pyrroles. 
This method was used to facilitate the synthesis of various highly functionalized 
enantiomerically enriched heterocyclic cyclopropanes bearing donor–acceptor groups on the 
cyclopropyl unit. 29-31 Wenkert 29 and Fowler30 studied highly diastereoselective 
cyclopropanations to access similar types of cycloadducts such as 96 and 97, although only few 
examples of enantioselective cyclopropanations31 have been realized by that time. Over the last 
decade, Reiser and Davies studied the general methods of heterocycles cyclopropanation with 
diazo esters in the presence of metal complexes illustrated in Scheme 15. Copper/aza-
bis(oxazoline) ligands complexes catalyzed reaction between pyrroles and acceptor-substituted 
diazo esters delivered cyclopropanated pyrroles 96a-Me in lower enantioselectivity and 
moderate yields, while more sterically hindered diazoester, bearing tBu substitution, gave rise 
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to 96a in excellent enantiomeric excess >99% and 37% yield (Scheme 15).32-37  The same 
catalytic system was employed in 2- and 3- ester-substituted furans, delivering 97b–c 
cyclopropanes with excellent enantioselectivity (91–95% ee), albeit in moderate yields (38–
61%).35–37 Alternatively rhodium complexes, Rh2(S-DOSP)4 and Rh2(S-TCPTTL)4 also 
demonstrated remarkably efficiency for the cyclopropanation of substituted furans, using a 
diversity of aryl diazoesters.32, 37 Recently, Davies and co-workers reported the ability of 
aryldiazoacetates to absorb visible light, to proceed photolysis by blue light irradiation in the 
presence of various trapping reagents such as styrene, carboxylic acids, amines, alkanes and 
arenes.38 The developed general procedure was applied to give an easy excess to the highly 
functionalized cyclopropanated pyrroles38 and furans15 in excellent yields, under mild 
conditions. (96, 97, Scheme 15) Although, it should be mentioned that this method does not 
apply for the synthesis of enantiomerically pure products. 
The demonstrated cyclopropanated pyrroles, which contain a vinyl cyclopropane unit, are 
ideal intermediates for further ring opening transformations delivering valuable nitrogen 
containing heterocycles, which will be discussed in the following sections.39,40,44,45 Therefore, 
the synthesis of new stereoselective substituted-cyclopropanated pyrroles have attracted 
continuously attention.  
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1.2 The synthesis of new 3-substituted cyclopropanated pyrroles. 
To expand the scope of these useful building blocks, Cu(II)-catalyzed cyclopropanation 
between 1H-pyrrole-1,3-dicarboxylate 98 and diazo ester 95a was investigated (Scheme 16). 
Different reaction conditions were tested in order to obtain the desired 3-substituted pyrroles. 
In the absence of a ligand, very low yield of product 99 was observed (5%). Instead, the 
combination of Cu(OTf)2 catalyst with ligand L-2 led to an important increase in the product 
yield. 
 
Scheme 16. The cyclopropanation of 98 with diazo ester. 
Low reaction temperature and slow addition rate of diazo acetate were also important for the 
efficiency of cyclopropanation, furnishing the desired 3- substituted cyclopropanated pyrrole 
99 in 42% yield. However, further investigation of enantioselective 3-substituted cyclopropane 
99 formation in the presence of other chiral ligands is required.  
Considering the importance of formyl and acetyl substitution, which can be later 
transformed to various functional groups, the direct formylation and acetylation of 
cyclopropanated pyrroles was investigated (Scheme 17). 
 
  
Scheme 17. The synthesis of formyl substituted cyclopropanated pyrroles. 
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The formyl substituted cyclopropanated pyrroles synthesis in the presence of in situ 
generated Vilsmeier reagent (VR) is widely utilized for the formylation of activated aromatic 
and heteroaromatic compounds.42  
In the first attempt of the preparation of Vilsmeier reagent from N, N-dimethylformamide 
(DMF) and phosphoryl trichloride (POCl3), the decomposition of the starting material was 
detected, either under the reflux or at room temperature (Table 1, entry 1 and 2). However, the 
in situ generation of the Vilsmeier reagent from oxalyl chloride and DMF led to the desired 
products 100a and 100a-Me in high yields and with high selectivity. 
Table 1. The conditions for formylation of cyclopropanes.a 
Entry Conditions Yields % 100a/100a-Me 
1. DMF, POCl3, 0 
oC; DCE, reflux, 30 min trace 
2. DMF, POCl3, 0 
oC; rt, DCE, 3 h 19 (100a)b 
3. DMF, (COCl)2, 0 
oC; rt, DCE, 1h, Na2CO3 75/ 71
 b 
a) DMF (1 mL), DCM (4 mL), oxalyl chloride (0,6 mmol, 1.2 equiv), at 0 °C, 96a, 96a-Me (0.5 mmol), 1 h; b) 
isolated yield based 
The reactivity of the Vilsmeier reagent was crucial for desired selective transformation.44 It 
is known, that VR prepared from POCl3 and DMF shows very high reactivity (Scheme 18 a), 
which supposedly caused the ring opening of cyclopropane and its further decomposition, while 
the second method of VR generation (Scheme 18 b) provides milder condition allowing the 
selective formylation of 96a. 
Scheme 18. The in-situ generation of Vilsmeier reagent. 
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Having the formylated cyclopropane products 100a and 100a-Me, next the acylation of 
96a-Me was investigated. The employment of an acid chloride in the presence of base led to 
the undesired ring opening reaction of 96a-Me (Table 2, entry 1). Thus, another procedure was 
followed: the Friedel crafts acylation46 of 96a-Me in the presence of various Lewis acids was 
screened. No reaction was observed in the presence of a Lewis Acid Sc(OTf)3 and acetyl 
chloride in DCM, while tin(VI) chloride (Table 2, entry 3) resulted in deprotection and further 
undesired ring opening of cyclopropane ring delivering compound 102 in 40% yield 
(Scheme  19). Based on this result, we assumed that deprotection of Boc group proceeded in 
acidic condition leading to the undesired ring opening, for that purpose we switched the NBoc 
group to a NTs 96b-Me. However, in this derivative the same undesired ring opening was 
observed. The use of other synthetic methods is required for the desired acylated cyclopropane 
formation. 
 
Scheme 19. Further attempts to synthesis formyl and acetyl cyclopropanated pyrroles. 
Table 2. Further attempts to synthesis compound 103. 
 
 
Entry Conditions Yields % 103 
1. Acid chloride (1.5 equiv), K2CO3 (2 equiv), ACN, rt to 50 
oC trace 
2. Sc(OTf)3, Acid chloride, DCM, rt, 3 h trace  
3. SnCl4, Acid chloride, DCM, r.t, 30 min n.d. 
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1.3 The ring opening of cyclopropanated pyrroles 
Ring opening reactions of donor-acceptor-substituted cyclopropanes is the most fundamental 
transformation for three membered ring systems.6–8 The combination of release of cyclopropane 
ring strain (approx. 27 kcal/mol) as well as matched electronics along the donor–acceptor 
substituted carbon–carbon bond gives rise to heterolytic cleavage of the latter, generating a 1,3-
dipole intermediate that can undergo manifold follow-up transformations such as 
cycloadditions, rearrangements, pericyclic reactions or reactions with electrophiles and 
nucleophiles.9–12  
 
Figure 2. Exo- and endo-bond cleavage in monocyclopropanated pyrroles and furans I. 
The cyclopropanated heterocycles I 13-15,33,30 (Figure 2) are ideal starting materials for ring-
opening process. This ring opening can happen at the exocyclic carbon-carbon cyclopropane 
bonds, due to the donor lone pair of the heteroatom / π-C–C bond and the π*-acceptor orbital 
of the carbonyl ester acceptor group are aligned in parallel with the σ*-C–C-orbital, which 
facilitates the push-pull effect between these groups. Consequently, both reaction pathways 
have been demonstrated in various synthetic applications.13, 14 
 In 2017, Reiser and co-workers reported the methodology of activated exocyclic C–C bond 
cleavage of cyclopropanated pyrroles delivering enantioselective homo-β-proline 105 in 
quantitative yields (Scheme 20).33 a 
 
Scheme 20. The ring cleavage of activated exocyclic C–C bond in 96a. 
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Rh/C catalyzed hydrogenation of 96a at atmospheric pressure provided 104 in quantitative 
yield. The intermediate 104 suffered the ring-opening through the activated exocyclic bond and 
deprotection of the Boc group under TFA/Et3SiH conditions resulting in 105 in excellent yield 
and enantioselectivity.43 
In contrast, the ring-opening of the non-activated, endocyclic cyclopropane bond in 96a is 
challenging given that the respective σ*-C–C-orbital is orthogonal to the donor atom in the five-
membered ring. Such ring-opening cleavage would be the most important from synthetic point 
of view, since it would open up the possibility for regio- and stereoselective synthesis of 
valuable six membered nitrogen and oxygen containing heterocycles.  
The synthesis of dihydropyridines and pyran derivatives has obtained much attention due 
to valuable synthetic and biological applications (Figure 3).44, 45 1,2-dihydropyridines are 
important structure motives as they can easily give access to a highly functionalized pyridines, 
which are in a high demand in current materials, agrochemicals and pharmaceuticals, albeit 
challenging in preparation due to the selective functionalization of pyridine moieties.45f 
 
Figure 3. Alkaloids, azasugars and drug candidates based on pyridine moiety. 
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1.4 Reaction design based on early observation of the desired ring opening 
The first indication that endocyclic ring-opening indeed would have occurred, was 
detected during the hydrogenation of 96a, being readily available in diastereo- and enantiopure 
form, next to the expected adduct 104 gave rise to piperidine 107 as a minor byproduct (Scheme 
21).43 Since piperidine 107 could not be generated from 104 neither under the reaction 
conditions nor under harsher conditions (e.g. changing from atmospheric hydrogen pressure to 
60 bar) or switching to various transition metals like platinum, iridium or rhodium catalysts, we 
summarized that 104 is not on the reaction pathway to 107. Instead, we proposed that 
intermediate 106, generated after hydropalladation of 96a, underwent the expected reductive 
elimination 104, is also able proceed endocyclic ring opening (Scheme 21). 
 
Scheme 21. Hydrogenation of 96a. 
Therefore, we assumed that the desired ring expansion of 96a, 96a-Me to dihydropyridines 
should become possible via an organopalladium intermediate of type 108 in which reductive 
elimination of Pd(0) but also β-hydride elimination of HPdX would be facilitated (Scheme 22). 
Instead, migration of PdX with concurrent cyclopropane ring opening, which has been 
described in a few previous cases,47, 48 could occur leading to 109. In order to close the catalytic 
cycle, a trans-β-hydride elimination of HPdX occurred obtaining 110. This process is feasible 
with the assistance of the neighboring nitrogen donor via a base mediated elimination of the 
fairly acidic H+, being allylic and next to an ester group R, and [PdX]–.49 
 
Scheme 22. Heck arylation of 96a, 96b with concurrent endocyclic cyclopropane bond 
cleavage. 
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Herein, we report that palladium catalyzed Heck-coupling reactions of cyclopropanated 
pyrroles provided the desired ring expansion with concurrent stereoselective introduction of an 
aryl or heteroaryl moiety from the exo-face of the bicyclic system. In this way, 6-aryl-1,6-
dihydropyridine-3-carboxylates can be accessed, and they can be further transformed with high 
diastereoselectivity to tetrahydropyridines or nipecotic acid derivatives as well as to ortho-
arylated pyridines.15 
 
1.4.1 Optimization studies 
Based on previous described reports of palladium-catalyzed Heck-coupling reaction with 
dihydrofurans and allylated cyclopropanes,50 it was carried out a search of the suitable reaction 
conditions. We started our studies with the reaction between 96a and p-methoxyiodobenzene 
(Table 3). Different reaction conditions including various palladium sources, solvents and 
reaction temperature were screened (Table 3). The employment of Pd(PPh3)4 in THF and 
NaHCO3/TBACl yielded the product in only 10%, while the reactions in the presence of 
Pd2(dba)3 CHCl3 and Pd2(dba)3 showed much better product yields (Table 3, entry 6 and 7). The 
influence of different solvents was also important for successful ring opening. Thus, the reaction 
carried in ethylene glycol resulted with no product formation, whereas benzene and toluene 
increased the yield delivering product in 66% and 67% yields, respectively (Table 3, entries 12 
and 13). The combination of inorganic base (NaHCO3) and tert-butyl ammonium bromide 
(TBAB) successfully increased the product yield. In the following reaction the role of tert-butyl 
ammonium bromide was very important. TBAB acts as a solid-liquid phase-transfer agent, it 
can also act as a stabilizing additive to increase the lifetime of underligated Pd(0) species to 
match slower oxidative addition rates with less reactive substrates.51 Pd2(dba)3 was identified 
as a suitable catalyst in combination with tetrabutylammonium bromide (TBAB, 2 equiv), 
NaHCO3 as base (2.5 equiv) and toluene as solvent to cleanly form 110a. While typically the 
alkene component is employed in excess (3–5 equiv) in Heck couplings, employing 96a and 
iodobenzene in equimolar amounts nevertheless gave an appreciable yield (61%, Table 3, entry 
20) of 110a. Considering that one of the substrates might be more valuable in a given 
transformation, employing the excess of iodobenzene yielded in 74% yield (Table 3, entry 21), 
while the excess of 96a provided 110a in 81% yield (Table 3, entry 22). Expectedly, the absence 
of a palladium source did not deliver the desired product 110a (Table 3, entry 23). 
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Table 3. Optimization of the reaction conditions. 
 
Entry Catalyst Solvent Base/Additive Yield (%)110a a,b 
1 Pd(OAc)2 THF NaHCO3/TBACl 30 
2 PdCl2 THF NaHCO3/TBACl 35 
3 Pd(dba)2 THF NaHCO3/TBACl 45 
4 Pd(PPh3)2Cl2 THF NaHCO3/TBACl 43 
5 Pd(PPh3)4 THF NaHCO3/TBACl 10 
6 Pd2 (dba)3*CHCl3 THF NaHCO3/TBACl 48 
7 Pd2 (dba)3 THF NaHCO3/TBACl 50 
8 Pd2 (dba)3 DMF NaHCO3/TBACl 65 
9 Pd2 (dba)3 Dioxane NaHCO3/TBACl 55 
10 Pd2 (dba)3 (CH2OH)2 NaHCO3/TBACl - 
11 Pd2 (dba)3 Benzene NaHCO3/TBACl 66 
12 Pd2 (dba)3 Toluene NaHCO3/TBACl 67 
13 Pd2 (dba)3 Toluene Na2CO3 TBACl 68 
14 Pd2 (dba)3 Toluene NaHCO3/No TBACl 30 
15 Pd2(dba)3 Toluene DIPEA/TBACl 67 
16 Pd2(dba)3 Toluene Proton Sponge
 /TBACl 29 
17 Pd2(dba)3 Toluene TEA/TBACl 64 
18 Pd2(dba)3 Toluene DMAP/TBACl 34 
19 Pd2(dba)3 Toluene 
NaHCO3/p-
NO2PhCO2H 
21 
20 Pd2(dba)3 Toluene NaHCO3/TBAB 61
c 
21 Pd2(dba)3 Toluene NaHCO3/TBAB 74d 
22 Pd2(dba)3 Toluene NaHCO3/TBAB 81e 
23 No Catalyst Toluene NaHCO3/TBAB - 
a) Condition I: 96a (0.5 mmol), Ar–I (0.75 mmol, 1.5 equiv), catalyst (3 mol%), base (2.5 
equiv), additive (2 equiv), solvent (1.5 mL), N2, 80 oC, 24 h, yield based on 96a; b) NMR yield 
using diphenylmethane as internal standard; c) 96a (1 equiv)/Ar–I (1 equiv); d) isolated yield 
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based on 96a; e) Condition II: Ar–I (0.5 mmol, 1 equiv), 96a (1.5 mmol, 3 equiv), catalyst (3 
mol%), base (2.5 equiv), additive (2 equiv), solvent (1.5 mL), N2, 80 oC, 24 h, isolated yield 
based on Ar–I. 
 
1.4.2 Substrate scope 
With the optimized reaction conditions in hand, we next explored the generality of the reaction 
scope (Scheme 9). Both aryl iodides (for 110a–110c, 110e-Me, 110g, 110h–110l, 110r) and aryl 
bromides (for 110d, 110f, 110i, 110m–110q) could be efficiently coupled with 96 to deliver the 
desired dihydropyridines 110. The electron rich aryl halides such as like p-methoxy benzene 
and 1-bromo-3,4-(methylenedioxy) benzene gave higher yields 74% and 67% respectively 
(110a and 110f), while electron deficient (110j–l) and electron neutral ones with a phenyl, 
 
Scheme 23. Substrate scope for the synthesis of 2,5-disubstituted-1,2-dihydropyridines. 
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naphthyl or phenanthryl moiety (110g–110i) also performed well in the coupling/ring-opening 
cascade. It should be noted that coupling of monocyclopropnated pyrrole with p-NO2 benzene 
iodide was carried out at 65 oC, while higher temperature resulted in aromatized product 
formation. 
Notable, as demonstrated with the synthesis of (–)-110a (proof of absolute stereochemistry via 
(+)-122, vide infra), using enantiopure (–)-110a (97% ee), this transformation proceeds with 
perfect chirality transfer, in which the Heck-arylation occurs from the convex face of the 
bicycle.  
 
Scheme 24. Substrate scope for the synthesis of 2,5-disubstituted-1,2-dihydropyridines: a) 
Condition I (Table 3a); b) Condition II (Table 3b). 
Considering the high importance of functionalization of heteroarenes, different heteroaromatic 
moieties were successfully incorporated forming 110m-110q in moderate yields. The increase 
of yields was observed, thus employing Condition II (for more details see Experimental section) 
furnishing 100q in 58% yield. 
Encouraged by these positive results, we added one more level of complexity to this sequence 
with the introduction of an ester or a formyl group into the 3-position of the cyclopropanated 
pyrrole. Despite steric hindrance, the construction of 2,3,5-trisubstituted-1,2-dihydropyridines 
product with moderate to good yields was obtained (Scheme 25). In this case as well the  
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Scheme 25. Substrate scope for the synthesis of 2,5-disubstituted-1,2-dihydropyridines: a) 
Condition I (Table 3a); b) Condition II (Table 3b). 
increase of yields was observed, while employing Condition II (for more details see 
Experimental section) resulting 100r in 73% yield. 
It is known that pyridines are the most widespread heteroarene found in FDA approved drugs 
that contain a nitrogen heterocycle.40 They are also a key structure of many valuable molecules 
utilized in agrochemicals, materials, and ligands for metal catalysts.52–54 As a consequence of 
its importance, direct methods that selectively functionalize pyridine moieties are in high  
 
Scheme 26. One-pot synthesis of pyridines from monocyclopropanated pyrroles 1 and aryl 
halides. 
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demand in the pharmaceutical sciences and beyond. However, they possess considerable 
challenges for their preparation. Classical electrophilic aromatic substitution reactions on 
pyridines as well as metalation-trapping sequences usually require harsh reaction conditions. 
Recent development in transition metal catalyzed C−H activation methodology afforded a 
series of selective reactions at the 2-, 3- and 4-position, respectively.44 The 2-arylated 
dihydropyridines46,47 110 are obviously suitable starting materials for this scaffold, 
nevertheless, ideally a one-pot synthesis of such pyridines from 96 would be desirable. Indeed, 
after the Heck coupling to 110, simple addition of powerful oxidant DDQ to the reaction 
mixture gave rise to the desired 2-arylpyridines 111 (Scheme 26). Yields of 111 were in some 
cases even improved in comparison to the synthesis of the corresponding dihydropyridines 110, 
for example, 111a (X-ray structure is illustrated in Figure 4) and 111b, pointing towards the 
lability of the latter to a certain extent.  
 
 
 
Figure 4: Single crystal X-ray structure of 111a (C = grey, H = white, O = red, N = blue). 
The expanding of the scope for the Heck cross-coupling reaction of monocyclopropanated 
furans 97 and aryl iodides delivering 2-arylated 2H−pyran was also investigated. 15 
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1.4.3 Mechanistic discussion 
The developed synthesis of cyclopropane ring opening triggered by palladium Heck cross-
coupling is an elegant method that showed high tolerance toward functionalization on aryl ring 
as well on cyclopropyl unit bearing acceptor or donor substituents. Thus, the cyclopropanated 
pyrrole derivative 112 bearing an electron donor group on cyclopropyl ring was subjected to 
the reaction conditions described in Scheme 23. Substrate 112 cleanly underwent the ring-
opening reaction, proving that an acceptor substituent for the assumed base induced trans--
hydride elimination is not necessary for desired product formation 113.  
 
 
Scheme 27. Ring opening of cyclopropanated pyrrole bearing electron donating group. 
Based on the previous reports48,51 as well as the obtained results the proposed reaction 
mechanism for the palladium catalyzed endocyclic bond cleavage of cyclopropanated 
derivatives (Scheme 27). The oxidative insertion of the aryl halide to LnPd(0) I generated the 
LnPd(II)ArX species II following carbometallation: from which the migratory insertion on 
96/112, occurred to deliver intermediate III. A facile and rapid migration of the metal over the 
alkyl chain through successive 1,3-hydrogen shifts subsequently led to the selective endocyclic 
ring-fragmentation of III providing intermediate IV, which underwent trans-β-hydride 
elimination to form ring opening products (110 and 113). The carbopalladation of the C−C 
double bond takes place from the sterically less encumbered face of 96, which is a key point 
for desired transformation. Besides the expected product 113, as a result of a formal chain walk 
of palladium with concurrent double bond isomerization the thermodynamically favoured 
conjugated carbonyl compound 114 was also observed.  
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Scheme 28. Proposed catalytic cycle. 
 
To further shed light on the mechanism and the substrate prerequisites, we subjected the 
cyclopropane derivatives 115 to the standard reaction conditions (Table 4, entry 1). No 
conversion was observed with these substrates, which is consistent with the formation of the 
organopalladium intermediate IV that cannot close the catalytic cycle by -hydride elimination.  
 
Scheme 29. Attempts of carbonylative Heck reactions. 
To achieve the ring opening cleavage of substrate 115, carbonylative Heck reactions were next 
attempted.56, 57 There is no doubt that β-hydride elimination is facilitated by the presence of the 
double bond; thus, the absence of β-hydride would make the mentioned process impossible. 
However, 116 can be a suitable intermediate for further CO insertion to generate 117 followed 
by nucleophile attack to form intermediate 118 (Scheme 29). Unfortunately, neither conversion 
of 115 was observed at rt or T= 80 oC, nor if higher reaction temperature (T = 110 oC) and 
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longer reaction time were used, instead the decomposition of 115 was observed (Table 4, entry 
2, 3 and 4). Further studies employing other synthetic methods are required in order to make 
the desired transformation occur. 
 
Table 4. Conditions for desired ring opening of 115. 
Entry Conditions Yield (%)b 118 
1. Standard condition: see Scheme 23 n.d 
2. 4-OMePh-I (1.5 equiv), Pd2(dba)3 (5 mol%), NaHCO3 (1.5 equiv), 
MeOH, CO (1 atm), rt-60 oC, 48h 
n.d 
3. 4-OMePh-I (1.5 equiv), Pd2(dba)3 (5 mol%), NaHCO3 (1.5 equiv), 
MeOH, CO (1 atm), 110 oC, 48h 
traces 
4. 4-OMePh-I (1.5 equiv), Pd2(dba)3 (5 mol%), NaHCO3 (1.5 equiv), 
DMF/H2O= 1:2, CO (1 atm), rt-60 oC, 48h 
n.d 
a) 115 (164 mg, 0.5 mmol), 4-iodoanisole (175 mg, 0.75 mmol, 1.5 equiv), catalyst (3 mol%), 
base (2.5 equiv), additive (2 equiv), solvent (1.5 mL), CO (1 atm), N2; b) determined by NMR  
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1.4.4 Application of 1,2-dihydropyridines.  
Dihydropyridines constitute versatile synthetic building blocks.58-59 Thus, representative 
transformations were carried out,15 which all proceeded with remarkable diastereoselectivity. 
Compounds 110a-Me was selectively hydrogenated to afford tetrahydropyridines 119. In 
addition, cyclopropanation of (–)-110a with methyl phenyldiazoacetate in the presence of 
Rh2(OAc)4 as catalyst give rise to bicycle (+)-120 as a single stereoisomer. The crystal structure 
of (+)-120 proved the absolute stereochemistry (–)-110.  
Further transformations leading to nipecotic acid deriative, as well as dihydroxylation of 110a 
to provide corresponding syn-diol and bromohydrin products were also realized.15 
 
 
 
 
 
 
Scheme 30. Transformations of 1,2-dihydropyridines derivatives. 
Conditions: a) H2 (balloon), Pd/C (10 wt%), MeOH, 25 
oC, 16 h; c) methyl phenyldiazoacetate 
(1.5 equiv), Rh2(OAc)4 (1 mol%), hexanes, 25 
OC, 2 h. 
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1.5 Conclusion 
In conclusion, a highly regio- and diastereoselective palladium-catalyzed Heck cross-coupling 
of monocyclopropanated heterocycles with hetero/aryl halides with concurrent ring opening of 
the non-activated cyclopropane bond has been realized. Almost all literature known reports 
demonstrate activated exocyclic bond cleavage of cyclopropane. In turn, the new elegant 
method of palladium-catalyzed Heck-coupling ring opening of non-activated C−C bond of 
cyclopropane was demonstrated.  
The developed method offers generous functional group tolerance in both heterocyclic 
cyclopropane moieties or aryl/heteroaryl groups giving an access to the highly functionalized 
6-membered N-heterocycles such as dihydropyridines and pyridines widely occurring in 
numerous natural and synthetic products, which are highly desirable in pharmaceutical sciences 
and beyond. The design of this reaction will open up new avenues in the chemistry of donor–
acceptor cyclopropanes. The further scope extension and mechanistic studies of palladium-
catalyzed Heck cross-coupling of monocyclopropanated heterocycles are currently ongoing in 
our group. 
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2. Synthesis of 5-substituted 3-pyrrolidin-2-ones via photoredox catalysis 
2.1 Introduction: Bioactivity and the synthesis of pyrrolidone derivatives. 
5-substituted 3-pyrrolidin-2-ones have special significance since they constitute a core structure 
of many compounds displaying marvelous biological and pharmacological activities:60–62 for 
example (–)-pramicin63, 64 demonstrated good antimicrobial activity against Candida 
parapsilosis, as well as good antibacterial activity against Bacillus subtilis; equisetin- is known 
as an antibiotic, as well as it has a significant cytotoxic and phytotoxic activities; penmacric 
acid- shows significant anti-inflammatory activity against acute inflammation, (±)-9,10-diepi-
stemoamide- used as an anticough agent and also for the treatment of respiratory diseases such 
as asthma and tuberculosis (Figure 5).65 
 
Figure 5. Natural products that contain the fragments of 5-substituted 3-pyrrolidin-2-one 
derivatives. 
The stereoselective transformations of pyrrolidin-2-ones continue to be rare, both in the field 
of organocatalytic synthesis and organometallic catalysis.66,67 The insufficiency of reactions is 
partially due to the challenges in the chemoselective activation of the α, β-unsaturated 
vinylogous system either as a donor or as an acceptor in chemical reactions.66 Satisfactory 
results were demonstrated in the report of Ye and co-workers (Scheme 31 a).67 The highly 
diastereo- and enantioselective synthesis of 5-substituted 3-pyrrolidin-2-ones was performed 
by direct organocatalytic asymmetric vinylogous Michael reaction of α,β-unsaturated γ-
butyrolactam 121 with α,β-unsaturated ketones 121. The corresponding Michael products 123 
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could be obtained with excellent enantio- (95% to 99% ee) and diastereoselectivity (4:1–30:1 
d.r.) but also in excellent yields (75–90%).  
 
Scheme 31. The synthesis of 2-pyrolidones. 
Reiser and co-workers reported exocyclic ring opening cleavage of cyclopropane 124 by radical 
chain process furnishing enantioselective 5-substituted 3-pyrrolidin-2-one (Scheme 31 b).33b 
Enantiopure 96a-Me was utilized as suitable intermediate for the synthesis of corresponding 
compound 124, since the direct employment of 96a-Me in above mentioned process resulted in 
undesired transformation. Firstly, the corresponding bromohydrin was obtained, from 96a-Me 
in the presence of NBS in water. Next, oxidative addition using Jones reagent furnished 124 in 
62% yield. The ring opening of exocyclic bond cleavage of 124 was realized by radical chain 
process employing Bu3SnH and AIBN delivering product 125 in 94% yield and 91% ee. The 
compound 125 was then subjected to further functionalization, obtaining various substituted 
pyrrolidine-2-ones. Besides, the enantioselective synthesis of natural product (S)-vigabatrin 
was demonstrated.   
Reiser and co-workers have also carried out the Lewis-acid-catalyzed a multicomponent 
approach to access cis-4,5-disubstituted pyrrolidinones 128 under microwave (mw) irradiation 
(Scheme 18 c).13c The reaction includes several processes: a Povarov reaction of aromatic 
imines generated from 126 and 127, following the Lewis acid promoted exocyclic ring opening 
of 96a-Me, and finally 1,4-furan ring migration occurred subsequently resulting with the 
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quinoline formation. The synthesized products 128 were obtained in high yields and excellent 
stereoselectivity. 
 
2.2 General concepts of visible-light photoredox catalysis and ATRA reactions 
 
The first discovery of photochemical reactions have been realized at the beginning of the twenty 
century by pioneer Italian photochemist of Armenian origin Giacomo Ciamician.68 During the 
last couple of decades, this fascinating discovery had a number of potential applications, 
emerging the area of photochemistry and photoredox-catalysis as a powerful tool in synthetic 
organic chemistry.69 Significant energy efficiency, simple setup, mild reaction conditions as 
well as replacing toxic or expensive reagents are important features of this class of 
reactions.70,71,72 The photoredox catalyzed reactions have been applied in numerous 
applications in both industry and academia for the preparations of natural products,69,73 drugs74 
and functional materials.75  
The basic principle of photoredox-catalysis is the promotion of an electron transfer to or from 
a substrate, subsequently forming reactive species, which usually followed by the extrusion of 
a leaving group generating neutral radical. The subsequent formed neutral radical acts as the 
active species which initiates a chemical transformation.  
 
Figure 6. Photoredox catalysis including reductive or oxidative pathways. 
The photoredox-catalysis undergoes two different electron-transfer pathways; both the 
“quenching” and the “regenerative” electron transfer can be efficient to give an access to desired 
chemical transformation. Ideally, the two electron-transfer processes are related by the 
substrates or intermediates of the catalyzed reaction and therefore do not require any sacrificial 
electron donor or acceptor, this type of photocatalytic cycles are called redox-neutral.69 In turn, 
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the photocatalyst can be quenched by a sacrificial electron donor or an electron acceptor and 
the reduced or oxidized photocatalyst can act as an oxidant or reductant.  
Visible-light-mediated atom transfer radical addition (ATRA) is one attractive methods of 
chemical transformation in photoredox-catalysis.76,77 Visible-light-catalyzed ATRA reactions 
starts with an electron transfer from a photocatalyst (PC=photocatalyst, such as Cu, Ru, or Ir 
based transition-metal complexes) to 129 (Figure 7). Excited state of photocatalysts I* can 
generate radical R. upon one-electron reduction of 130. The R. radical can react with the olefin 
130 furnishing radical 131, which can get oxidized by PC+ to form carbocation 132 with parallel 
regeneration of the photocatalyst. To form the final product 133, cation 132 recombines with 
X-.69b 
 
Figure 7. Visible-light-mediated atom transfer radical addition process. 
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2.3 The initial attempts of pyrrolidizines alkaloids synthesis 
Initially, we hypothesized that cyclopropane ring opening processes can be mediated by visible 
light (ATRA reactions), which we believed would lead to a new way for the synthesis of 
pyrrolidizines derivatives, a class of important compounds in drug development. 
 
Scheme 32. The proposed approach to synthesis of novel pyrrolidizines alkaloids. 
 
We proposed that electron transfer from PC to 124 would proceed the extrusion of Br-
subsequently generating radical 134, which will be a key step for ring opening process 
furnishing 135 radical intermediate. Further, recombination of Br– could give rise to 136, which 
is a valuable building block for the construction of complex molecules. In addition, radical 135 
could be trapped by various olefins to furnish 137, which can be used as an intermediate for the 
synthesis of pyrrolidizines alkaloids.  
Based on previous observations, we commenced our study utilizing various photocatalysts 
and reaction conditions to carry out the desired transformation (Scheme 33). The reaction of 
substrate 124 with styrene in the presence of fac-Ir(ppy)3 photocatalyst failed to provide desired 
product 137a (Table 5, entry 1). The irradiation of photochemical reactions in the presence of 
[Cu(dap)2]Cl and [Ru(bpy)3]Cl2 catalysts also was unsuccessful. Next, the photoredox reaction 
of 124 with electron-neutral, or electron rich alkenes such as like diphenylethylene 140 and α-
acetoxystyrene 141, as well as with Michael acceptors as, methylvinyl ketone 142, methyl 
acrylates 143 and D-Carvon 144 was tested. In all attempts, the formation of the 137 type of 
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Scheme 33. Photocatalytic study of 124 with the tested alkenes. 
Table 5. Photocatalytic conditions of 124 with the styrene.a 
Entry Photocatalyst Conditions Yield (%)b 
137a 
1. fac-Ir(ppy)3 (2 mol%)  139 (5 equiv), ACN, LED450 nm n. d. 
2. [Cu(dap)2 Cl] (2 mol%) 139 (5 equiv), ACN, LED530 nm trace 
3. [Ru(bpy)3] Cl2(2 mol%) 139 (5 equiv), ACN, LED450 nm trace 
4. fac-Ir(ppy)3 (2 mol%) 139 (5 equiv), ACN /H2O (1:1), 
LED450 nm 
trace 
5. fac-Ir(ppy)3 (2 mol%) 139 (5 equiv), LiBr, DMF/H2O (1 eq.), 
LED450 nm 
trace 
a) 124 (166 mg, 0.5 mmol), 139 (280 mL, 2.5 mmol, 5 equiv), catalyst (2 mol%), additive (2 
equiv), solvent (1.5 mL), LED450 nm or LED530 nm N2, rt, 24 h; b) determined by NMR  
 
products were not observed. Instead compound 145 formed, while oxidative quenching cycle 
was employed. In the presence fac-Ir(ppy)3 the substrate 124 was fully converted forming five-
member ring 145 (X-ray structure of 145 is illustrated in Figure 8), although desired ATRA 
type products 136 or 137 were not observed (Scheme 33).  
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Figure 8. Single crystal X-ray structure of 145 (C = grey, H = white, O = red, N = blue). 
 
2.4 Synthesis of trapping products 
To carry out the formation of trapping products from 124 via photoredox catalysis, electron 
enriched heterocycles were screened under photocatalytic condition illustrated in Scheme 34. 
To our delight, ring opening of 124 with electron-rich heterocycles via oxidative photoredox 
catalysis resulted in the formation of δ-substituted α, β-unsaturated γ-lactams. However, the 
formation of compound 145 was also observed. 
 
Scheme 34. Photoredox catalysis between 124 and furan. 
Table 6. Screening of photocatalyst.a 
Entry Photocatalyst Convertion (%) b 
124 
d.r. (%) 
147b) 
Yields (%) b 
147/145 
1. fac-Ir(ppy)3 (2 mol%) 80 2:1 30/40 
2. Ir(dtbbpy)(ppy)2PF6 (2 mol%) 80 2:1 25/37 
3. [Ru(bpy)3] Cl2 (2 mol%) 80 - trace 
4. Eosyn Y (5 mol%)d 70 - trace 
5. fac-Ir(ppy)3 (2 mol%)
 c) 85 2:1 41/35 
a) 124 (166 mg, 0.5 mmol), 146a (5 equiv), catalyst (2 mol%), ACN (1.5 mL), LED450 nm, N2, 
rt, 12 h; b) determined by NMR; c) 146a (10 equiv); d) LED530 nm. 
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To proceed a selective products formation, different photochemical conditions were screened. 
fac-Ir(ppy)3 was found a suitable photocatalyst. Based on the obtained results, we realized that 
photoinduced ring opening of 124 and subsequent generation of 145 is a very fast process. In 
order to proceed the selective formation of desired product 147, more equivalents of furan were 
added in the presence of fac-Ir(ppy)3, indeed resulting in the rise of product yields (Table 6, 
entry 5). The other reaction parameters: solvent, base and reaction were also tested (Table 7). 
The investigation revealed that DMF was the most effective solvent to promote the reaction 
delivering product in 45% yield (Table 7, entry 4), while the use of other solvents such as 
acetonitrile, 1,2-dichloroethane or dimethyl sulfoxide, resulted in lower yields. In addition, the 
employment of a base in the photochemical reaction induced a rise of the yields of product 147, 
and at the same time the amount of generated compound 145 was decreased (Table 7, entries 
Table 7. Screening of base, solvent and reaction temperature.a 
Entry Solvent Base Temperature 
(oC) 
Conversion 
(%) b 124 
d.r. (%) 
147b) 
Yields (%) 
b 147/ 145 
1. DCM - 24 70 - trace 
2. DMSO - 24 85 2:1 40/ 31 
3. DMF - 24 90 2:1 45/ 30 
4. DMF KH2PO4 24 95 2:1 47/ 29 
5. DMF- K2CO3 24 95 2:1 49/ 28 
6. DMF Na2CO3 24 100 2:1 50/ 27 
7. DMF- Cs2CO3 24 90 2:1 46/ 30 
8. DMF Na2CO3 24 100 2:1 55/ 24 
c) 
9. DMF Na2CO3 24 100 1:1 55/ 35
 e) 
10. DMF Na2CO3 0 100 5:1 65/ 15 
11. DMF Na2CO3 -10 100 7:1 70/ - 
12. DMF Na2CO3 -20 100 7:1 70/ - 
13. DMF Na2CO3 -10 100 7:1 70
f)/ - 
14. g) DMF Na2CO3 24 - - - 
15. h) DMF Na2CO3 24 - - - 
a) 124 (166 mg, 0.5 mmol), 146a (10 equiv), catalyst (2 mol%), base (2 equiv), solvent (1.5 
mL), LED450 nm, N2, rt, 12 h; b) determined by NMR; c) 146a (15 equiv); e) under O2; f) catalyst 
(1 mol%); g) no PC, h) no light. 
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4-8). Indeed, a better yield of 147 was obtained when Na2CO3 was used (Table 7, entry 7). The 
employment of more:15 equivalents of furan resulted in 55% product yield. 
Considering the unsatisfied low diastereomeric ratio of product 147 (2:1) at ambient 
temperature and the formation of undesired compound 145, the reaction was performed at lower 
temperatures. It was found that low temperature was crucial for obtaining high 
diastereoselectivities (Table 6, entries 11, 12, 13). Under these conditions product 147 was 
obtained exclusively in 70% yield and d.r. = 7:1 (entry 11). The yield was retained upon 
treatment with only 1 mol % of fac-Ir(ppy)3 (entry 13). Control experiments confirmed that the 
ring opening of 147 is indeed a photochemically mediated process: if either the photocatalyst 
(entry 14) or the light source (entry 15) were omitted, no yields of desired product were 
observed. Thus, the combinations of 15 equiv of furan, 1 mol % of fac-Ir(ppy)3, 1.2 equiv of 
Na2CO3 in DMF at -10 
oC under the blue irradiation for 20 minutes are the optimal conditions 
for this transformation. 
 
 50 
 
2.4.1 Substrate scope 
 
Scheme 35. The synthesis of 5-Substituted 3-pyrrolidin-2-ones via photoredox catalysis. 
Under the optimized conditions (Table 7 entry 13), the substrate scope of the photochemical 
transformation was investigated (Scheme 35). It has to be noticed that the reaction was 
significantly affected by the electronic effects of substituents. Thus, using N-methylpyrrole as 
a reagent resulted 147d in high yields, although low diastereoselectivity (3:1 d.r.), while N-
pyrrole give rise to 147c in good yield and high diastereoselectivity (8:1 d.r.). The employment 
of N-Boc protected pyrrole led to the compound 147e in low yields and low 
diastereoselectivities, presumablydue to the nature of electron withdrawing Boc substitution 
and its steric hindrance. A 2-methylpyrrole derivative furnished the product 147b in 43% yield, 
3:1 d.r. Finally, the use of furan generated 147a in 70% yield and 7:1 d. r. The cristal structure 
is required to determine the absolute configuration of obtained products.  
The use of other heterocycles such as thiophen, benzofuran, indole, imidazole was also 
investigated. Unfortunately, no desired products were observed in these cases.  
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Scheme 36. The photoreaction of 124 through the oxidative and reductive quenching cycles. 
 
Investigation of the oxidative quenching cycle of the ring opening of 124 employing 1 mol 
% of fac-Ir(ppy)3, 1.2 equiv of Na2CO3 in DMF at -10 
oC under blue irradiation resulted 
compound 145 in 71% yield. In turn, the photoreaction of 124 through the reductive quenching 
cycle, using DIPEA as a sacrificial electron donor led to the compound 148 in 45% yield, 
showing the efficiency oxidative quenching cycle. 
 
 
2.4.2 Proposed mechanism 
 
Scheme 37. Proposed mechanism for photocatalyzed reductive and oxidative cycles. 
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Path A: Oxidative quenching cycle: A plausible mechanism for the formation of product 145, 
involving oxidative quenching cycles has been proposed. Single electron transfer from the 
excited Ir(ppy)3 to 124 led after cyclopropane ring-opening to the radical 150. Oxidation of this 
radical by the oxidized form of the photocatalyst to the corresponding cation 151 followed by 
deprotonation, which yields the product 145 and recover the photocatalyst in its initial state 
completing the catalytic cycle. The mechanism of the formation of radical 135 has been proved 
by utilizing well known radical marker TEMPO with targeting substrate 124 and fac-Ir(ppy)3 
in DMF under visible light irradiation. After 30 minutes the TEMPO trapped intermediate 150 
was detected (see the Experimental section for more details). 
 
Path B: Reductive quenching cycle: The proposed mechanism pathway of formation product 
148 involves generation of the reduced form of the photocatalyst via reduction of its excited 
state with DIPEA (as a sacrificial electron donor). Next the reduced photocatalyst transfers an 
electron to the substrate 124 inducing cyclopropane ring-opening and forming the same key 
intermediate as in the pathway A the radical 135, which is directly converted to the product 148 
via abstraction of hydrogen atom from DIPEA 
 
 
2.3.4 Further transformation attempts  
Next, we were intrigued to facilitate the cascade photocatalytic cyclization between 
substrate 124 and allyl alcohol 154 (the substrates which contains hydrogen source) to form 
cyclized pyrrolidone type product 153 (Scheme 38). The structural analogues of 153 are known 
to be human glutamate transporters EAAT1, EAAT2, and EAAT3, and iGlu receptors.78 
Pharmacological characterization of those Glu analogues has provided important information 
about the binding mode of Glu to Glu receptors and transporters, as well as the structural 
requirements for Glu receptor agonist/antagonist activity, Glu transporter substrate/inhibitor 
activity, and subtype selectivity.78 Unfortunately, no desired product was detected in this 
transformation, while the formation of reductive product 3,4-didehydropyroglutamic esters 148  
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Scheme 38. The formation of isomerized product. 
 
was obtained. We believed that the allylic alcohol 152, which acts as sacrificial electron donor 
by giving a hydrogen in the following photochemical reaction formed 148 (Scheme 38).  
Having developed a new approach to a variety of 5-substituted 3-pyrrolidin-2-one 
derivatives by photoredox catalysis, we then devoted our efforts to exploring further 
transformations, aiming synthesize tricyclic ring systems, which are important skeletons of 
many biologically active compounds. The treatment of 147c with Lewis acid failed to give the 
desired adduct 154, instead the isomerizes product 155 was observed in 45% yields (Scheme 
39). 
 
Scheme 39. The formation of isomerized product 
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2.5 Conclusion 
In summary, the exocyclic ring-opening of α-bromoketone via photoredox catalysis 
delivering pyrrolidone derivatives was studied. Upon irradiation the formation of 
exclusively Michael acceptor 145 was obtained through oxidative quenching from 
substrate 124. Moreover, the corresponding ring opening radical generated from 124 was 
trapped with electron rich heterocycles providing 5-substituted 3-pyrrolidin-2-one 
derivatives, despite the limited substratescope, the formed products were obtained in good 
yields and in some case with high d.r. ratio. On the other hand, photochemical ring opening 
of 124 through the reductive quenching cycle delivered 148, in lower yields than the 
previously reported.33b Despite of this fact, it was an alternative method to avoid the 
employment of replacing hazardous reagent (AIBN).  
The synthesized 5-substituted 3-pyrrolidin-2-ones can serve as valuable 
intermediates in a number of biologically active compounds and might be of importance 
in natural product synthesis due to their potential utility towards construction of complex 
molecules. 
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3. Photoredox mediated direct arylsulfonylation of cyclopropanated pyrrole 
derivatives 
3.1 Literature synthesis of arylated and arylsulfonylated heterocycles. 
Arylated pyrrolidines are structural key motifs present in many natural and synthetic useful 
molecules.80 The core structure of some medicinally important synthetic molecules is built on 
arylated pyrrolidine. As an example, CCK antagonist (RP 66803)80h and angiotensin-converting 
enzyme (ACE) inhibitor80i, j having potential trypanosomal activity should be noted. Apart from 
their pharmacological applications, enantioenriched arylated pyrrolidine frameworks are 
important intermediates in organic synthesis.81 The widespread utilization of arylated 
pyrrolidine derivatives, in both medicinal chemistry and organic synthesis, demands the 
development of novel and applicable methods for their preparation. Over the years diverse 
procedures have been reported for the aryl−heteroaryl bonds construction.82 One of the recent 
methods of aryl−heteroaryl bonds construction is the direct arylation of heteroarenes by C−H 
bond activation via photoredox catalysis. In this section we aimed to develop a photochemical 
method of cyclopropane arylation employing different aryl sources. 
In 2012, König and co-workers developed a metal-free method for the visible-light-
mediated direct C−H arylation of heteroarenes 156 with aryl diazonium salts 157 (Scheme 
40).83 As photoredox catalyst, it was employed the organic dye Eosin Y, which allows the 
reaction to occur at room temperature without using a transition-metal catalyst or base, and 
delivering arylated heteroarene products 158 in high yields. The aryl radical 159 was formed  
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Scheme 40. Literature known visible light mediated direct arylation of heterocycles. 
by SET from the excited state of eosin Y to aryl diazonium salt 157, which followed the addition 
of aryl radical 159 to heterocyclic compound 156 forming radical intermediate 160. Next, 
radical 160 transformed to carbocation intermediate 161 by two possible pathways: i) oxidation 
of the radical intermediate 160 by the eosin Y radical cation to give 161 and ii) the oxidation of 
160 by aryl diazonium salt 157 in a radical chain transfer mechanism. The coupling product 
158 was resulted after deprotonation of intermediate 161, regenerating the aromatic system. 
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3.2 Synthesis of 3-substituted arylated cyclopropane 
 
Utilizing the above-mentioned strategy,83 we commenced our study with the reaction between 
N-carbomethoxypyrrole 96a-Me and diazonium salt 157a under photochemical conditions 
aiming to form the arylated coupling product 162 (Scheme 41).  
 
 
Scheme 41. Proposed C-H arylation of cyclopropanated pyrrole with aryl diazonium salts. 
 
The photochemical reaction between 96a-Me and p- nitrobenzenediazonium tetrafluoroborate 
157a in the presence of Eosin Y in DMSO resulted in unclear reaction mixture. Targeting to 
proceed the direct C−H arylation of cyclopropanated 96a-Me substrate with aryl diazonium 
salts using various photocatalytic conditions was then investigated, but the reactions failed to 
give the desired products (Table 8, entries 1-3). However, an immediate color change was 
observed after mixing the substrate 96a-Me with diazonium salt in DMSO at room temperature 
after 5 minutes in the absence of any photocatalysts and LED source.  
 
Table 8. Screening of base, solvent and reaction temperature.a 
Entry Conditions Yields (%) b 
163 
1. Eosin Y (5 mol%), DMSO, 20 oC, LED 530 nm traces 
2. [Ru(bpy)3] Cl2 (2 mol%), DMSO, 20 
oC, LED 435 nm traces 
3. fac-Ir(ppy)3(2 mol%), DMSO, 20 
oC, LED 435 nm traces 
4 No PC, DMSO, 20 oC, 10 min 13 
5. No PC, DMF, 20 oC, 10 min 15 
6. No PC, DMF, 0 oC, 10 min 20 
7. No PC, DMF, -10 oC, 10 min 33 
8. No PC, DMF, -10 oC, 10 min 31c 
9. NaOAc (1.1 equiv), ACN, 20 oC, 2 h traces 
10. Cu(OTf)2 (0.15 equiv), ACN, 2 h traces 
a) 96a-Me (120 mg, 0.5 mmol), 157a (177 mg, 0.75 mmol, 1.5 equiv), solvent (1.5 mL), N2, 
24 h; b) determined by NMR; c) in the dark. 
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After the purification of the resulting mixture, the formation of compound 163 was isolated in 
13% yield. Since the chemical process was exothermic, the lower reaction temperature favored 
the reaction and when the reaction was performed at -10 ºC in DMF, the product 163 was 
provided in 33 % yield (Table 8, entries 5−7). Further attempts to increase reaction yields by 
transition-metal-free Meerwein arylation84 and classical copper-catalyzed addition of an aryl 
diazonium salt85 to a cyclopropanated pyrroles only led to decomposition of the substrate. 
Firstly, we proposed that the reaction might proceed by nucleophilic attack of enamine to the 
aryl radical 159a, which was formed in DMF solution after dinitrogen extrusion (Scheme 41 
a). However, we found out that it is an unlikely process, while experimental data showed that 
the same reaction with electron-donating substitution on aryl fragment did not afford the desired 
adducts (unclean crude reaction was observed).  
 
 
 
Scheme 42. C−H arylation of 96a-Me with aryl diazonium salts. 
 
Thus, we proposed that formation of product 163, was plausibly promoted due to the electron-
withdrawing effect of nitro group at para-position of the aryldiazonium salt 157a (Scheme 42 
b), which is known to be a very active reagent that stabilizes the aromatic ring by mesomeric 
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effect. As a result, the nucleophilic aromatic substitution is favored and consequent electrophilic 
addition at the C3-position of substrate 96a-Me delivers 164. The following extrusion of N2 
and further deprotonation furnishes the final product 163.  
In 2018, Reiser and co-workers published a visible-light-mediated temperature controlled 
arylation or arylsulfonylation of heterocyclic compounds (Scheme 43).84 Alternatively to 
aryldiazonium salt, in this work arylsulfonyl chloride was utilized as a reagent. This starting 
material has several advantages, they are biocompatible, relatively cheap, commercially 
available and arylsulfonyl chlorides can be stored for longer periods of time under ambient 
conditions.85 In this work the importance of the temperature for the selective visible light 
mediated C−C or C−S bond formation was demonstrated. Thus, at room temperature (23 °C) 
the selective C2-sulfonylation into 167 was realized, resulting 169 in 70−90% yields. While, at 
higher temperature (45 °C), the exclusive C2-arylation products 170 were obtained in 70−76% 
yields.  
 
 
 
Scheme 43. Known temperature control, selective sulfonylation or arylation of heterocycles 
via photoredox catalysis. 
 
 
 
3.3. Synthesis of 3-substituted arylsulfonylated cyclopropanes.  
3.3.1 Optimization studies 
Intrigued by this observation, we next investigated the visible-light photocatalyzed cross-
coupling reactions between arylsulfonyl chloride and substrate 168a. Thus, the reaction at 
50  oC did not yield the desired cross-coupling arylated product resulting in a unclear reaction 
mixture. In turn, the photochemical reaction between substrate 96a-Me and 4-
methoxybenzenesulfonyl chloride 168a at room temperature gave rise to arylsulfonylation 171 
product. Surprisingly, no ring opening was observed, albeit compound 171 can serve as a 
building block for further transformation. To optimize reaction conditions, different 
photocatalysts and reaction conditions were screened. During the photochemical reaction 
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between 96a-Me and 168a, fac-Ir(ppy)3 and Ru(bpy)3Cl2 showed almost the same efficiency 
(Table 9, entries 1 and 4). Therefore, the less expensive Ru(bpy)3Cl2 was chosen as optimal 
catalyst. Switching the solvent did not give satisfying results (Table 8, entries 5−7), while 
the employment of K2HPO4 promoted the formation of arylsulfonylated product in 45% 
yield (entry 11). 
 
 
 
Scheme 44. The synthesis of 3-subsitituted arylsulfonylated cyclopropane. 
 
Table 9. Optimization reaction.a 
 
Entry Photocatalyst Base Solvent Yields (%)b 
171 
1. fac-Ir(ppy)3 (2 mol%) Na2CO3 ACN 33 
2. Ir(dtbbpy)(ppy)2PF6 (2 mol%) Na2CO3 ACN 16 
3. Ir[p-F(t-Bu)-ppy]3 (2 mol%) Na2CO3 ACN 17 
4 [Ru(bpy)3] Cl2 (2 mol%) Na2CO3 ACN 32 
5. [Ru(bpy)3] Cl2 (2 mol%) Na2CO3 DCM 20 
6. [Ru(bpy)3] Cl2 (2 mol%) Na2CO3 DMSO 23 
7. [Ru(bpy)3] Cl2 (2 mol%) Na2CO3 DMF 30 
8. [Ru(bpy)3] Cl2 (2 mol%) NaHCO3 ACN 39 
9. [Ru(bpy)3] Cl2 (2 mol%) K2CO3 ACN 33 
10. [Ru(bpy)3] Cl2 (2 mol%) Cs2CO3 ACN 25 
11. [Ru(bpy)3] Cl2 (2 mol%) K2HPO4 ACN 45 
12 [Ru(bpy)3] Cl2 (2 mol%)
c K2HPO4 ACN - 
13. No PC K2HPO4 ACN - 
a) 96a-Me (120 mg, 0.5 mmol), 168a (135 mg, 0.65 mmol, 1.3 equiv), base (1.5 equiv), solvent 
(1.5 mL), N2, 24 h; b) determined by NMR; c) no light. 
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3.3.2 Substrate scope and proposed mechanism of 3-substituted arylsulfonylated cyclopropanes 
 
The substrate scope of the photochemical transformation was then investigated (Scheme 
44). The reaction was affected by the electronic effects of the substituents on the arylsulfonyl 
chlorides. The arylsulfonyl chlorides bearing electron-withdrawing (171e, 171f) or neutral 
groups (171g) showed slightly lower yields than those bearing electron- donating (171a, 171b). 
Electronic effects of the protecting groups at the nitrogen atom also influenced the efficiency 
of the photochemical process. The more electron withdrawing group Ts afforded 171c only in 
30%, while switching to Boc group 171b delivered the product in 42% yield. 
 
 
Scheme 45. The direct arylsulfonylation of cyclopropanated pyrrole derivatives. 
 
Based on previous literature reports,82−90 a plausible mechanism for the direct 
arylsulfonylation was proposed (Scheme 45). The irradiation of [Ru(bpy)3]Cl2 with visible light 
promotes metal-to-ligand charge transfer state of the photocatalyst generating [Ru(bpy)3]Cl2*. 
A single electron transfer from the excited [Ru(bpy)3]Cl2* to the arylsulfonyl chloride 168g 
affords [Ru(bpy)3]Cl2 and the arylsulfonyl radical 172. The coupling of 172 with a 
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cyclopropanated pyrrole 96a-Me at C3-position would generate the radical on the C2 position 
173, which is favored due to the effective stabilization by nitrogen. Subsequently 173 would 
transform into the corresponding carbocation intermediate 174 by oxidation with the oxidized 
photocatalyst which in turn regenerates the catalyst. Deprotonation of carbocation intermediate 
174 resulted the desired 3-arylsulfonyl substituted pyrrole. The base K2HPO4 was employed in 
the reaction to neutralize the hydrogen chloride generated as a byproduct in the reaction. The 
cyclopropane cleavage was not observed, which could be explained in terms of unfavored 
radical addition at the C2-position, generating a non-stabilized primary radical. 
 
 
Scheme 46. Proposed mechanism. 
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3.3.3 Formation of dimer 
 
It is important to note that the reaction set up was crucial for the desired direct 
arylsulfonylation. The efficient transformation requires first irradiation of photocatalyst with 
aryl sulfonyl chloride 168 and a base following the addition of 96a-Me. Otherwise, the mixture 
of 96a-Me and aryl sulfonyl chloride in ACN gives rise to the quick formation of dimer 175 
(3:1 d.r.), no photocatalyst and irradiation is required for this transformation (Scheme 46). The 
generation of dimers was already described upon treatment under acidic condition with TFA36 
or gold(I) catalysis.92 The possible explanation is that aryl sulfonyl chloride under moisturizing 
conditions generates aryl sulphonyl acid 179 and acid chloride, even small amount of any of 
these acids will facilitate acid catalyze dimerization.  
 
 
 
Scheme 47. Proposed mechanism for the acid-catalyzed dimerization of enecarbamate.  
 
It is known that enamides display two opposing reaction pathways, they can undergo reactions 
with both electrophiles and nucleophiles. The protonation of 96a-Me would give rise to the 
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iminium species 176 which act as electrophiles for the dimer formation. A second molecule of 
96a-Me then acts as nucleophile and attacks the iminium ion to generate 176. The elimination 
of H+ will close catalytic cycle resulting in dimer 175. The resulting product 175 containing 
1,3-diamine framework, can be used as an intermediate in natural product synthesis93 and 
medicinal chemistry.94 The generation of acidic condition can also explain the low yields of 
arylsulfonylated products, since acidic condition beside dimerization can also promote 
undesired ring opening of the cyclopropanated substrates.  
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3.4. Application of arylated and arylsulfonylated cyclopropanes.  
 
 
Scheme 48. Aryl and arylsulfonylated products as a suitable intermediate for the synthesis of 
homo-β-proline derivatives. 
3-substituted aryl and arylsulfonylated products can serve as a suitable intermediate for the 
synthesis of new drug candidates such as homo-β-proline derivatives, GABA uptake inhibitors, 
utilizing in the treatment of neurological and psychiatric disorders, such as anxiety, Parkinson’s 
disease, epilepsy and some forms of schizophrenia (Scheme 47).95 
The synthesized arylsulfonylated products are an interesting building blocks for further 
transformation, allowing to access an important 6-membered nitrogen containing heterocycles 
(Scheme 48). The palladium catalyzed reaction between 171a with 4-iodoanisole was 
conducted to obtain coupling product, albeit the ring opening reaction resulted in pyridine 
product 180 in 43%, with no desired coupling product formation. Albeit, product 180 is a 
valuable intermediate, which contains a key structure of many biological active compounds and 
drug candidates.44  
 
 
Scheme 49. Ring expansion furnishing pyridine derivative. 
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3.5 Conclusion 
The visible-light-mediated reaction between aryl sulfonyl chloride and targeting 
cyclopropanated pyrrole derivatives resulted in direct arylsulfonylation. The reaction set up is 
very important for desired transformation to take place. Thus, photoredox catalysis gave rise to 
C−S bond formation, while employing acidic conditions led to dimerization. In addition, the 
formation of direct arylated cyclopropane was also achieved. The synthesized products 
constitute convenient scaffolds for the synthesis of valuable five- and six-membered 
heterobiaryls, which are important structural motifs frequently found in natural products, 
pharmaceuticals and functional materials.96,97 
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C. Summary  
In this thesis the importance of monocyclopropanated pyrroles as a valuable intermediate 
for the design of highly functionalized five- and six-membered nitrogen containing heterocycles 
has been shown. Previously, the ring-opening of rather activated exocyclic carbon-carbon bond 
of cyclopropanes was realized, while the cleavage of non-activated carbon-carbon bond was 
challenging in the area for the long time. In the first part of the thesis we put our efforts to 
develop the general method of desired ring expansion on cyclopropane ring system (Scheme 
49).  
 
 
Scheme 49. Palladium catalyzed ring-opening of the non-activated cyclopropanes delivering 
valuable six-membered heterocycles. 
Delightfully, highly regio- and diastereoselective palladium-catalyzed Heck cross-coupling of 
monocyclopropanated pyrroles with hetero/aryl halides with concurrent ring-opening of the 
non-activated cyclopropane bond has been realized, delivering highly functionalized 
dihydropyridines and pyridines. The developed general method demonstrated the wide scope 
of transformation between cycloadducts and various aryl and heteroaryl substrates. Despite 
steric hindrance the introduction of an ester or a formyl group into the 3-position of the 
cyclopropanated pyrrole also proceed well in cross-coupling reaction delivering highly 
functionalized dihydropyridines. Notable, employing enantiopure cyclopropanated pyrrole, this 
transformation occurred with perfect chirality transfer, in which the Heck-arylation occurs from 
the convex face of the bicycle. In addition, a one-pot synthesis of biaryl pyridine was realized: 
starting from the Heck coupling to dihydropyridine, the subsequent addition of oxidant (DDQ) 
to the reaction mixture resulted in desired 2-arylpyridines, which are very important 
pharmacophores, albeit challenging in the preparation. Pleasantly, the substitution of alcohol 
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on cyclopropyl group, instead of classical donor-acceptor group, also provide the desired 
transformation, presenting the generosity of developed palladium catalyzed Heck cross-
coupling method. Finally, the transformations of corresponding dihydropyridines as a suitable 
intermediate was demonstrated.  
In the second section of the thesis, the visible light mediated ring opening of α-
bromoketone 124 furnishing valuable five membered nitrogen containing pyrrolidone 
derivatives was demonstrated (Scheme 50). 
 
Scheme 50. The visible light mediated ring opening of α-bromoketone. 
The irradiation of 124 thorough the oxidative quenching cycle provided the fast ring-
opening, delivering product 145. In turn, the photochemical reaction of 124 through the 
reductive quenching cycle, in the presence of DIPEA as an electron donor facilitated compound 
148. Finally, the trapping products 147 were formed utilizing oxidative quenching cycle 
between substrate 124 and electron enriched heterocycles. The synthesized 5-substituted 3-
pyrrolidin-2-one derivatives are important intermediates and highly desirable in natural product 
synthesis and medicinal chemistry. 
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Scheme 51. Direct arylation and arylsulfonylation of cycloadducts. 
Visible-light-promoted catalyzed reaction between cyclopropanated pyrrole derivatives 
and arylsulfonyl chlorides gave rise to the construction of sulfur containing products 171 
through the simple C–S bond-formation, which was discussed in the third section of the thesis 
(Scheme 51). In addition, the direct C–H arylation of cyclopropanated pyrroles with 
nitrobenzenediazonium tetrafluoroborate substrate in DMF was obtained, delivering arylated 
cyclopropane 163. The provided aryl and arylsulfonylated cyclopropanes can serve a as 
building block for further transformation to construct complex structure molecules. 
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D. Zusammenfassung 
Die vorliegende Arbeit beschreibt die Anwendung einfach-cyclopropanierter Pyrrole als 
Ausgangsmaterial zur Synthese von funktionalisierten fünf- und sechsgliedrigen Stickstoff-
Heterocyclen. Während die Ringöffnung aktivierter exocyclischer C–C-Bindungen in 
Cyclopropanen bekannt ist, stellt der Bruch der unaktivierten C–C-Bindung, und damit die 
Ringerweiterung, schon lange eine Herausforderung dar. Im ersten Teil der Arbeit wird eine 
Methode für ebendiese Ringerweiterung beschrieben (Schema 49). 
 
Schema 49. Die Palladium katalysierte Ringöffnung eines Cyclopropans an der inaktivierten 
Bindung setzt einen wertvollen sechs-gliedrigen Heterozyklus frei.  
Zu unserer Freude konnte eine regio- und diastereoselektive palladiumkatalysierte Heck-
Kopplung von monocyclopropanierten Pyrrolen mit (hetereo)arylhalogeniden und damit 
einhergehender Ringerweiterung durchgeführt werden, um hochfunktionalisierte 
Dihydropyridine und Pyridine darzustellen. Die entwickelten Reaktionsbedingungen 
ermöglichen die Umsetzung einer großen Bandbreite sowohl von Cycloaddukten als auch Aryl- 
und Heteroarylhalogeniden. Trotz erhöhten sterischen Anspruchs hinderte die Einführung eines 
Esters oder einer Formylgruppe in 3-Position des Pyrrols die Reaktivität in der Kreuzkupplung 
nicht und ermöglichte die Darstellung hochfunktionalisierter Dihydropyridine. Bei 
Verwendung von enantiomerenreinem cyclopropaniertem Pyrrol wurde ein vollständiger 
Übertrag der Chiralität beobachtet, da die Heck-Reaktion nur von der convexen Seite des 
Bicyclus stattfinden kann. Weiterhin wurde eine Ein-Topf Synthese von Arylpyridinen 
entwickelt, wobei die aus der Heckkupplung erhaltenen Dihydropyridine durch Addition eines 
Oxidans (DDQ) zu den erwarteten 2-Arylpyridinen umgesetzt wurden, welche einen sonst 
schwer darzustellenden Pharmakophor darstellen. Erfreulicherweise konnte auch ein Alkohol 
an der Cyclopropylgruppe, statt des klassischen Donor-Akzeptor-Systems, verwendet werden, 
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was die Substratbreite der entwickelten Palladiumkatalysierten Heckkupplung hervorhebt. 
Zuletzt wurden weitere Transformationen der Dihydropyridine unternommen, um ihren Nutzen 
als Intermediate bei der Naturstoffsynthese zu zeigen. 
Im zweiten Teil dieser Arbeit wurde die durch sichtbares Licht mediierte Ringöffnung von α-
Bromoketon 124 zu wertvollen fünfgliedrigen Pyrrolidinderivaten gezeigt. 
 
Schema 50. Ringöffnung eines α-Bromoketons ausgelöst durch sichtbares Licht. 
Die Umsetzung von 124 durch den oxidativen Cyclus eines Photokatalysators ergab eine 
schnelle Ringöffnung die zu Produkt 145 führte. Alternativ führte die photochemische 
Umsetzung in Gegenwart von DIPEA als Elektronendonor im reduktiven Cyclus eines 
Photokatalysators zu 148. Zuletzt wurden die Additionsprodukte 147 unter Nutzung des 
oxidativen Cyclus in Gegenwart elektronenreicher Heterocyclen gewonnen.  
 
Schema 51. Arylierung und arylsulfonylierung von Cycloadditionsproducten. 
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Die Photoreaktion zwischen cyclopropanierten Pyrrolen und Arylsulfonylchloriden führte zu 
den schwefelhaltigen Produkten 171 durch die Addition eines Schwefelradikals, welche im 
dritten teil der vorliegenden Arbeit behandelt wird. Zusätzlich wurde eine Arylierung der 
cyclopropanierten Pyrrole durch Umsetzung mit Nitrobenzoldiazoniumtetrafluoroborat in 
DMF erreicht, was zu Produkt 163 führte. Die erhaltenen Aryl- und Arylsulfonylcyclopropane 
können als Ausgangsmaterialien für weitere Umsetzungen dienen, um Moleküle mit 
anspruchsvoller Struktur zu erhalten.  
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E. Experimental Part  
 
1. General Information  
Commercially available chemicals were used as received, without any further purification. All 
reactions were carried out in oven dried glassware under atmospheric conditions unless other-
wise stated. Reactions with moisture or oxygen sensitive reagents were carried out in flame 
dried glassware under an atmosphere of predried nitrogen. Anhydrous solvents were prepared 
by established laboratory procedures. Solvents for column chromatography were distilled 
prior to use. The reported yields are referred to the isolated compounds unless otherwise 
stated.  
 
 
Chromatography  
Analytical thin layer chromatography was performed with TLC precoated aluminium sheets 
(Merck silica gel 60 F254, 0.25 mm layer thickness). Visualization was done with UV light 
(λ=  254 nm) and staining with vanillin (6 g vanillin in 100 mL EtOH and 5 mL H2SO4), sodium 
permanganate (1 g KMnO4 and 2 g Na2CO3 in 100 mL H2O), PMA (1 g ceric ammonium sul-
phate and 2.5 g ammonium molybdate in 10 mL H2SO4 and 90 mL H2O) or anisaldehyde (5  mL 
p-anisaldehyde in 5 mL H2SO4 and 100 mL EtOH) followed by heating. Column chromatog-
raphy was performed with silica gel (Merck, Geduran 60, 0.063 - 0.200 mm particle size). Flash 
column chromatography was performed with silica gel (Merck, Geduran 60, 0.040–0.063 mm 
particle size)  
 
 
1H-, 13C- and 19F-NMR  
NMR-spectra were recorded on a FT-NMR-spectrometer of the type BRUKER Avance 300 
(300 MHz for 1H, 75 MHz for 13C, 282 MHz for 19F), BRUKER Avance III 400 “Nanobay” 
(400 MHz for 1H, 100 MHz for 13C, 386 MHz for 19F) or BRUKER Avance III 600 (600 MHz 
for 1H, 151 MHz for 13C, 565 MHz for 19F) at ambient temperature. All spectra were recorded 
in CDCl3 unless otherwise stated. Chemical shift δ for 1H-NMR were reported in ppm relative 
to the signal of CDCl3 at 7.26 ppm. Spectra were evaluated in 1st order and coupling constants 
J were reported in Hz. Splitting patterns for the spin multiplicity in the spectra are given as 
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follows: s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of a doublet, ddd = doublet 
of a doublet of a doublet, dt = doublet of a triplet, b = broad and m = multiplet. Chemical shift 
δ for 13C-NMR were reported in ppm relative to the signal of CDCl3 at 77.2 ppm. 
 
 
IR-Spectroscopy 
ATR-IR spectroscopy was carried out on a Biorad Excalibur FTS 3000 spectrometer, equipped 
with a Specac Golden Gate Diamond Single Reflection ATR-System. Solid and liquid com-
pounds were measured neatly and the wave numbers are reported as cm-1. FTIR spectroscopy 
was carried out on a Cary 630 FTIR Spectrometer. Solid and liquid compounds were measured 
neatly and the wave numbers are reported as cm-1. 
 
 
Gas Chromatography 
Gas chromatography was performed on a Fisons GC 8000 Series with a flame ionization detec-
tor (FID). DB1 (100% Dimethylpolysiloxan, 30 m, ID 0.25 mm, 0.25 μm Film) was used as 
stationary phase. 
 
 
Mass Spectroscopy 
Mass spectroscopy was performed using a Jeol AccuTOF GCX, Agilent Q-TOF 6540 UHD at 
the Central Analytical Laboratory (University of Regensburg). High-resolution mass spectra 
were measured using atmospheric pressure chemical ionization (APCI), chemical ionization 
(CI), electron ionization (EI), electrospray ionization (ESI), field desorption (FD) or field ioni-
zation (FI) with a quadrupole time-of-flight (Q-TOF) detector. 
 
 
Analytical high-performance liquid chromatography (HPLC) 
Analytical high-performance liquid chromatography (HPLC) was conducted on a Varian 920-
LC chromatograph equipped with Diode Array detector. Phenomenex Lux Cellulose-1 and 2 
served as chiral stationary phase and mixtures of n-heptane and i-PrOH were used for elution. 
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Optical rotations 
Optical rotations [α] were determined using Perkin Elmer 241 polarimeter at λ = 589 nm (so-
dium-d-line) in a 1.0 dm measuring cell and the specified solvent. 
 
 
Melting Point  
Melting point measurements were carried out on a SRS MPA 100 OptiMelt at a heating rate 
of 1 °C/min.  
 
 
X-ray  
X-ray analysis of single crystals was performed using a Agilent Technologies SuperNova, Ag-
ilent Technologies Gemini R Ultra, Agilent GV 50 or Rigaku GV 50 at the Central Analytical 
Laboratory (University of Regensburg). The ellipsoid contour percent probability level is set to 
50%. The structure was solved with the ShelXT (Sheldrick, 2015) structure solution program, 
using the Intrinsic Phasing solution method. The model was refined with version 2016/6 of 
ShelXL (Sheldrick, 2015) using Least Squares minimisation. 
 
 
Light Sources  
Photochemical reactions were performed using a LED-plate or a LED-stick.  
Green LED-plate LED530 six green light emitting diodes (3 W, λ max = 530 nm, produced by 
LUXEON Lumiled, purchased from Conrad Electronic SE) mounted on a heat sink. A LUMO-
tech LEDlight 1 -20 VA Universal was used as power supply unit.  
Blue LED-plate LED455 six blue light emitting diodes (3 W, λ max = 455 nm, produced by 
LUXEON Lumiled, purchased from Conrad Electronic SE) mounted on a heat sink. A LUMO-
tech LEDlight 1 -20 VA Universal was used as power supply unit.  
Green LED-stick LED530 One green light emitting diode Cree XP-E (3 W, λ max = 520-535 
nm).  
Blue LED-stick LED455 One blue light emitting diode Cree XP-E (3 W, λ max = 450-465 nm). 
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2. Synthesis of Literature Known Compounds and Reagents  
Following compounds were synthesized according to literature known procedures or were on stock 
in the laboratories of the Reiser group: 
Tert-butyl diazoacetate,2 methyl diazoacetate,3 methyl phenyldiazoacetate,4 (-)-(S,S)-bis(4-
isopropyloxazoline),5 tert-butyl-1H-pyrrole-1-carboxylate6, di-tert-butyl 1H-pyrrole-1,3-
dicarboxylate,7 tert-butyl N-hydroxycarbamate,8 compounds 96a,9 (-)-96a,9 96a-Me,10, 112,11 
115, 12 12413, 96b17 were prepared following the previously reported procedures and their 
analytical data were consistent with those published in the literature. 
 
 
Di-tert-butyl 1H-pyrrole-1,3-dicarboxylate (I): 
 
To a solution of tert-butyl 1H-pyrrole-3-carboxylate (1.34 g, 8 mmol) and DMAP (98 mg, 0.8 
mmol, 0.1 equiv) in DCM (40 mL) was added portion wise di-tert-butyl dicarbonate (2.27 g, 
10.4 mmol, 1.3 equiv) at 25 oC under an atmosphere of nitrogen. The reaction mixture was 
stirred at the same temperature for 16 h and then the solvent was removed in vacuo. Column 
chromatography eluting with PE/EtOAc afforded I as yellowish crystals (1.96 g, 92%). Rf = 
0.75 (PE/EtOAc = 10:1); Mp = 73-75 oC. 
1H NMR (300 MHz, CDCl3) δ: 7.73 – 7.70 (m, 1H), 7.15 (dd, J = 3.3, 2.2 Hz, 1H), 6.52 (dd, 
J = 3.3, 1.6 Hz, 1H), 1.58 (s, 9H), 1.52 (s, 9H); 13C NMR (75 MHz, CDCl3) δ: 163.5, 148.1, 
124.4, 121.3, 120.4, 112.1, 84.8, 80.4, 28.3, 27.9; IR (neat, cm-1): 2951, 1700, 1710, 1351, 
1250, 1171, 997, 650; HRMS (ESI): m/z calculated for C14H21NO4 (M+H)
+ : 267.1471. Found 
267.1369.  
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2.1. Synthesis of 3-substituted cyclopropanated pyrroles. 
Tri-tert-butyl-2-azabicyclo [3.1.0] hex-3-ene-2,4,6-tricarboxylate (99): 
 
According to literature procedure,8 in a flame dried Schlenk flask under N2-atmosphere 
Cu(OTf)2 (20 mg, 56 μmol, 0.01 equiv) and (-)-(S,S)-bis(4-isopropyloxazoline) (30 mg, 0.112 
mmol, 0.02 equiv) were dissolved in anhydrous CH2Cl2 (10 mL) at room temperature and 
stirred for 1 hour at the same temperature. In a second flask under nitrogen atmosphere di-tert-
butyl 1H-pyrrole-1,3-dicarboxylate (I) (1.5 g, 5.6 mmol) was dissolved in dry CH2Cl2 (10 mL) 
and the resulting solution was cooled down to -20 °C by the use of a cryostat. The Cu/ligand 
mixture was added via a syringe to this flask and phenylhydrazine (6 μL, 0.056 mmol, 0.01 
equiv) was added dropwise. Tert-butyl diazoacetate (11.4 wt% solution in anhydrous CH2Cl2, 
1.42 g; 11.2 mmol, 2 equiv) was added via a syringe pump (addition rate:1 drop/20 s). After 
completion of the addition, the reaction mixture was stirred for additional 6 h at -20 oC and 
subsequently filtered through a pad of basic alumina and washed with CH2Cl2 (200 mL. The 
residue obtained after removal of solvents was subjected to column chromatography (silica gel, 
PE/EtOAc) to afford 99 as a white solid (900 mg, 42%). Rf = 0.65 (PE/EtOAc = 10:1); Mp = 
163-165 oC.; [α]D20 -115.894. (c 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3) δ: 7.37 – 7.05 (m, 1H), 4.50 – 4.11 (m, 1H), 3.01 (s, 1H), 1.51 (s, 
9H), 1.48 (s, 9H), 1.43 (s, 9H), 0.93 (s, 1H); 13C NMR (101 MHz, CDCl3) δ: 171.4, 163.8, 
150.4, 137.4 + 137.0, 117.6, 83.2, 81.2, 80.7, 44.6, 29.9 + 29.0, 28.3, 28.2, 28.2, 23.0 (signal 
doubling due to rotamers); IR (neat, cm-1): 2985, 1692, 1587, 1412, 1367, 1136, 1025, 831, 
760; HRMS (ESI): m/z calculated for C20H31NO6 (M+H)
+: 382.2151. Found 382.2227. 
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2-(Tert-butyl) 6-methyl 4-formyl-2-azabicyclo [3.1.0] hex-3-ene-2,6-
dicarboxylate(101a- Me): 
 
Method A: According literature procedure14, phosphorus oxychloride (1 mmol) was added 
dropwise to DMF (1 mmol) at 10 oC in a period of 3 min and the mixture was stirred for 20 
min. To the cooled mixture (5 oC) was added ethylene dichloride (2 ml) and then a solution of 
96a-Me (165 mg, 0.75 mmol) in ethylene dichloride (1.5 ml) over a period of 30 min. The 
solution was stirred at 0-5 0C for 1 h and refluxed for 15 min. After work-up with aqueous 
sodium acetate, the combined organic layer was dried on Na2SO4. The resulting solution was 
purified by column chromatography (silica gel, PE/EA 4:1), to afford 101a-Me as a yellowish 
oil (50 mg, 25%). Rf = 0.14 (PE/EtOAc = 2:1). 
Method B: According literature procedure15 to a solution of DMF (1 mL) in CH2Cl2 (4 mL) at 
0 °C was added oxalyl chloride (51 μL, 0,6 mmol, 1.2 equiv) dropwise. The solution was stirred 
at 0 °C for 10 min. To the resultant white suspension was added the 96a-Me (120 mg, 0,5 mmol, 
1 equiv) shown above in CH2Cl2 (1 mL). The solution was warmed to room temperature and 
stirred for 1 h. The mixture was quenched with saturated aqueous Na2CO3 (30 mL) and stirred 
vigorously for 15 min. The resultant solution was extracted with CH2Cl2 and dried (Na2SO4). 
The residue obtained after removal of solvents was subjected to column chromatography (silica 
gel, PE/EtOAc= 3:1) to afford 101a-Me as a white solid (100 mg, 75%).  
1H NMR (400 MHz, Chloroform-d) δ 9.54 (s, 1H), 7.39 (s, 1H), 4.46 (s, 1H), 3.69 (s, 3H), 
3.18 (dd, J = 6.7, 2.8 Hz, 1H), 1.54 (s, 9H), 1.06 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 
184.55, 172.12, 149.64, 144.23, 126.79, 84.38, 52.19, 44.84, 28.07, 26.87, 21.85; IR (neat, cm-
1):2981, 1718, 1662, 1408, 1358, 1278, 1144, 980, 730. HRMS (ESI): m/z calculated for 
C22H29NO5 (M+H)
 + 267.1107; Found 267.1189 
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Di-tert-butyl-4-formyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate (101a): 
 
Following Method B, 101a was prepared from 96a (140 mg, 0.5 mmol). The residue obtained 
after removal of solvents was subjected to column chromatography (silica gel, PE/EtOAc= 3:1) 
to afford 101a as a white solid (110 mg, 71%). Rf = 0.2 (PE/EtOAc = 2:1); Mp= 157-159 
oC. 
1H NMR (400 MHz, Chloroform-d) δ 9.54 (s, 1H), 7.34 (s, 1H), 4.40 (s, 1H), 3.27 – 2.96 (m, 
1H), 1.55 (s, 9H), 1.44 (s, 9H), 0.96 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 184.6, 170.7, 149.8, 
144.0, 127.0, 84.1, 81.5, 44.6, 28.1, 28.0, 26.3, 22.9; HRMS (ESI): m/z calculated for 
C16H23NO5 (M+H)
+: 310.1576. Found 310.1576. 
 
 
 
Methyl 2-(4-acetyl-1H-pyrrol-3-yl) acetate (102):  
 
According to the literature,18 to a stirring solution of 96a-Me (120 mg, 0.5 mmol) in CH2Cl2 (2 
mL) under nitrogen at 0 °C was added. acetyl chloride (0.7 mL, 1 mmol) in a single portion via 
syringe and then SnCl4 (0.4 mL, 1.2 mmol was added in small portions to the suspension. The 
mixture was stirred for 30 at room temperature. After being quenched with ice and water (30 
mL), the mixture was filtered to remove inorganic precipitates, and the organic material was 
extracted with ethyl acetate (50 mL) and was dried over Na2SO4. The resulting solution was 
purified by column chromatography (silica gel, PE/EA 3:1), to afford 102 as a brownish solid 
(75 mg, 40%). Mp= 68-70 oC. Rf = 0.23 (PE/EA = 10:1). 
1H NMR (400 MHz, Chloroform-d) δ 10.49 (s, 1H), 6.85 – 6.81 (m, 1H), 6.12 – 6.08 (m, 1H), 
3.73 (s, 2H), 3.69 (s, 3H), 2.39 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 187.7, 170.3, 131.8, 
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117.7, 110.3, 52.3, 33.2, 25.2; IR (neat, cm-1):3272, 3239, 1736, 1617, 1488, 1412, 1222, 1162, 
1259, 793. HRMS (ESI): m/z calculated for C22H29NO5 (M+H)
 + 182.0739; Found 182.0741 
 
 
2-(Tert-butyl) 6-ethyl -6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate (115): 
 
Compound 115 was synthesized according to a literature procedure.16 A flame dried 30 mL 
Schlenck tube equipped with a magnetic stirring bar was charged with tert-butyl-1H-pyrrole-1-
carboxylate (3.34 mL, 10 mmol, 5 equiv), ethyl 2-diazo-2-phenylacetate (380 mg, 2 mmol, 1.0 
equiv) and anhydrous DCM (15 mL). The deeply orange-colored reaction mixture was stirred 
and irradiated with blue light (LED,  = 455 nm) for 24 hours giving a reddish-colored solution. 
After complete consumption of the diazo ester (monitoring by TLC) the solvent was removed 
in vacuuo and the product was isolated by flash column chromatography (PE/EtOAc= 10:1) 
affording 115 (430 mg, 65%) as a white solid. Rf = (PE/EtOAc = 3:1) = 0.6; Mp = 90 – 93 °C. 
1H NMR (400 MHz, Chloroform-d) δ 7.28 (d, J = 6.3 Hz, 2H), 7.19 – 7.07 (m, 2H), 6.08 (dd, 
J = 63.4, 3.8 Hz, 1H), 5.25 – 5.12 (m, 1H), 4.67 (dd, J = 47.0, 6.8 Hz, 1H), 4.20 – 4.03 (m, 2H), 
3.39 – 3.28 (m, 1H), 1.62 (s, 4H), 1.48 (s, 5H), 1.22 – 1.09 (m, 3H); 13C NMR (101 MHz, 
CDCl3) δ 173.2, 151.4, 132.6, 131.3, 130.4, 127.7, 127.1, 107.4, 81.5, 61.1, 49.2, 39.2, 38.0, 
28.1, 14.1; HRMS (+APCI): calcd. for C19H23NO4 [M+H]+ 330.1627 found 330.1628. 
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3. General Procedures for Pd-Catalyzed 1,2-Dihydropyridines Preparation 
(GP-1a, GP-1b): 
General procedure 96a (GP-96a): Conditions I 
An oven dried 10 mL Schlenk flask equipped with a magnetic stirring bar was charged with 
a monocyclocpropanated N-Boc pyrrole 96a, (-)-96a, 96a-Me or 99 (0.5 mmol, 1 equiv), 
(hetero)aryl halide (1.5 mmol), Pd2(dba)3 (14 mg, 3 mol%), NaHCO3 (105 mg, 1.25 mmol, 2.5 
equiv), and tetrabutylammonium bromide (TBAB) (322 mg, 1 mmol, 2 equiv) followed by 
addition of dry toluene (1.5 mL). The resulting mixture was degassed by “pump-freeze-thaw” 
cycles (×3), then stirred for 5 min at room temperature and subsequently placed on a pre-heated 
oil bath at 80 oC for 24–56 h. After completion of the reaction (as monitored by TLC), the 
reaction mixture was cooled down to room temperature, diluted with CH2Cl2 (15 mL) and 
filtered through a pad of Celite. The obtained filtrates were concentrated under reduced pressure 
and subjected to column chromatography using PE/ EtOAc, as eluent to afford products 110a-
110s. 
General procedure 99 (GP-99): Conditions II 
An oven dried 10 mL Schlenk flask equipped with a magnetic stirring bar was charged with 
(hetero)aryl halide (0.5 mmol, 1 equiv), monocyclocpropanated N-Boc pyrrole 96a (1.5 mmol, 
3 equiv), Pd2(dba)3 (14 mg, 3 mol%), NaHCO3 (105 mg, 1.25 mmol, 2.5 equiv), and 
tetrabutylammonium bromide (TBAB) (322 mg, 1 mmol, 2 equiv) followed by addition of dry 
toluene (1.5 mL). The resulting mixture was degassed by “pump-freeze-thaw” cycles (×3), then 
stirred for 5 min at room temperature and subsequently placed on a pre-heated oil bath at 80 oC 
for 24–56 h. After completion of the reaction (as monitored by TLC), the reaction mixture was 
cooled down to room temperature, diluted with CH2Cl2 (15 mL) and filtered through a pad of 
Celite. The obtained filtrates were concentrated under reduced pressure and subjected to column 
chromatography using PE/ EtOAc, as eluent to afford products 110a, 110q and 110r. Yield 
based on aryl halide. 
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Di-tert-butyl 6-(4-methoxyphenyl) pyridine-1,3(6H)-dicarboxylate (110a): 
 
Following GP-96a- Conditions I, 110a was prepared from 96a (141 mg, 0.5 mmol, 1 equiv) 
and 4-iodoanisole (175 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel; PE/EtOAc= 10:1) to afford 110a as a yellowish oil (143 mg, 74% 
yield. Rf = 0.40 (PE/EtOAc = 10:1). Reaction time was 24 hours. 
Following GP-99- Conditions II, 110a was prepared from 96a (420 mg, 1.5 mmol, 3 equiv) and 
4-iodoanisole (117 mg, 0.5 mmol, 1 equiv) to afford 110a (157 mg, 81% yield. Yield based on 
aryl halide). Reaction time was 24 hours. 
1H NMR (300 MHz, CDCl3) δ: 7.89 (br s, 1H), 7.31 – 7.25 (m, 2H), 6.86 – 6.79 (m, 2H), 6.42 
(d, J = 9.9 Hz, 1H), 5.69 (br s, 1H), 5.54 (dd, J = 9.9, 5.2 Hz, 1H), 3.76 (s, 3H), 1.50 (s, 9H), 
1.42 (s, 9H); 13C NMR (75 MHz, CDCl3) δ: 165.1, 159.3, 152.2, 134.7, 134.2, 128.1, 121.4, 
118.7, 113.8, 108.6, 83.0, 80.1, 56.5, 55.2, 28.3, 28.0; IR (neat, cm-1): 2880, 1770, 1500, 1450, 
1356, 1250, 1150, 977, 850; HRMS (ESI): m/z calculated for C22H29NO5 (M+H)
+: 388.2046. 
Found 388.2120. HPLC analysis (CHIRALPAK-IA, n-heptane/i-PrOH 9:1, flow 0.5 mL/min): 
tr= 4.044 min ((+)-110a), tr= 4.296 min ((-)-110a). 
Di-tert-butyl (S)-6-(4-methoxyphenyl)pyridine-1,3(6H)-dicarboxylate ((-)-110a): 
 
Following GP-96a- Conditions I, (–)-110a was prepared from (–)-96a (141 mg, 0.5 mmol; 97% 
ee) and 4-iodoanisole (175 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by 
column chromatography (silica gel; PE/EtOAc= 10:1) to afford (-)-110a as a yellowish oil (143 
mg, 74%). Rf = 0.40 (PE/ EtOAc=10:1). Reaction time was 24 hours. 
NMR and IR data were identical with those reported for the racemate; HRMS (ESI): m/z 
calculated for C22H29NO5 (M+H)
+: 388.2046. Found 388.2128; HPLC analysis 
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(CHIRALPAK-IA, n-heptane/i-PrOH 9:1, flow 0.5 mL/min): tr= 4.296 min (major peak); ee 
(97% ee); [α]D20 –268.4 (c 1.0, CHCl3). 
 
 
Di-tert-butyl 6-(3-methoxyphenyl) pyridine-1,3(6H)-dicarboxylate (110b): 
 
Following GP-96a- Conditions I, 110b was prepared from 96a (141 mg, 0.5 mmol) and 3-
iodoanisole (175 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc =10:1) to afford 110b as a yellow oil (128 mg, 67% 
yield). Rf = 0.40 (PE/EtOAc = 10:1). Reaction time was 36 hours. 
1H NMR (400 MHz, CDCl3) δ: 7.94 (br s, 1H), 7.28 – 7.20 (m, 1H), 6.95 – 6.76 (m, 3H), 6.40 
(d, J = 9.8 Hz, 1H), 5.72 (br s, 1H), 5.57 (dd, J = 9.8, 5.1 Hz, 1 H), 3.77 (s, 3H), 1.50 (s, 9H), 
1.41 (s, 9H). 13C NMR (101 MHz, CDCl3) δ: 165.0, 159.9, 152.2, 144.0, 134.9, 129.7, 121.2, 
119.0, 118.7, 112.9, 112.3, 108.6, 83.1, 80.2, 57.6, 55.3, 28.3, 28.0; IR (neat, cm-1): 2978, 2973, 
1722, 1699, 1587, 1390, 1244, 1125, 1080, 1010, 849, 752; HRMS (ESI): m/z calculated for 
C22H29NO5 (M+H)
+: 388.2046. Found 388.1952.  
Di-tert-butyl 6-(2-methoxyphenyl) pyridine-1,3(6H)-dicarboxylate (110c): 
 
Following GP-96a- Conditions I, 110c was prepared from 96a (141 mg, 0.5 mmol) and 2-
iodoanisole (175 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc =10:1) to afford 110b as a yellow oil (106 mg, 54% 
yield). Rf = 0.4 (PE/ EtOAc =10:1). Reaction time was 36 hours. 
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1H NMR (300 MHz, CDCl3) δ: 8.07 (br s, 1H), 7.24 – 7.17 (m, 2H), 6.93 – 6.82 (m, 2H), 6.23 
(dt, J=10.0, 1.4, 1H), 6.12 (d, J = 4.4 Hz, 1H), 5.65 (br s, 1H), 3.83 (s, 3H), 1.50 (s, 9H), 1.30 
(s, 9H). 13C NMR (75 MHz, CDCl3) δ: 165.2, 154.2, 152.3, 135.1, 132.3, 128.5, 125.7, 121.2, 
121.1, 117.7, 110.2, 108.1, 82.7, 80.0, 55.3, 52.6, 28.3, 27.8. IR (neat, cm-1): 2974, 1722, 1367, 
1233, 1140, 1025, 846, 749; HRMS (ESI): m/z calculated for C22H29NO5 (M+H)
+: 388.2046. 
Found 388.1942. 
 
Di-tert-butyl 6-(3,4,5-trimethoxyphenyl) pyridine-1,3(6H)-dicarboxylate (110d): 
 
Following GP-96a- Conditions I, 110d was prepared from 96a (141 mg, 0.5 mmol) and 5-
bromo-1,2,3-trimethoxybenzene (185 mg, 0.75 mmol, 1.5 equiv). The crude product was 
purified by column chromatography (silica gel, PE/EA=10:1) to afford 110d as a yellow oil 
(129 mg, 58% yield). Rf = 0.25 (PE/EA=10:1). Reaction time was 36 hours. 
1H NMR (400 MHz, CDCl3) δ: 7.89 (br s, 1H), 6.59 – 6.42 (m, 3H), 5.73 (br s, 1H), 5.58 (dd, 
J=9.7, 5.2, 1H), 3.82 (s, 9H), 1.50 (s, 9H), 1.44 (s, 9H). 13C NMR (101 MHz, CDCl3) 165.1, 
153.4, 152.3, 138.4, 137.8, 134.8, 120.9, 119.4, 108.9, 103.8, 83.2, 80.3, 60.9, 56.2, 56.2, 56.17, 
28.3, 28.1; IR (neat, cm-1): 2974, 2937, 1699, 1367, 1237, 1125, 1039, 1006, 849, 752; HRMS 
(ESI): m/z calculated for C24H33NO7 (M+H)
+: 448.2257. Found 448.2178. 
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1-(Tert-butyl) 3-methyl 6-(4-methoxyphenyl)pyridine-1,3(6H)-dicarboxylate (110a-Me): 
 
Following GP-96a- Conditions I, 110a-Me was prepared from 96a-Me (120 mg, 0.5 mmol) 4-
iodoanisole (175 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/EtOAc=10:1) to afford 110a-Me as a yellow oil (112 mg, 65% 
yield). Rf = 0.38 (PE/EtOAc=10:1). Reaction time was 24 hours. 
1H NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 7.28 – 7.215 (m, 2H), 6.85 – 6.79 (m, 2H), 6.46 
(d, 1H), 5.71 (s, 1H), 5.59-5.53 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 1.43 (s, 9H); 13C NMR (101 
MHz, CDCl3) δ 166.2, 159.4, 152.1, 135.5, 134.2, 128.1, 121.6, 118.4, 113.8, 107.1, 83.2, 56.2, 
55.2, 51.4, 28.0; IR (neat, cm-1) 2981, 1703, 1587, 1513, 1338, 1237, 1144, 1032, 853, 771, 
730; HRMS (ESI): m/z calculated for C19H23NO5 (M+H)
+: 346,1649; Found 346,1651 
(M+H)+.  
 
 
Di-tert-butyl 6-(benzo[d][1,3] dioxol-5-yl)pyridine-1,3(6H)-dicarboxylate (110f): 
 
Following GP-96a- Conditions I, 110f was prepared from 96a (141 mg, 0.5 mmol) and 1-
bromo-3,4-(methylenedioxy) benzene (150 mg, 0.75 mmol, 1.5 equiv). The crude product was 
purified by column chromatography (silica gel, PE/ EtOAc=10:1) to afford 110f as a yellow oil 
(134 mg, 67% yield). Rf = 0.55 (PE/ EtOAc=10:1). Reaction time was 24 hours. 
1H NMR (400 MHz, CDCl3) δ: 7.88 (br s, 1H), 6.88 – 6.69 (m, 3H), 6.41 (d, J = 9.8 Hz, 1H), 
5.92 – 5.89 (m, 2H), 5.65 (br s, 1H), 5.52 (dd, J=9.8, 5.2, 1H), 1.49 (s, 9H), 1.43 (s, 9H). 13C 
NMR (101 MHz, CDCl3) δ 165.0, 152.1, 147.9, 147.3, 136.1, 134.7, 121.2, 120.2, 118.9, 108.6, 
108.1, 107.5, 101.1, 83.1, 80.2, 56.6, 28.3, 28.0; IR (neat, cm-1): 2978, 2933, 1699, 1487, 1367, 
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1237, 1140, 1036, 752; HRMS (ESI): m/z calculated for C22H27NO6 (M+H)
+: 402.1838. Found 
402.1734. 
Di-tert-butyl 6-phenylpyridine-1,3(6H)-dicarboxylate (110g): 
 
Following GP-96a- Conditions I, 110g was prepared from 96a (141 mg, 0.5 mmol) and 
iodobenzene (153 mg, 84 mL, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc= 30:1) to afford 110g as a yellow oil (100 mg, 56% 
yield). Rf = 0.45 (PE/ EtOAc = 10:1). Reaction time was 36 hours. 
1H NMR (400 MHz, CDCl3) δ: 7.88 (br s, 1H), 7.26 – 7.13 (m, 5H), 6.34 (d, J = 9.8 Hz, 1H), 
5.67 (br s, 1H), 5.51 (dd, J=9.8, 5.2, 1H), 1.45 (s, 9H), 1.33 (s, 9H); 13C NMR (101 MHz, 
CDCl3) δ: 164.7, 151.8, 148.8, 147.6, 134.7, 127.3, 124.1, 120.2, 119.8, 108.8, 83.9, 80.7, 56.4, 
28.3, 28.0; IR (neat, cm-1): 2978, 1699, 1341, 1244, 1129, 1077, 909, 726, 697; HRMS (ESI): 
m/z calculated for C21H27NO4 (M+H)
+: 358.1940. Found 358.2013.  
 
1-(Tert-butyl) 3-methyl 6-phenylpyridine-1,3(6H)-dicarboxylate (110g-Me): 
 
Following GP-96a- Conditions I, 110g-Me was prepared from 96a-Me (120 mg, 0.5 mmol) 
and iodobenzene (153 mg, 84 L, 0.75 mmol, 1.5 equiv). The product isolated after column 
chromatography contained impurities which could be removed after its conversion to 111b-Me. 
Rf = 0.45, (PE/ EtOAc= 10:1); NMR yield = 57%.  Reaction time was 36 hours. 
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1H NMR (400 MHz, CDCl3) δ: 8.02 (br s, 1H), 7.35– 7.24 (m, 5H), 6.45 (d, J = 9.7 Hz, 1H), 
5.75 (br s, 1H), 5.61 (dd, J = 9.7, 5.2 Hz, 1H), 3.77 (s, 3H), 1.41 (s, 9H); HRMS (ESI): m/z 
calculated for C18H21NO4 (M+H)
+ : 316.1471; Found 316.1401.  
 
 
Di-tert-butyl 6-(naphthalen-1-yl) pyridine-1,3(6H)-dicarboxylate (110h): 
 
Following GP-96a- Conditions I, 110h was prepared from 96a (141 mg, 0.5 mmol) and 1-
iodonaphthalene (190 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc =30:1) to afford 110h as a yellowish oil (122 mg, 60% 
yield). Rf = 0.70 (PE/ EtOAc = 10:1). Reaction time was 36 hours. 
1H NMR (400 MHz, CDCl3) δ: 8.20 (br s, 1H), 8.13 – 8.05 (m, 1H), 7.90 – 7.85 (m, 1H), 7.81 
– 7.76 (m, 1H), 7.59 – 7.42 (m, 4H), 6.57 (br s, 1H), 6.30 (d, J = 9.9 Hz, 1H), 5.72 (dd, J = 9.9, 
4.5 Hz, 1H), 1.54 (s, 9H), 1.15 (br s, 9H). 13C NMR (101 MHz, CDCl3) δ: 165.2, 152.3, 140.4, 
135.3, 133.7, 129.0, 128.7, 128.1, 126.6, 126.0, 125.8, 122.9, 122.3, 121.3, 118.1, 107.7, 83.1, 
80.3, 54.8, 28.4, 27.8; IR (neat, cm-1): 2978, 2933, 1699, 1595, 1367, 1244, 1125, 1010, 809, 
730; HRMS (ESI): m/z calculated for C25H29NO4 (M+H)
+: 408.2097. Found 408.2181.  
 
 
Di-tert-butyl 6-(phenanthren-9-yl) pyridine-1,3(6H)-dicarboxylate (110i): 
 
Following GP-96a- Conditions I, 110i was prepared from 96a (141 mg, 0.5 mmol) and 9-
bromophenanthrene (192 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
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chromatography (silica gel, PE/ EtOAc, 20:1) to afford 110i as a yellow oil (128 mg, 56% 
yield). Rf = 0.37 (PE/EtOAc = 10:1). Reaction time was 48 hours. 
1H NMR (400 MHz, CDCl3) δ: 8.82 – 8.74 (m, 1H), 8.70 – 8.62 (m, 1H), 8.32 (br s, 1H), 8.20 
– 8.10 (m, 1H), 7.92 – 7.84 (m, 1H), 7.77 – 7.56 (m, 5H), 6.62 (br s, 1H), 6.35 (d, J = 10.0 Hz, 
1H), 5.88 – 5.76 (m, 1H), 1.57 (s, 9H), 1.18 (br s, 9H). 13C NMR (101 MHz, CDCl3) δ: 165.2, 
152.3, 138.4, 135.3, 131.8, 130.8, 130.1, 128.8, 128.2, 127.1, 126.8, 126.7, 126.6, 123.5, 123.4, 
122.9, 122.5, 121.0, 118.4, 107.8, 83.2, 80.4, 54.9, 28.4, 27.8; IR (neat, cm-1): 2974, 1714, 
1367, 1233, 1140, 950, 905, 846, 723; HRMS (ESI): m/z calculated for C29H31NO4 (M+H)
+: 
458.2253. Found 458.2147.  
 
 
Di-tert-butyl 6-(4-fluorophenyl) pyridine-1,3(6H)-dicarboxylate (110j): 
 
Following GP-96a- Conditions I, 110j was prepared from 96a (141 mg, 0.5 mmol) and 4-
fluoroiodobenzene (167 mg, 86 L, 0.75 mmol, 1.5 equiv). The crude product was purified by 
column chromatography (silica gel, PE/ EtOAc= 40:1) to afford 110j as a yellowish oil (80 mg, 
43% yield). Rf = 0.35 (PE/EtOAc= 10:1). Reaction time was 36 hours. 
1H NMR (400 MHz, CDCl3) δ: 7.89 (br s, 1H), 7.35 – 7.28 (m, 2H), 7.02 – 6.94 (m, 2H), 6.43 
(d, J = 9.8 Hz, 1H), 5.73 (br s, 1H), 5.54 (dd, J=9.8, 5.2, 1H), 1.50 (s, 9H), 1.41 (s, 9H). 13C 
NMR (101 MHz, CDCl3) δ: 165.0, 163.7, 152.0, 134.7, 128.6, 121.0, 119.2, 115.6, 115.3, 
108.7, 83.3, 80.3, 56.4, 28.3, 28.0; IR (neat, cm-1): 2978, 1714, 1509, 1367, 1230, 1140, 905, 
834; HRMS (ESI): m/z calculated for C21H26FNO4 (M+H)
+: 376.1846. Found 376.1742.  
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Di-tert-butyl 6-(4-nitrophenyl) pyridine-1,3(6H)-dicarboxylate (110k): 
 
Following GP-96a- Conditions I, (reaction temperature 65 °C), 110k was prepared from 96a 
(141 mg, 0.5 mmol) and 1-iodo-4-nitrobenzene (186 mg, 0.75 mmol, 1.5 equiv). The crude 
product was purified by column chromatography (silica gel, PE/EtOAc = 30:1) to afford 110k 
as a yellow oil (80 mg, 40% yield). Rf = 0.25 (PE/EtOAc = 10:1). Reaction time was 56 hours. 
1H NMR (400 MHz, CDCl3) δ: 8.22 – 8.14 (m, 2H), 7.92 (br s, 1H), 7.55 – 7.45 (m, 2H), 6.46 
(d, J = 9.8 Hz, 1H), 5.87 (br s, 1H), 5.55 (dd, J=9.8, 5.2, 1H), 1.51 (s, 9H), 1.42 (s, 9H); 13C 
NMR (101 MHz, CDCl3) δ: 164.7, 151.8, 148.8, 147.6, 134.7, 127.3, 124.1, 120.2, 119.8, 
108.8, 83.9, 80.7, 56.4, 28.3, 28.0; IR (neat, cm-1): 2978, 1699, 1520, 1345, 1244, 1140, 1006, 
849, 730; HRMS (ESI): m/z calculated for C21H2N2O6 (M+H)
+: 403.1791. Found 403.1184.  
 
 
Di-tert-butyl 6-(4-(ethoxycarbonyl) phenyl)pyridine-1,3(6H)-dicarboxylate (110l): 
 
Following GP-96a- Conditions I, 110l was prepared from 96a (141 mg, 0.5 mmol) and ethyl 4-
iodobenzoate (207 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc =10:1) to afford 110l as a yellow oil (102 mg, 48 % 
yield). Rf = 0.4 (PE/ EtOAc =10:1). Reaction time was 48 hours. 
1H NMR (400 MHz, CDCl3) δ: 8.07 – 7.92 (m, 3H), 7.44 – 7.34 (m, 2H), 6.41 (d, J = 9.8 Hz, 
1H), 5.78 (br s, 1H), 5.61 – 5.50 (m, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.51 (s, 9H), 1.40 (s, 9H), 
1.37 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 166.3, 164.9, 151.9, 147.1, 134.8, 
130.1, 129.8, 126.2, 120.6, 119.4, 108.7, 83.5, 80.4, 61.0, 57.8, 28.3, 28.0, 14.4; IR (neat, cm-
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1): 2978, 1699, 1367, 1271, 1244, 1140, 909, 849, 1006, 767, 730; HRMS (ESI): m/z calculated 
for C24H31NO6 (M+H)
+: 430.2151. Found 430.2215.  
 
Di-tert-butyl 6-(benzo[b]thiophen-5-yl) pyridine-1,3(6H)-dicarboxylate (110m): 
 
Following GP-96a- Conditions I, 110m was prepared from 96a (141 mg, 0.5 mmol) and 5-
bromo-1-benzothiophene (159 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by 
column chromatography (silica gel, PE/ EtOAc= 40:1) to afford 110m as a yellow oil (100 mg, 
48% yield). Rf = 0.30 (PE/ EtOAc= 10:1). Reaction time was 48 hours. 
1H NMR (300 MHz, CDCl3) δ: 7.97 (br s, 1H), 7.88 – 7.75 (m, 2H), 7.47 – 7.29 (m, 3H), 6.46 
(d, J = 9.9 Hz, 1H), 5.88 (br s, 1H), 5.63 (dd, J=9.9, 5.2, 1H), 1.53 (s, 9H), 1.41 (br s, 9H). 13C 
NMR (75 MHz, CDCl3) δ: 165.2, 152.2, 139.8, 139.4, 138.7, 134.9, 127.0, 124.0, 123.2, 122.7, 
121.6, 121.4, 118.8, 108.6, 83.2, 80.3, 57.5, 28.3, 28.0; IR (neat, cm-1) 2978, 2933, 1695, 1341, 
1237, 1125, 1010, 735; HRMS (ESI): m/z calculated for C23H27NO4S (M+H)
+: 414.1661. 
Found 414.1737. 
 
 
Di-tert-butyl 6-(2-methylbenzo[d]thiazol-5-yl) pyridine-1,3(6H)-dicarboxylate (110n): 
  
Following GP-96a- Conditions I, 110n was prepared from 96a (141 mg, 0.5 mmol) and 5-
bromo-2-methyl benzothiazole (170 mg, 0.75 mmol, 1.5 equiv). The crude product was purified 
by column chromatography (silica gel, PE/ EtOAc = 30:1) to afford 110n as a yellowish oil 
(128 mg, 60% yield). Rf = 0.35 (PE/ EtOAc=10:1). Reaction time was 48 hours. 
 100 
1H NMR (400 MHz, CDCl3) δ: 8.00 – 7.87 (m, 2H), 7.78 – 7.70 (m, 1H), 7.40 – 7.31 (m, 1H), 
6.43 (d, J=9.8, 1H), 5.86 (br s, 1H), 5.60 (dd, J=9.8, 5.2, 1H), 2.79 (s, 3H), 1.50 (s, 9H), 1.44 
(br s, 9H); 13C NMR  (101 MHz, CDCl3) δ: 167.7, 164.9, 153.7, 152.1, 140.4, 135.2, 134.7, 
123.4, 121.5, 121.1, 120.3, 119.1, 108.8, 83.2, 80.2, 57.8, 28.3, 28.0, 20.2; IR (neat, cm-1): 
2978, 2933, 1695, 1341, 1241, 1125, 1010, 812, 730. HRMS (ESI): m/z calculated for 
C23H28N2O4S (M+H)
+: 429.1770. Found 429.1847.  
 
Di-tert-butyl 6-(2-methyl-1H-indol-5-yl) pyridine-1,3(6H)-dicarboxylate (110o): 
 
Following GP-96a- Conditions I, 110o was prepared from 96a (141 mg, 0.5 mmol) and 5-brom-
1-methyl-1H-indol (158 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc= 40:1) to afford 110o as a yellow oil (110 mg, 55% 
yield). Rf = 0.30 (PE/ EtOAc=10:1). Reaction time was 48 hours. 
1H NMR 7.97 (br s, 1H), 7.60 (br s, 1H), 7.33 – 7.21 (m, 1H), 7.07 – 6.99 (m, 1H), 6.50 – 6.39 
(m, 2H), 5.86 (br s, 1H), 5.64 (dd, J=9.8, 5.2, 1H), 3.76 (s, 3H), 1.54 (s, 9H), 1.42 (s, 9H); 13C 
NMR (101 MHz, CDCl3) δ: 165.4, 152.3, 136.5, 134.9, 133.5, 129.3, 128.4, 122.2, 120.8, 
119.3, 118.2, 109.3, 108.6, 101.2, 82.7, 79.9, 57.7, 32.9, 28.2, 28.0; IR (neat, cm-1): 2978, 1692, 
1367, 1244, 1125, 1077, 905, 726, HRMS (ESI): m/z calculated for C24H30N2O4 (M+H)
+: 
411.2206. Found 411.2093.  
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Di-tert-butyl 6-(9H-carbazol-3-yl) pyridine-1,3(6H)-dicarboxylate (110p): 
 
Following GP-96a- Conditions I, 110p was prepared from 96a (141 mg, 0.5 mmol) and 2-
bromo-9H-carbazole (184 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by 
column chromatography (silica gel, PE/ EtOAc= 30:1) to afford 110p as a yellowish oil (105 
mg, 47% yield). Rf = 0.30 (PE/ EtOAc= 10:1). Reaction time was 48 hours. 
1H NMR (400 MHz, CDCl3) δ: 8.37 – 7.93 (m, 4H), 7.46 – 7.35 (m, 3H), 7.30 – 7.17 (m, 2H), 
6.49 (d, J=9.7, 1H), 5.92 (br s, 1H), 5.67 (dd, J=9.7, 5.1, 1H), 1.58 (s, 9H), 1.41 (s, 9H); 13C 
NMR (101 MHz, CDCl3) δ: 165.4, 152.3, 140.7, 140.0, 139.8, 135.0, 125.9, 123.0, 123.0, 
121.9, 120.3, 120.3, 119.4, 118.4, 118.0, 110.7, 108.7, 108.6, 83.2, 80.4, 58.1, 28.3, 27.9; IR 
(neat, cm-1): 3391, 2974, 1707, 1587, 1367, 1241, 1133, 1010, 905, 849, 775; HRMS (ESI): 
m/z calculated for C27H30N2O4 (M+H)
+: 447.2206. Found 447.2283.  
 
Di-tert-butyl 6-(2-methylquinolin-6-yl) pyridine-1,3(6H)-dicarboxylate (110q): 
 
Following GP-96a- Conditions I, 110q was prepared from 96a (141 mg, 0.5 mmol, 1 equiv) 
and 6-bromo-2-methylquinoline (167 mg, 0.75 mmol, 1.5 equiv). The crude product was 
purified by column chromatography (silica gel, PE/ EtOAc= 20:1) to afford 110q as a yellow 
oil (85 mg, 40% yield). Rf = 0.25 (PE/ EtOAc= 10:1). Reaction time was 56 hours. 
Following GP-99- Conditions II, 110q was prepared from 99a (420 mg, 1.5 mmol, 3 equiv) 
and   6-bromo-2-methylquinoline (111 mg, 0.5 mmol, 1 equiv) to afford 110q (123 mg, 58% 
yield. Yield based on aryl halide). Reaction time was 56 hours. 
 102 
1H NMR (400 MHz, CDCl3) δ: 8.05 – 7.89 (m, 3H), 7.71 – 7.60 (m, 2H), 7.25 – 7.19 (m, 1H), 
6.43 (d, J=9.9, 1H), 5.88 (s, 1H), 5.59 (dd, J=9.8, 5.2, 1H), 2.63 (s, 3H), 1.44 (s, 9H), 1.29 (s, 
9H). 13C NMR (101 MHz, CDCl3) δ: 165.0, 159.2, 152.0, 147.5, 139.3, 136.3, 134.8, 129.3, 
128.3, 126.2, 124.8, 122.3, 120.9, 119.1, 108.5, 83.3, 80.3, 57.0, 28.3, 27.9, 25.3; IR (neat, cm-
1): 2978, 1695, 1367, 1244, 1140, 1080, 976, 730; HRMS (ESI): m/z calculated for C25H30N2O4 
(M+H)+: 423.2206. Found 423.2278.  
 
 
Tri-tert-butyl 2-(4-methoxyphenyl) pyridine-1,3,5(2H)-tricarboxylate (110r): 
 
Following GP-96a- Conditions I, 110r was prepared from 99 (190 mg, 0.5 mmol, 1 equiv) and 
4-iodoanisole (175 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc= 30:1) to afford 110r as a yellowish oil (120 mg, 50 % 
yield). Rf = 0.55 (PE/ EtOAc =10:1). Reaction time was 56 hours. 
Following GP-99- Conditions II, 110r was prepared from 99 (570 mg, 1.5 mmol, 3 equiv) and 
4-iodoanisole (117 mg, 0.5 mmol, 1 equiv) to afford 110r (178 mg, 73% yield. Yield based on 
aryl halide). Reaction time was 56 hours. 
1H NMR (400 MHz, CDCl3) δ: 8.06 (br s, 1H), 7.51 (d, J=1.3, 1H), 7.32 – 7.24 (m, 2H), 6.80 
– 6.71 (m, 2H), 6.14 (br s, 1H), 3.74 (s, 3H), 1.50 (s, 9H), 1.44 (s, 9H), 1.38 (s, 9H); 13C NMR 
(101 MHz, CD3CN) δ 165.0, 164.8, 160.6, 152.4, 139.3, 134.1, 129.4, 129.0, 124.2, 114.6, 
109.3, 84.9, 81.7, 81.4, 55.8, 55.7, 28.4, 28.2, 28.0; IR (neat, cm-1) 2978, 1699, 1513, 1457, 
1367, 1244, 1133, 1032, 909, 846, 767, 730; HRMS (ESI): m/z calculated for C27H37NO7 
(M+H)+: 488.2570. Found 488.2658.  
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Di-tert-butyl 5-formyl-6-(4-methoxyphenyl)pyridine-1,3(6H)-dicarboxylate (110s): 
 
Following GP-96a- Conditions I, 110s was prepared from 100a (100 mg, 0.32 mmol) and 4-
iodoanisole (115 mg, 0.48 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc= 5:1) to afford 110s as a yellowish oil (55 mg, 42% 
yield). Rf = 0.65 (PE/ EtOAc= 2:1). Reaction time was 36 hours. 
1H NMR (400 MHz, Chloroform-d) δ 9.43 (s, 1H), 8.32 (s, 1H), 7.37 (d, J = 1.2 Hz, 1H), 7.29 
(d, J = 8.7 Hz, 2H), 6.80 (d, J = 8.8 Hz, 2H), 6.20 (s, 1H), 3.76 (s, 3H), 1.55 (s, 9H), 1.45 (s, 
9H); 13C NMR (101 MHz, CDCl3) δ 189.7, 164.0, 159.7, 141.5, 138.2, 133.3, 131.3, 128.4, 
127.7, 113.8, 107.9, 84.8, 81.3, 55.3, 54.3, 28.4, 28.0; HRMS (ESI): m/z calculated for 
C23H29NO6 (M+H)
+: 416.1995. Found 416.9999. 
 
 104 
3.1 General Procedure for One-Pot Synthesis of Pyridines (GP-2). 
The toluene solution from dihydropyridine formation (see GP-96a) was cooled to 0 °C in an 
ice bath and stirred at this temperature for 5 min before DDQ (283.75 mg, 1.25 mmol, 2.5 equiv) 
was added. The mixture was stirred at 0 oC for an additional hour and then allowed to warm to 
room temperature overnight. After complete consumption of the starting material (as monitored 
by TLC), the reaction solution was thoroughly washed with NaHCO3, brine and the aqueous 
phases were extracted with CH2Cl2 (3 x 10 mL). The organic layers were combined, dried over 
anhydrous Na2SO4 and filtered. The obtained solution was concentrated and subjected to 
column chromatography using PE/EtOAc as eluent to afford products 111a-111e.  
 
 
Methyl 6-(4-methoxyphenyl) nicotinate (111a-Me): 
 
Following GP-2, 111a-Me was prepared from 96a-Me (120 mg, 0.5 mmol) and 4-iodoanisole 
(175 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column chromatography 
(silica gel, PE/ EtOAc= 30:1) to afford 111a-Me as a beige solid (77.5 mg, 65% yield); Rf = 
0.25 (PE/ EtOAc =10:1). Mp = 161-165 oC.  
1H NMR (400 MHz, CDCl3) δ: 9.22 (d, J = 2.1 Hz, 1H), 8.28 (dd, J = 8.4, 2.1 Hz, 1H), 8.05 – 
8.00 (m, 2H), 7.73 (d, J = 8.4 Hz, 1H), 7.04 – 6.96 (m, 2H), 3.95 (s, 3H), 3.87 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ: 166.1, 161.4, 160.6, 151.0, 137.8, 130.9, 128.9, 123.5, 119.0, 
114.4, 55.5, 52.3; IR (neat, cm-1): 2952, 1714, 1591, 1472,1431, 1248, 1110, 1017, 827, 782, 
738; HRMS (ESI): m/z calculated for C14H13NO3 (M+H)
+: 244.0895. Found 244.0974. 
 
 
 105 
Methyl 6-phenylnicotinate (111b-Me): 
 
Following GP-2, 111b-Me was prepared from 96a-Me (120 mg, 0.5 mmol) and iodobenzene 
(153 mg, 84 mL, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc = 30:1) to afford 111b-Me as a beige solid (64 mg, 60% 
yield); Rf = 0.35 (PE/ EtOAc =10:1). Mp = 155-157 
oC.  
1H NMR (400 MHz, CDCl3) δ: 9.28 (d, J = 2.0 Hz, 1H), 8.34 (dd, J = 8.3, 2.0 Hz, 1H), 8.10 – 
8.02 (m, 2H), 7.81 (d, J = 8.3 Hz, 1H), 7.55 – 7.44 (m, 3H), 3.97 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ: 166.0, 161.0, 151.0, 138.4, 138.0, 130.0, 129.0, 127.4, 124.3, 119.9, 52.4; IR (neat, 
cm-1): 2944, 1714, 1591, 1285, 1199, 1114, 1077, 846, 749, 697; HRMS (ESI): m/z calculated 
for C13H11NO2 (M+H)
+: 214.0790. Found 214.0868.  
 
 
Methyl 6-(4-chlorophenyl) nicotinate (111c): 
 
Following GP-2, 111c-Me was prepared from 96a-Me (120 mg, 0.5 mmol) and 1-chloro-4-
iodobenzene (178 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc = 30:1) to afford 111c-Me as a brownish solid (73 mg, 
59% yield). Rf = 0.4 (PE/ EtOAc = 10:1). Mp = 125-128 
oC. 
1H NMR (400 MHz, CDCl3) δ: 9.26 (dd, J=2.2, 1.0, 1H), 8.34 (dd, J = 8.3, 2.2 Hz, 1H), 8.04 
– 7.98 (m, 2H), 7.78 (d, J = 8.3 Hz, 1H), 7.49 – 7.44 (m, 2H), 3.97 (s, 3H), 13C NMR (101 
MHz, CDCl3) δ: 165.8, 159.7, 151.1, 138.1, 136.7, 136.3, 129.2, 128.7, 124.5, 119.7, 52.5; IR 
(neat, cm-1): 2929, 1699, 1595, 1472, 1367, 1293, 1210, 842, 782; HRMS (ESI): m/z calculated 
for C13H10ClNO2 (M+H)
+: 248.0400. Found 248.0476.  
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Tert-butyl 6-(4-nitrophenyl) nicotinate (111a): 
 
Following GP-2, 111a was prepared from 96a (141 mg, 0.5 mmol) and 1-iodo-4-nitrobenzene 
(186 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column chromatography 
(silica gel, PE/ EtOAc = 30:1) to afford 111a as a yellow solid (80 mg, 53% yield). Rf = 0.32 
(PE/ EtOAc =10:1); Mp = 103-105 oC. 
1H NMR (400 MHz, CDCl3) δ: 9.27 (s, 1H), 8.43 – 8.30 (m, 3H), 8.24 (d, J = 8.8 Hz, 2H), 
7.83 (d, J = 8.5 Hz, 1H), 1.64 (s, 9H). 13C NMR (101 MHz, CDCl3) δ: 164.1, 157.8, 151.3, 
138.2, 128.4, 128.2, 127.3, 124.5, 124.2, 120.6, 82.5, 28.3; IR (neat, cm-1): 2987, 1710, 1513, 
1252, 1341, 1107, 1017, 838, 745; HRMS (ESI): m/z calculated for C16H16N2O4 (M+H)
 +: 
301.1110. Found 301.1195 
 
 
Tert-butyl 6-(4-fluorophenyl)nicotinate (111b): 
  
Following GP-2, 111b was prepared from 96a (141 mg, 0.5 mmol) and 4-fluoroiodobenzene 
(167 mg, 86 mL, 0.75 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc = 20:1,) to afford 111b as a yellow solid (69 mg, 50% 
yield). Rf = 0.35 (PE/ EtOAc =10:1); Mp = 110-112 
oC. 
1H NMR (600 MHz, CDCl3) δ: 9.21 (dd, J=2.2, 0.9, 1H), 8.29 (dd, J=8.3, 2.2, 1H), 8.09 – 8.02 
(m, 2H), 7.74 (dd, J=8.3, 0.9, 1H), 7.21 – 7.15 (m, 2H), 1.62 (s, 9H); 13C NMR (151 MHz, 
CDCl3) δ: 164.5, 164.1, 159.4, 151.0, 138.0, 134.6, 129.4, 126.0, 119.5, 116.0, 82.1, 28.3; 19F 
NMR (377 MHz, CDCl3) δ: -111.96; IR (neat, cm-1) 2952, 1714, 1587, 1289, 1244, 1107, 1017, 
838, 745; HRMS (ESI): m/z calculated for C16H16N2O4 (M+H)
 +: 273.1165. Found 273.1200. 
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Methyl 6-(naphthalen-1-yl) nicotinate (111d-Me): 
 
Following GP-2, 111d-Me was prepared from 96a (120 mg, 0.5 mmol) and1-iodonaphthalene 
(190 mg, 0.75 mmol, 1.5 equiv). The crude product was purified by column chromatography 
(silica gel, PE/ EtOAc= 20:1,) to afford 111d-Me as a yellow solid (69 mg, 50% yield). Rf = 
0.5 (PE/ EtOAc =10:1); Mp = 87-90 oC. 
1H NMR (400 MHz, CDCl3) δ: 9.42 – 9.37 (m, 1H), 8.41 (dd, J=8.1, 2.2, 1H), 8.13 – 8.07 (m, 
1H), 7.97 – 7.89 (m, 2H), 7.70 – 7.61 (m, 2H), 7.59 – 7.45 (m, 3H), 4.00 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ: 165.8, 163.1, 150.7, 137.5, 137.5, 133.9, 130.8, 129.7, 128.5, 127.9, 
126.8, 126.1, 125.3, 125.2, 124.6, 124.2, 52.4; IR (neat, cm-1): 2952, 1718, 1595, 1438, 1282, 
1125, 1021, 770, 764; HRMS (ESI): m/z calculated for C17H13NO2 (M+H)
+: 264.0946. Found 
264.1023.  
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Tert -Butyl -5-(hydroxymethyl)-2-(4-methoxyphenyl)pyridine-1(2H)-carboxylate (113): 
 
Following GP-99a- Conditions I, 112 (100 mg, 0.5 mmol) and 4-iodoanisole (175 mg, 0.75 
mmol, 1.5 equiv) were reacted to yield after column chromatography (silica gel, PE/ EtOAc= 
2:1) 113 as a yellowish oil (65 mg, 41% yield) and 114 as a yellowish oil (28 mg, 18% yield). 
Reaction time was 48 hours. 
Rf = 0.30 (PE/ EtOAc= 2:1). 1H NMR (400 MHz, Acetonitrile-d3) δ 7.28 (d, J = 8.7 Hz, 2H), 
6.86 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 31.0 Hz, 1H), 6.05 (d, J = 9.1 Hz, 1H), 5-79-5.61 (m, 2H), 
4.06 – 3.95 (m, 2H), 3.76 (s, 3H), 2.79 (s, 1H), 1.44 (s, 9H); 13C NMR (101 MHz, CD3CN) δ 
160.1, 135.8, 128.7, 124.4, 124.0, 123.6, 122.8, 122.4, 114.6, 82.1, 79.1, 62.8, 55.8, 28.3 (signal 
doubling due to rotamers); HRMS (ESI): m/z calculated for C18H23NO4 (M+H)
+: 318.1627. 
Found 318.1706. 
Tert-Butyl-3-formyl-6-(4-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate (114): 
 
114: Rf = 0.5 (PE/ EtOAc= 2:1).1H NMR (400 MHz, Acetonitrile-d3) δ 9.39 (s, 1H), 7.13 (d, J 
= 8.4 Hz, 1H), 7.09 (dd, J = 4.9, 2.8 Hz, 1H), 6.85 (d, J = 8.8 Hz, 1H), 5.59 (d, J = 5.1 Hz, 1H), 
4.37 (d, J = 18.6 Hz, 1H), 3.75 (s, 3H), 3.29 (d, J = 17.9 Hz, 1H), 2.88 (dd, J = 7.7, 4.7 Hz, 2H), 
1.47 (s, 9H); 13C NMR (101 MHz, CD3CN) δ 192.4, 159.4, 155.2, 147.7, 138.5, 132.7, 128.3, 
114.3, 80.4, 78.7, 55.4, 30.4, 29.6, 28.1; HRMS (ESI): m/z calculated for C18H23NO4 (M+H)
+: 
318.1627. Found 318.1626. 
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3.2 Derivatization Reactions 
1-(tert-Butyl) 3-methyl 6-phenyl-5,6-dihydropyridine-1,3(4H)-dicarboxylate (119): 
 
Pd/C (10 wt.%) (7 mol%, 37 mg) was added to 110g-Me (0.5 mmol, 158 mg) dissolved in dry 
THF (1 mL) and the resulting suspension was intensively stirred at 25 oC under H2 (balloon) 
for 3 hours. After that time, the mixture was filtered over a plug of Celite, concentrated under 
reduced pressure, and purified by column chromatography (silica gel, PE/EtOAc) to afford 119 
as a white solid (123 mg, 77% yield). Mp = 118-120 oC; Rf = 0.58 (PE/EA= 10:1).  
1H NMR (400 MHz, CDCl3) δ: 8.33 (br s, 1H), 7.37 – 7.17 (m, 3H), 7.10 – 7.04 (m, 2H), 5.32 
(s, br 1H), 3.73 (s, 3H), 2.38 (d, J=16.6, 1H), 2.12 – 2.02 (m, 1H), 2.02 – 1.89 (m, 1H), 1.89 – 
1.75 (m, 1H), 1.37 (br s, 9H). 13C NMR (101 MHz, CDCl3) δ: 167.9, 151.9, 141.3, 135.9, 128.5, 
127.0, 125.1, 107.5, 82.5, 55.2, 51.3, 27.9, 27.2, 16.5; IR (neat, cm-1): 2952, 1725, 1692, 1636, 
1312, 1244, 1133, 764, 680; HRMS (ESI): m/z calculated for C18H23NO4 (M+H)
+: 318.1627. 
Found 318.1699. 
 
 
 
3,5-Di-tert-butyl 7-methyl (1R,2S,6S,7R)-2-(4-methoxyphenyl)-7-phenyl-3-azabicyclo-
[4.1.0]hept-4-ene-3,5,7-tricarboxylate ((+)-122): 
 
A solution of methyl phenyldiazoacetate (48 mg, 0.272 mmol, 1.5 equiv) in dry petroleum ether 
(1.2 mL) was added using a syringe pump (addition rate:1 drop/10 s) to a vigorously stirred 
mixture of dihydropyridine (-)-110a (70 mg, 0.181 mmol) and Rh2(OAc)4 (2.4 mg, 5.4 µmol, 
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3 mol%) in the same solvent (1.2 mL) at 25 oC under an atmosphere of nitrogen. After the 
addition was completed, the resulting mixture was left for additional 30 min and then the solvent 
was evaporated. Column chromatography eluting with Et2O/PE afforded (+)-122 as colorless 
crystals (71 mg, 70%). Rf = 0.41 (20% EtOAc/PE); Mp= 150-151 
oC; [α]D20= +51.9  o(c 1.0, 
CHCl3). 
1H NMR (400 MHz, DMF, 80 oC) δ: 7.47 (s, 1H), 7.40 – 7.26 (m, 7H), 7.00 – 6.95 (m, 2H), 
5.64 (s, 1H), 3.83 (s, 3H), 3.61 (s, 3H), 2.92 (dd, J = 9.8, 0.9 Hz, 1H), 2.71 (dd, J = 9.8, 0.7 Hz, 
1H), 1.59 (s, 9H), 1.29 (s, 9H); 13C NMR (101 MHz, C6D6, 70 
oC) δ: 172.1, 166.4, 159.9, 150.8, 
135.1, 134.9, 133.8, 131.2, 128.6, 128.1, 127.6, 114.6, 108.2, 81.8, 79.8, 54.9, 52.0, 50.9, 40.95, 
36.6, 28.4, 27.9, 24.2; IR (neat, cm-1): 2974, 2937, 1718, 1689, 1644, 1510, 1368, 1234, 1170, 
1141, 988, 705; HRMS (ESI): calculated for C31H37NO7Na (M+Na)+ 558.2462. Found 
558.2466. 
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4. General Procedure of 5-Substituted 3-Pyrrolidin-2-ones synthesis (GP-3): 
An oven dried 10 mL Schleck flask equipped with a magnetic stir bar and septum was charged 
with heteroarene 146 (15 equiv.), Na2CO3 (106 mg, 1 mmol, 2 equiv) and ( fac-Ir(ppy)3 (3,27 
mg, 1.00 mol %) in 2 mL dry DMF, then substrate 124 (167 mg, 0.5 mmol, 1 equiv.) was added. 
The resulting suspension was deoxygenated by three freeze-pump-thaw cycles (3x). The 
reaction mixture was irradiated with blue light emitting diode (LED, λmax= 455nm) at -10 oC 
for 20 minutes. After complete conversion of starting materials (monitored by TLC analysis), 
the reaction mixture was saturated with brine solution (15 mL) and the product was extracted 
with ethyl acetate (3x15 mL), the combined organic layers were dried over Na2SO4 and 
concentrated, the residue was purified by column chromatography on silicagel using PE/ 
EtOAc, as eluent to afford products 147a-147e.  
 
Tert-butyl-2-((R)-1-(furan-2-yl)-2-methoxy-2-oxoethyl)-5-oxo-2,5-dihydro-1H-pyrrole-1-
carboxylate (147a, 147´a): 
 
 
 
 
 
Following GP-3, 147a and 147´a was prepared from 124 (100 mg, 0,3 mmol) and furan (15 
equiv, 3 mmol, 0.217 mL). The crude product was purified by column chromatography (silica 
gel, PE/ EtOAc= 10:1) to afford both 147a and 147´a as a dark yellow oil (69mg, 70% yield). 
147a - Rf = 0.4 and 147´a - Rf = 0.3 (PE/ EtOAc= 10:1). The diastereomeric ratio was deter-
mined by NMR (7:1) 147a major and 147´a minor d.r. 
 
147a: 1H NMR (300 MHz, CDCl3) δ 7.44 (dd, J = 6.2, 2.1 Hz, 1H), 7.25 (d, J = 0.7 Hz, 1H), 
6.25 (dd, J = 3.2, 1.9 Hz, 1H), 6.10 – 6.07 (m, 1H), 5.95 (dd, J = 6.2, 1.6 Hz, 1H), 5.13 – 5.09 
(m, 1H), 4.93 (d, J = 4.3 Hz, 1H), 3.78 (s, 3H), 1.59 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 
169.8, 168.40 , 149.51 , 148.31 , 145.82, 142.82 , 127.61, 110.41, 110.23, 83.55, 62.14, 52.71 
, 45.30, 28.11; IR (neat, cm-1): 3116, 2981, 1781, 1736, 1707, 1502, 1438, 1356, 1315, 1252, 
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1151, 987, 935, 834, 749. HRMS (ESI): exact m/z calculated for C16H19NO6 (M+H)+ : 
322,1212; Found  322,1216 (M+H)+. 
 
147´a: 1H NMR (300 MHz, Chloroform-d) δ 7.48 – 7.40 (m, 1H), 7.29 (dd, J = 6.2, 2.0 Hz, 
1H), 6.44 – 6.37 (m, 2H), 6.13 (dd, J = 6.2, 1.6 Hz, 1H), 5.01 – 4.95 (m, 1H), 4.87 (d, J = 4.5 
Hz, 1H), 3.65 (s, 3H), 1.60 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 168.61, 168.22, 149.33, 
148.01, 147.51, 142.81, 127.32, 110.73, 109.31, 83.61, 62.83, 52.51, 46.12, 28.11; IR (neat, 
cm-1):  3112, 2978, 1736, 1628, 1438, 1356, 1315, 1252, 1103, 1151, 1047, 842, 805, 745; 
HRMS (ESI): exact m/z calculated for C16H19NO6 (M+H)+ : 322.1212; Found  322.1216 
(M+H)+.  
 
 
Tert-butyl -2-((R)-2-methoxy-1-(5-methylfuran-2-yl)-2-oxoethyl)-5-oxo-2,5-dihydro-1H-
pyrrole-1-carboxylate (147b, 147´b): 
 
 
 
 
 
Following GP-3, 147b and 147´b was prepared from 124 (100 mg, 0,3 mmol) and 2-methylfu-
ran (15 equiv, 3 mmol, 0.265 mL). The crude product was purified by column chromatography 
(silica gel, PE/ EtOAc= 10:1) to afford both 147b and 147´b as a brawn oil (44 mg, 43% yield). 
147b- Rf = 0.5 and 147´b- Rf = 0.4 (PE/ EtOAc= 10:1).  The diastereomeric ratio was deter-
mined by NMR (3:1) 147b major and 147´b minor dr. 
 
 147b: 1H NMR (400 MHz, Chloroform-d) δ 7.45 (dd, J = 6.2, 2.1 Hz, 1H), 5.97 (dd, J = 6.2, 
1.6 Hz, 1H), 5.95 (d, J = 3.1 Hz, 1H), 5.81 (dd, J = 3.0, 0.8 Hz, 1H), 5.09 (m, J = 6.2 Hz, 1H), 
4.87 (d, J = 4.4 Hz, 1H), 3.77 (s, 3H), 2.16 (d, J = 0.5 Hz, 3H), 1.59 (d, J = 3.8 Hz, 9H); 13C 
NMR (101 MHz, CDCl3) δ 170.1, 168.5, 152.4, 149.5, 148.4, 143.8, 127.5, 111.0, 106.4, 83.4, 
62.1, 52.6, 45.3, 28.1, 13.51; IR (neat, cm-1):  3104, 2981,1781, 1736, 1707, 1628, 1561, 1438, 
1356, 1319, 1282, 1252, 1155, 939, 872, 797, 693. HRMS (ESI): exact m/z calculated for 
C16H19NO6 (M+H)
+ : 336,1369; Found  336,1372 (M+H)+.  
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147´b: 1H NMR (400 MHz, CDCl3) δ 7.32 (dd, J = 6.2, 2.0 Hz, 1H), 6.26 (d, J = 3.1 Hz, 1H), 
6.13 (dd, J = 6.2, 1.7 Hz, 1H), 5.95 (dd, J = 3.0, 1.0 Hz, 1H), 4.99 – 4.92 (m, 1H), 4.82 (d, J = 
4.5 Hz, 1H), 3.64 (s, 3H), 2.29 (s, 3H), 1.60 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 168.7, 
168.3, 152.6, 149.3, 148.3, 145.5, 127.1, 110.0, 106.6, 83.5, 62.9, 52.4, 46.1, 28.1, 13.6; IR 
(neat, cm-1):  3354, 2929, 2855, 1774, 1736, 1628, 1438, 1319, 1282, 1252, 1103, 1051, 946, 
842, 797, 749; HRMS (ESI): exact m/z calculated for C16H19NO6 (M+H)
+ : 336,1369; Found  
336,1372 (M+H)+.  
 
Tert-butyl-2-((R)-2-methoxy-2-oxo-1-(1H-pyrrol-2-yl)ethyl)-5-oxo-2,5-dihydro-1H-
pyrrole-1-carboxylate (147c, 147´c): 
 
Following GP-3, 147c and 147´c was prepared from 124 (100 mg, 0,3 mmol) and furan (15 
equiv, 3 mmol, 0.217 mL). The crude product was purified by column chromatography (silica 
gel, PE/ EtOAc= 10:1) to afford both 147c and 147´c as a dark yellow oil (66 mg, 67% yield). 
147c- Rf = 0.25 and 147´c-Rf = 0.2 (PE/ EtOAc= 10:1). The diastereomeric ratio was 
determined by NMR (8:1) 147c major and 147´c minor d.r. 
147c: 1H NMR (400 MHz, Chloroform-d) δ 8.53 (s, 1H), 7.27 – 7.24 (m, 1H), 6.66 (dd, J = 
4.1, 2.7 Hz, 1H), 6.07 (dd, J = 5.9, 2.8 Hz, 1H), 5.95 (dd, J = 6.2, 1.5 Hz, 1H), 5.87 (t, J = 3.6 
Hz, 1H), 5.03 – 4.94 (m, 1H), 4.76 (d, J = 4.5 Hz, 1H), 3.80 (s, 3H), 1.60 (s, 9H);13C NMR (75 
MHz, CDCl3) δ 168.6, 168.2, 149.3, 148.0, 147.5, 142.8, 127.3, 110.7, 109.3, 83.6, 62.8, 52.5, 
46.1, 28.1; IR (neat, cm-1): 3112, 2978, 1736, 1628, 1438, 1356, 1315, 1252, 1103, 1151, 1047, 
842, 805, 745; HRMS (ESI): exact m/z calculated for C16H19NO6 (M+H)
+ : 322.1212; Found  
322.1216 (M+H)+.  
 
147´c: 1H NMR (400 MHz, Chloroform-d) δ 9.15 (s, 1H), 7.03 (dd, J = 6.2, 2.0 Hz, 1H), 6.79 
(dd, J = 4.1, 2.6 Hz, 1H), 6.21 – 6.14 (m, 1H), 6.09 (dd, J = 6.2, 1.6 Hz, 2H), 4.91 (d, J = 5.4 
Hz, 1H), 4.82 (dt, J = 5.4, 1.9 Hz, 1H), 3.66 (s, 3H), 1.61 (s, 9H); 13C NMR (75 MHz, 
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CDCl3) δ 169.8, 168.4 , 149.5 , 148.3 , 145.8, 142.8 , 127.6, 110.4, 110.2, 83.5, 62.1, 52.7 , 
45.3, 28.1; IR (neat, cm-1):  3116, 2981, 1781, 1736, 1707, 1502, 1438, 1356, 1315, 1252, 
1151, 987, 935, 834, 749. HRMS (ESI): exact m/z calculated for C16H19NO6 (M+H)
+ : 
322,1212; Found  322,1216 (M+H)+.  
 
Tert-butyl-2-((R)-2-methoxy-1-(1-methyl-1H-pyrrol-2-yl)-2-oxoethyl)-5-oxo-2,5-dihydro-
1H-pyrrole-1-carboxylate (147d, 147´d): 
 
 
 
Following GP-3, 147d and 147´d was prepared from 124 (100 mg, 0,3 mmol) and N-
Methylpyrrole (15 equiv, 3 mmol, 0.265 mL). The crude product was purified by column 
chromatography (silica gel, PE/ EtOAc= 10:1) to afford both 147d and 147´d as a brawn oil 
(80 mg, 80% yield). 147d- Rf = 0.4 and 147´d - Rf = 0.3 (PE/ EtOAc= 10:1). The diastereomeric 
ratio was determined by NMR (3:1) 147d major and 147´d minor dr. 
147d: 1H NMR (400 MHz, CDCl3) δ 7.57 (dd, J = 6.2, 2.0 Hz, 1H), 6.51 – 6.45 (m, 1H), 6.00 
(dd, J = 6.2, 1.6 Hz, 1H), 5.98 – 5.95 (m, 1H), 5.80 (dd, J = 3.7, 1.6 Hz, 1H), 5.10 (dt, J = 3.8, 
1.8 Hz, 1H), 4.80 (d, J = 3.9 Hz, 1H), 3.71 (s, 3H), 3.48 (s, 3H), 1.57 (s, 9H);  13C NMR (101 
MHz, CDCl3) δ 171.5, 168.5, 150.3, 149.6, 127.6, 123.2, 109.5, 107.9, 83.6, 62.8 , 52.5, 42.8, 
33.6, 28.1; IR (neat, cm-1):  2981, 1781, 1936, 1703, 1606, 1487, 1457, 1315, 1252, 1215, 10054, 
834, 715; HRMS (ESI): exact m/z calculated for C17H22N2O5 (M+H)
+ 335,1529; Found 
335,1531 (M+H)+. 
 
 
147´d: 1H NMR (400 MHz, CDCl3) δ 7.36 (dt, J = 6.5, 3.3 Hz, 1H), 6.67 – 6.62 (m, 1H), 6.27 
(dd, J = 3.6, 1.6 Hz, 1H), 6.12 (dd, J = 6.0, 2.3 Hz, 1H), 4.88 (d, J = 4.7 Hz, 1H), 4.74 – 4.64 
(m, 1H), 3.70 (s, 3H), 3.62 (s, 3H), 1.60 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 169.1, 168.7, 
150.1, 148.7, 127.6, 124.5, 123.3, 109.3, 107.0, 83.6, 63.0, 52.2, 43.6, 34.0, 28.1; IR (neat, cm-
1): 2922, 2851, 1781, 1736, 1703, 1606, 1457, 1315, 1252, 1155, 1051, 1107, 998, 842, 716; 
HRMS (ESI): exact m/z calculated for C17H22N2O5 (M+H)
+ :335,1529; Found  335, 1531 
(M+H)+. 
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Tert-butyl 2-(1-(1-(tert-butoxycarbonyl)-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)-2-methoxy 2-
oxoethyl)-1H-pyrrole-1-carboxylate (147e, 147´e): 
 
 
 
 
Following GP-3, 147e and 147´e was prepared from 124 (100 mg, 0,3 mmol) and N-Boc-
pyrrole (15 equiv, 3 mmol, 0.5 mL). The crude product was purified by column chromatography 
(silica gel, PE/ EtOAc= 10:1) to afford both 147e and 147´e as a brawn oil (60 mg, 48% yield). 
147e- Rf = 0.4 and 147´e- Rf = 0.3 (PE/ EtOAc= 10:1). The diastereomeric ratio was determined 
by NMR (2:1) 147e major and 147´e minor d.r. 
 
 147e: 1H NMR (400 MHz, CDCl3) δ 7.43 (dd, J = 6.1, 2.2 Hz, 1H), 7.14 – 7.05 (m, 1H), 6.04 
(t, J = 3.4 Hz, 1H), 5.99 (dd, J = 3.3, 1.7 Hz, 1H), 5.85 (dd, J = 6.1, 1.5 Hz, 1H), 5.41 (d, J = 
4.2 Hz, 1H), 5.31 – 5.23 (m, 1H), 3.71 (s, 3H), 1.58 (s, 9H), 1.54 (s, 9H); 13C NMR (101 MHz, 
CDCl3) δ 170.9, 168.9, 149.3, 149.1, 126.2, 125.6, 122.7, 116.5, 110.1, 84.1, 83.1, 63.0, 52.2, 
44.7, 28.1, 27.9, 27.9; IR (neat, cm-1):   2981, 1781, 1736, 1435, 1367, 1315, 1248, 1155, 1062, 
913, 842, 723; HRMS (ESI): exact m/z calculated for C21H28N2O7 (M+H)
+ : 421,1897; Found  
421,1898 (M+H)+.  
 
 
 147´e: 1H NMR (400 MHz, Chloroform-d) δ 7.24 (dt, J = 3.5, 1.8 Hz, 2H), 6.29 (dd, J = 3.0, 
1.3 Hz, 1H), 6.15 (t, J = 3.4 Hz, 1H), 6.11 (dd, J = 6.2, 1.5 Hz, 1H), 5.29 – 5.26 (m, 1H), 5.24 
(d, J = 5.0 Hz, 1H), 3.62 (s, 3H), 1.57 (s, 9H), 1.55 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 
169.7, 169.0, 149.3, 149.1, 148.3, 127.6, 127.4, 122.4, 113.8, 110.2, 84.3, 83.4, 62.0, 52.1, 45.9, 
28.1, 27.9; IR (neat, cm-1): 2981, 1781, 1736, 1479, 1367, 1312, 1252, 1151, 1118, 914, 842, 
771; HRMS (ESI): exact m/z calculated for C21H28N2O7 (M+H)
+ : 421,1897; Found  421, 1898 
(M+H)+.  
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Tert-butyl (E)-2-(2-methoxy-2-oxoethylidene)-5-oxo-2,5-dihydro-1H-pyrrole-1-
carboxylate (145): 
 
 
 
An oven dried 10 mL Schleck flask equipped with a magnetic stirring bar was charged with 
substrate 124 (167 mg, 0.5 mmol), fac-Ir(ppy)3 (3,27 mg, 0.005 mmol, 1.00 mol %) in 2 mL 
dry DMF. The resulting suspension was deoxygenated by three freeze-pump-thaw cycles. The 
reaction mixture was irradiated with blue light emitting diode (LED, λmax= 455nm) at room 
temperature for 10 min. After complete conversion of starting materials, the reaction mixture 
was saturated with brine solution (15 mL) and the product was extracted with ethyl acetate 
(3x15 mL), the combined organic layer was dried over Na2SO4, and concentrated under reduced 
pressure and subjected to column chromatography using PE/ EtOAc= 10:1 as an eluent to afford 
145 (90 mg, 71% yield) as a white solid, Mp= 125-127 oC, Rf = 0.6 (PE/ EtOAc= 10:1).  
 
1H NMR (300 MHz, CDCl3) δ 8.37 (dd, J = 6.2, 0.6 Hz, 1H), 6.93 – 6.68 (m, 1H), 6.20 (ddd, 
J = 6.2, 1.6, 0.6 Hz, 1H), 3.71 (t, J = 8.8 Hz, 3H), 1.53 (t, J = 5.6 Hz, 9H); 13C NMR (75 MHz, 
CDCl3) δ 167.1, 166.2, 148.6, 147.5, 138.1, 125.9, 106.5, 84.9, 77.4, 77.0, 76.6, 51.9, 28.0; IR 
(neat, cm-1): 2985, 1759, 1632, 1453, 1297, 1133, 987, 823, 730; HRMS (ESI): exact m/z 
calculated for C12H15NO5 (M+H)
+ : 254,0950; Found  254,1024 (M+H)+.  
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The experimental procedure for capturing radicals 150. 
 
 
An oven dried 10 mL Schleck flask equipped with a magnetic stirring bar was charged with 
substrate 124 (167 mg, 0.5 mmol), fac-Ir(ppy)3 (3,27 mg, 0.005 mmol, 1.00 mol %) and 
TEMPO (2 equiv) in 2 mL dry DMF. The resulting suspension was deoxygenated by three 
freeze-pump-thaw cycles (3x). The reaction mixture was irradiated with blue light emitting 
diode (LED, λmax= 455nm) at room temperature. After 30 minutes of irradiation, a TEMPO 
trapped compound 150 was detected by mass spectra. 
 
 
Tert-butyl 2-(2-methoxy-2-oxoethyl)-5-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate (148): 
 
 
 
An oven dried 10 mL Schleck flask equipped with a magnetic stirring bar was charged 
with substrate 124 (167 mg, 0.5 mmol), fac-Ir(ppy)3 (3,27 mg, 0.005 mmol, 1.00 mol %) and 
DIPEA (1.5 mmol, 3 equiv) in 2 mL dry DMF. The resulting suspension was deoxygenated by 
three freeze-pump-thaw cycles (3x). The reaction mixture was irradiated with blue light 
emitting diode (LED, λmax= 455nm) at room temperature for 10 min. After complete 
conversion of starting materials, the reaction mixture was saturated with brine solution (15 mL) 
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and the product was extracted with ethyl acetate (3x15 mL), the combined organic layer was 
dried over Na2SO4, was concentrated under reduced pressure and subjected to column 
chromatography using PE/ EtOAc= 10:1 as a eluent to afford 148 a yellowish oil in 45% yield. 
Rf = 0.3 (PE/ EtOAc= 10:1). 
1H NMR (300 MHz, CDCl3): δ 1.56 (s, 9H), 2.43 (dd, J ) 10.0, 16.1 Hz, 1H), 3.33 (dd, J ) 4.0, 
16.1 Hz, 1H), 3.71 (s, 3H), 4.88 (ddd, J ) 1.9, 3.8, 10.0 Hz, 1H), 6.12 (dd, J ) 1.6, 6.1 Hz, 1H), 
7.34 (dd, J ) 2.0, 6.1 Hz, 1H). 13C NMR (75 MHz, CDCl3): ä 28.1, 36.5, 52.1, 58.7, 83.6, 127.0, 
149.3, 149.9, 168.6, 170.4.  
 
 
Methyl (E)-2-(5-oxopyrrolidin-2-ylidene)-2-(1H-pyrrol-2-yl)acetate (155): 
 
To a solution of 147c (50 mg, 0.15 mmol, 1 equiv) in DCM (1 mL) at 0 °C slowly was added 
SnCl4 (9 μL, 0.07 mmol, 0.5 equv) and stirred vigorously for 5 minutes. After the reaction 
mixture was quenched with water. The resultant solution was extracted with DCM, NaHCO3 
brine solution and was dried (Na2SO4). The residue obtained after removal of solvents was 
subjected to column chromatography (silica gel, PE/EtOAc= 3:1) to afford 155 as a yellowish 
oil (15 mg, 45%); Rf = 0.3 (PE/ EtOAc) = 1:1. 
1H NMR (600 MHz, Chloroform-d) δ 10.28 (s, 1H), 8.48 (s, 1H), 6.81 (s, 1H), 6.24 (s, 1H), 
6.07 (s, 1H), 3.77 (s, 3H), 2.97-2.85 (m, 2H), 2.56 – 2.42 (m, 2H); 13C NMR (151 MHz, CDCl3) 
δ 177.63, 168.03, 156.98, 124.01, 117.64, 109.21, 108.40, 96.78, 77.23, 77.02, 76.81, 52.02, 
28.07, 27.46; HRMS (ESI): exact m/z calculated for C11H12N2O3 (M+H)
+ : 221,0840; Found  
221,0830 (M+H)+;  
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5. General Procedure for arylation and arylsulfonylation of cyclopropanes  
 
5.1 Procedure for arylsulfonylation of cyclopropane 96a-Me 
 
2-(Tert-butyl) 6-methyl-4-(4-nitrophenyl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate 
(  163): 
 
 
 
An oven dried 10 mL Schleck flask equipped with a magnetic stir bar was charged with 
substrate 96a-Me (120 mg, 0.5 mmol) in 2 mL dry DMF. Then 4-nitrobenzenediazonium 
tetrafluoroborate (236 mg, 1mmol, 2 equiv) was added at -10 oC portion wise and resulting 
mixture was stirred for 15 minutes (note that longer reaction time give rise to decomposition of 
product). The resulting mixture was saturated with brine solution (15 mL) and the product was 
extracted with ethyl acetate (3x15 mL), the combined organic layer was dried over Na2SO4 and 
concentrated, the residue was purified by column chromatography (silica gel, PE/EtOAc= 10:1, 
was treated with 1 % TEA) to afford product 163 (58 mg, 33%) as a yellow oil. Rf = 0.6 
(PE/EtOAc = 3:1). 
1H NMR (300 MHz, Chloroform-d) δ 8.19 (d, J = 8.9 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 7.12 
(d, J = 63.2 Hz, 1H), 4.50 (d, J = 45.7 Hz, 1H), 3.75 (s, 3H), 3.24 – 3.09 (m, 1H), 1.56 (s, 9H), 
1.21 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 172.93, 150.5, 146.0, 140.0, 128.1, 124.8, 124.2, 
122.1, 83.1, 52.2, 44.5, 29.7, 28.2, 22.4; HRMS (+APCI): calcd. for C18H20N2O6 [M+H]+ 
361.1321, Found 361.1327. 
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5.2 General Procedure for arylsulfonylation of cyclopropanes (GP-4) 
 
An oven dried 10 mL Schlenk flask was charged with benzenesulfonyl chloride (1 mmol, 2 
equiv), K2HPO4 (174 mg, 1mmol, 2 equiv) and Ru(bpy)3 (7.48 mg, 2 mol %) in 1 mL dry 
acetonitrile. The resulting suspension was degassed by “pump-freeze-thaw” cycles (×3). The 
reaction mixture was irradiated with blue light emitting diode (LED, λmax = 455 nm) and then 
substrate 96a, 96a-Me or 96b-Me was added under positive nitrogen atmosphere. After 
complete conversion of starting materials (monitored by TLC analysis), the reaction mixture 
was saturated with brine solution (15 mL) and the product was extracted with ethyl acetate 
(3x15 mL), the combined organic layers were dried over Na2SO4 and concentrated, the residue 
was purified by column chromatography on silicagel using PE/ EtOAc, as eluent to afford 
products 171a-171g.  
 
 
2-(Tert-butyl) 6-methyl -4-((4-methoxyphenyl)sulfonyl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-
dicarboxylate (171a):  
 
Following GP-4, 171a was prepared from 96a-Me (120 mg, 0.5 mmol) and 4-
methoxybenzenesulfonyl chloride (206.65 mg, 1 mmol, 2 equiv). The crude product was 
purified by column chromatography (silica gel, PE/EA=10:1) to afford 171a as a yellowish oil 
(91 mg, 45% yield). Rf = 0.3 (PE/EA = 5:1). 
1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.8 Hz, 1H), 7.28 (s, 1H), 6.98 (t, J = 12.6 Hz, 1H), 
4.45 (s, 1H), 3.87 (s, 3H), 3.67 (s, 3H), 2.96 (d, J = 5.2 Hz, 1H), 1.52 (s, 9H), 0.97 (s, 1H); 13C 
NMR (101 MHz, CDCl3) δ 171.92, 163.63, 149.91, 137.01, 131.88, 129.59, 124.32, 114.60, 
84.22, 55.71, 52.27, 45.41, 28.06, 20.78; IR (neat, cm-1 ): 2881, 1719, 1576, 1498, 1371, 1256, 
1133, 1088, 976, 834, 670; HRMS (ESI): m/z calculated for C19H23NO7S (M+H)
+: 410,1195 ; 
Found 410,1538 (M+H)+ 
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Di-tert-butyl -4-((4-methoxyphenyl)sulfonyl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-
dicarboxylate (171b): 
 
Following GP-4, 171b was prepared from 96a (140 mg, 0.5 mmol) and 4-iodoanisole (206 mg, 
1 mmol, 2 equiv). The crude product was purified by column chromatography (silica gel; 
PE/EtOAc= 7:1,) to afford 171b as a yellowish oil (97 mg, 42%). Rf = 0.37 (PE/ EtOAc=5:1) 
1H NMR (400 MHz, Chloroform-d) δ 7.86 – 7.82 (m, 2H), 7.24 (s, 1H), 7.03 – 6.98 (m, 2H), 
4.40 (s, 1H), 3.88 (s, 3H), 2.88 (s, 1H), 1.51 (s, 9H), 1.41 (s, 9H), 0.83 (s, 1H); 13C NMR (101 
MHz, CDCl3) δ 170.5, 163.5, 149.9, 136.7, 131.9, 129.5, 124.4, 114.5, 84.0, 81.6, 55.6, 45.0, 
28.0, 28.0, 21.9; IR (neat, cm-1 ): 2978, 1714, 1576, 1330, 1297, 1136, 1092, 946, 833, 730, 
670; HRMS (ESI): m/z calculated for C22H29NO7S (M+H)
+: 452,1665; Found 452.1675 
(M+H)+ 
 
 
Tert-butyl-4-((4-methoxyphenyl)sulfonyl)-2-tosyl-2-azabicyclo[3.1.0]hex-3-ene-6-
carboxylate (171c): 
 
Following GP-4, 171c was prepared from 96b-Me (120 mg, 0.5 mmol) and 4-
Methoxybenzenesulfonyl chloride (206.65 mg, 1 mmol, 2 equiv). The crude product was 
purified by column chromatography (silica gel, PE/EA=10:1) to afford 171c as a yellowish oil 
(74 mg, 30% yield). Rf = 0.3 (PE/EA) = 5:1. 
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1H NMR (400 MHz, Chloroform-d) δ 7.90 (d, J = 8.8 Hz, 2H), 7.80 (d, J = 8.2 Hz, 2H), 7.49 
(d, J = 8.2 Hz, 2H), 7.11 (d, J = 8.9 Hz, 2H), 4.20 (d, J = 6.9 Hz, 1H), 4.00 (s, 2H), 2.90 (dd, J 
= 6.9, 2.9 Hz, 1H), 2.59 (s, 3H), 1.51 (s, 9H), 0.45 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 
169.9, 163.7, 145.5, 137.2, 133.1, 131.2, 130.4, 129.7, 127.3, 127.0, 114.6, 81.8, 55.7, 45.6, 
28.9, 28.0, 21.7, 20.4; ; IR (neat, cm-1): 2974, 2929, 1703, 1576, 1494, 1367, 1133, 1010, 905, 
831, 723, 663; HRMS (ESI): m/z calculated for C24H27NO7S2 (M+H)
+: 506.1229; Found 506. 
1237 (M+H)+.  
 
 
2-(Tert-butyl) 6-methyl-4-((4-nitrophenyl)sulfonyl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-
dicarboxylate (171e): 
 
Following GP-4, 171e was prepared from 96a-Me (120 mg, 0.5 mmol) and 4-
nitrobenzenesulfonyl chloride (222 mg, 1 mmol, 2 equiv). The crude product was purified by 
column chromatography (silica gel, PE/EA=10:1) to afford 171e as a yellowish oil (75 mg, 35% 
yield). Rf = 0.25 (PE/EA = 5:1). 
1H NMR (400 MHz, Chloroform-d) δ 8.39 (d, J = 8.8 Hz, 2H), 8.10 (d, J = 8.8 Hz, 2H), 7.43 
(s, 1H), 4.49 (s, 1H), 3.68 (s, 3H), 3.02 (dd, J = 7.0, 2.7 Hz, 1H), 1.52 (s, 9H), 0.93 (s, 1H); 13C 
NMR (101 MHz, CDCl3) δ 171.4, 167.8, 150.4, 146.2, 139.6, 133.5, 128.6, 123.5, 121.6, 84.9, 
52.4, 45.5, 28.0, 20.3; IR (neat, cm-1): 2881, 1722, 1569, 1371, 1338, 1282, 1140, 1088, 853, 
730; HRMS (ESI): m/z calculated for C18H20N2O8S (M+H)
+: 425.0940; Found 425.0957 
(M+H)+.  
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2-(Tert-butyl) 6-methyl -4-((5-bromothiophen-2-yl)sulfonyl)-2-azabicyclo[3.1.0]hex-3-
ene-2,6-dicarboxylate (171d): 
 
Following GP-4, 171d was prepared from 96a-Me (120 mg, 0.5 mmol) and 5-Bromothiophene-
2-sulfonyl chloride (262 mg, 1 mmol, 2 equiv). The crude product was purified by column 
chromatography (silica gel, PE/EA=7:1) to afford 171d as a yellowish oil (95 mg, 37% yield). 
Rf = 0.2 (PE/EA = 5:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.43 (d, J = 3.9 Hz, 1H), 7.31 (s, 1H), 7.10 (d, J = 4.0 
Hz, 1H), 4.46 (s, 1H), 2.95 (d, J = 5.7 Hz, 1H), 1.52 (s, 9H), 1.43 (s, 9H), 0.90 (s, 1H); 13C 
NMR (101 MHz, CDCl3) δ 206.9, 170.3, 149.7, 142.8, 133.1, 130.8, 123.3, 121.7, 84.4, 81.9, 
45.1, 30.9, 28.0, 28.0, 21.8; IR (neat, cm-1): 2978, 1722, 1572, 1334, 1133, 1084, 969, 769, 
670; HRMS (ESI): m/z calculated for C19H24BrNO6S2 (M+H)
+: 506.0228; Found 506.0228 
(M+H)+.  
 
2-(Tert-butyl) 6-methyl-4-((4-fluorophenyl)sulfonyl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-
dicarboxylate (171f): 
 
Following GP-4, 171f was prepared from 96a-Me (120 mg, 0.5 mmol) and 4-iodoanisole (206 
mg, 0.1 mmol, 2 equiv). The crude product was purified by column chromatography (silica gel; 
PE/EtOAc= 10:1) to afford 171f as a colorless oil (65 mg, 33%). Rf = 0.5 (PE/ EtOAc=5:1). 
1H NMR (400 MHz, CDCl3) δ 7.94 (m, 1H), 7.34 (s, 1H), 7.25 (m, 2H), 4.49 (s, 1H), 3.69 (s, 
3H), 2.99 (dd, 1H), 1.53 (s, 9H), 1.27 (s, 1H), 0.97 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 
171.7, 166.8, 164.3, 149.6, 137.8, 136.5, 130.2, 130.1, 123.2, 116.8, 116.5, 84.4, 52.3, 45.4, 
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31.8, 28.0, 20.6; HRMS (ESI): m/z calculated for C18H20FNO6S (M+H)
+: 398.0998 ; Found 
398.1068 (M+H)+.  
 
 
2-(Tert-butyl) 6-methyl -4-(phenylsulfonyl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-
dicarboxylate (171g): 
 
Following GP-4, 171g was prepared from 96a-Me (120 mg, 0.5 mmol) and benzenesulfonyl 
chloride (0.128 mL, 1 mmol, 2 equiv). The crude product was purified by column 
chromatography (silica gel, PE/EA=5:1) to afford 171g as a yellowish oil (60 mg, 30% yield). 
Rf = 0.11 (PE/EA = 10:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.64 (d, J = 7.5 Hz, 2H), 7.36 (t, J = 7.3 Hz, 1H), 7.29 
(d, J = 7.8 Hz, 2H), 7.06 (s, 1H), 4.19 (s, 1H), 3.39 (s, 3H), 2.75 – 2.68 (m, 1H), 1.24 (s, 9H), 
0.68 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 171.7, 149.7, 140.3, 137.7, 133.4, 129.3, 127.2, 
123.4, 84.3, 52.2, 45.4, 28.0, 20.6; IR (neat, cm-1 ):2981, 1722, 1572, 1371, 1136, 1088, 976, 
719, 669; HRMS (ESI): m/z calculated for C18H21NO6S (M+H)
+: 380.1090; Found 380.1091 
(M+H)+.  
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2-(Tert-butyl)6-methyl-2-(tert-butoxycarbonyl)-6-(methoxycarbonyl)-2-azabicyclo 
[3.1.0]hexan-3-yl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate (177): 
 
An 10 mL Schlenk flask equipped with a magnetic stirring bar was charged with 96a-Me (120 
mg, 0.5 mmol, 1.0 equiv) in acetonitrile (2 ml). The resulting mixture was stirred for 10 min at 
room temperature. After completion of the reaction (as monitored by TLC), the resulting 
mixture was saturated with brine solution (15 mL) and the product was extracted with ethyl 
acetate (3x15 mL), the combined organic layer was dried over Na2SO4 and concentrated, the 
residue was purified by column chromatography (silica gel; PE/EtOAc= 10:1) to afford 181 as 
a colorless oil (51 mg, 33 % yield. Rf = 0.30 (PE/EtOAc = 10:1).  
1H NMR (400 MHz, Chloroform-d) δ 6.47 – 6.23 (m, 1H), 4.43 – 4.19 (m, 2H), 3.82 – 3.74 
(m, 2H), 3.66 (s, 6H), 2.79 – 2.69 (m, 1H), 2.21 – 2.13 (m, 2H), 1.67 – 1.63 (m, 1H), 1.47 (s, 
9H), 1.42 (s, 9H), 1.07 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 171.10, 171.09, 155.01, 150.90, 
149.21, 124.62, 83.85, 80.66, 57.067, 51.81, 51.71, 51.71, 45.41, 34.82, 28.23, 28.26, 27.97, 
24.93, 22.25;  
 
 
Methyl 5-(4-methoxyphenyl)sulfonyl)nicotinate (181): 
 
An oven dried 10 mL Schlenk flask equipped with a magnetic stirring bar was charged with a 
monocyclocpropanated N-Boc pyrrole 171a (204 mg, 0.5 mmol, 1 equiv), Pd2(dba)3 (14 mg, 3 
mol%), 4-iodoanisole (0.6 mmol, 1.2 equiv), NaHCO3 (105 mg, 1.25 mmol, 2.5 equiv), and 
tetrabutylammonium bromide (TBAB) (322 mg, 1 mmol, 2 equiv) followed by addition of dry 
 126 
toluene (1.5 mL). The resulting mixture was degassed by “pump-freeze-thaw” cycles (×3), then 
stirred for 5 min at room temperature and subsequently placed on a pre-heated oil bath at 80 oC 
for 48 h. After completion of the reaction (as monitored by TLC), the reaction mixture was 
cooled down to room temperature, diluted with CH2Cl2 (15 mL) and filtered through a pad of 
Celite. The crude product was purified by column chromatography (silica gel; PE/EtOAc= 
10:1) to afford 181 as a colorless oil (51 mg, 33 % yield. Rf = 0.30 (PE/EtOAc = 10:1).  
1H NMR (400 MHz, Chloroform-d) δ 9.28 (d, J = 31.9 Hz, 1H), 8.74 (d, J = 2.1 Hz, 1H), 7.99 
– 7.72 (m, 2H), 7.08 – 6.85 (m, 2H), 3.98 (s, 3H), 3.86 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
164.14, 154.02, 151.62, 139.27, 135.95, 131.58, 130.26, 126.45, 115.00, 77.37, 77.05, 76.73, 
55.80, 52.97; IR (neat, cm-1): 2952, 1714, 1591, 1472,1431, 1248, 1110, 1017, 827, 782, 738; 
HRMS (ESI): m/z calculated for C14H13NO3S (M+H)
+: 308.0514. Found 308.0523. 
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F Appendix 
1. Copies of NMR spectra 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
96a 
96a 
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1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
96a-Me 
96a-Me 
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1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
124 
124 
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1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
I 
I 
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1H 
NMR (400 MHz, CDCl3)
  
13C NMR (101 MHz, CDCl3) 
1b 99 
99 
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1H NMR (400 MHz, CDCl3)
 
13C NMR (101 MHz, CDCl3) 
100a 
100a 
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1H NMR (400 MHz, CDCl3)
13C NMR (101 MHz, CDCl3) 
100a-Me 
100a-Me 
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1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
115 
115 
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1H NMR (300 MHz, CDCl3) 
13C NMR (75 MHz, CDCl3) 
110a 
110a 
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1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
110b 
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1H NMR (300 MHz, CDCl3) 
13C NMR (75 MHz, CDCl3) 
110c 
110c 
 139 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
110d 
110d 
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1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
110a-Me 
110a-Me 
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1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
110f 
110f 
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1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
110g 
110g 
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1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
110h 
110h 
 144 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
110i 
110i 
 145 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
110j 
110j 
 146 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
110k 
110k 
 147 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
110l 
110l 
 148 
1H NMR (300 MHz, CDCl3) 
 
13C NMR (75 MHz, CDCl3) 
110m 
110m 
 149 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
110n 
110n 
 150 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
110o 
110o 
 151 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
110p 
110p 
 152 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
110q 
110q 
 153 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CD3CN)
110r 
110r 
 154 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
111a-Me 
111a-Me 
 
 155 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3)
111b-Me 
111b-Me 
7b 
 156 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
111c-Me 
111c-Me 
 157 
 
1H NMR (400 MHz, CDCl3)
13C 
NMR (101 MHz, CDCl3) 
111a 
111a 
 158 
 
1H NMR (600 MHz, CDCl3) 
 
13C NMR (151 MHz, CDCl3) 
111b 
111b 
 159 
 
19F NMR (377 MHz, CDCl3) 
111b 
 160 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
111d-Me 
111d-Me 
f 
 161 
 
 
1H NMR (400 MHz, CD3CN) 
 
13C NMR (101 MHz, CD3CN) 
113 
f 
113 
f 
 162 
1H NMR (400 MHz, CD3CN) 
13C NMR (101 MHz, CD3CN) 
114 
f 
114 
f 
 163 
 
1H NMR (400 MHz, CD3CN) 13C NMR (101 MHz, CD3CN) 
114 
f 
 164 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
119 
119 
 
 165 
 
1H NMR (400 MHz, CDCl3)
13C NMR (101 MHz, CDCl3) 
 
 
147a 
147a 
 166 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
147`a 
147`a 
 167 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
147b 
147b 
 168 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
147`b 
147`b 
 169 
 
 
1H NMR (400 MHz, CDCl3)
13C NMR (101 MHz, CDCl3) 
147c 
 
147c 
 
 170 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
147´c 
 
147´c 
 
 171 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
 
147d 
 
147d 
 
 172 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
147`d 
 
147`d 
 
 173 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
147e 
 
147e 
 
 174 
 
1H NMR (400 MHz, CDCl3)
 
13C NMR (101 MHz, CDCl3) 
147`e 
 
147`e 
 
 175 
 
1H NMR (400 MHz, CDCl3)
 
13C NMR (101 MHz, CDCl3) 
145 
145 
 176 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
148 
148 
 177 
1H NMR (600 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
 178 
      
1H NMR (300 MHz, CDCl3)
13C NMR (101 MHz, CDCl3) 
163 
163 
 179 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
 
171a 
171a 
 180 
 
1H NMR (400 MHz, CDCl3) 
 
 13C NMR (101 MHz, CDCl3) 
171b 
171b 
 181 
 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
 
171c 
171c 
 182 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
171e 
171e 
 183 
 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (101 MHz, CDCl3) 
171g 
171g 
 184 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
171f 
171f 
 185 
 
1H NMR (400 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
 
171d 
171d 
 186 
1H NMR (300 MHz, CDCl3) 
13C NMR (101 MHz, CDCl3) 
177 
177 
 187 
1H NMR (300 MHz, CDCl3)
13C NMR (101 MHz, CDCl3) 
181 
181 
 188 
2. HPLC chromatograms 
Data for 96a: 
 
Peak Results: 
Index Time (min) Area (mAU.min)  Area (%) 
1 10.39 332.5 46.876 
2 15.13 376.9 53.124 
Total  709.4 100.00 
Data for (-)-96a: 
 
Peak Results: 
Index Time (min) Area (mAU.min)  Area (%) 
1 9.72 121.5 98.67 
2 15.38 2.7 1.33 
Total  124.1  
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Data for 110a: 
 
Peak Results: 
Index Time (min) Area (mAU.s) Area (%) 
1 4.04 320.90115 49.99 
2 4.30 321.02954 50.01 
Total  641.93069  
Data for 110a: 
 
Peak Results: 
Index Time (min) Area (mAU.s) Area (%) 
1 4.04 156.29250 1.60 
2 4.30 2976.55981 98.39 
Total  3132.85231  
 
(+)-110a 
 
(-)-110a 
(-)-110a 
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2. X-ray crystallography data 
 
 
 
 
 
 
Table 1. Crystal data and structure refinement for 111a. 
Compound  R002  
 Identification code  JA-487-2 
Formula  C16H16N2O4  
Dcalc./ g cm
-3  1.3795  
 /mm-1  0.833  
Formula Weight  300.32  
Colour  clear colourless  
Shape  plate  
Size/mm3  0.25×0.16×0.07  
T/K  123.00(10)  
Crystal System  triclinic  
Space Group  P-1  
a/Å  5.8128(3)  
b/Å  10.1519(4)  
c/Å  12.5413(4)  
α/°  83.613(3)  
β/°  89.482(3)  
γ/°  79.429(4)  
V/Å3  722.95(5)  
Z  2  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  Cu K   
min/
°  3.55  
max/
°  74.26  
Measured Refl.  14758  
Independent Refl.  2872  
Reflections Used  2541  
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Reflection Statistics 
 
Total reflections (after 
filtering) 
14758 Unique reflections 2872 
Completeness 0.973 Mean I/s 21.71 
hklmax collected (7, 12, 15) hklmin collected (-7, -12, -15) 
hklmax used (7, 12, 15) hklmin used (-7, -12, 0) 
Lim dmax collected 100.0 Lim dmin collected 0.77 
dmax used 12.46 dmin used 0.8 
Friedel pairs 2439 Friedel pairs merged 1 
Inconsistent equivalents 5 Rint 0.0405 
Rsigma 0.022 Intensity transformed 0 
Omitted reflections 0 Omitted by user (OMIT 
hkl) 
0 
Multiplicity (1420, 1264, 953, 808, 
551, 247, 62, 6) 
Maximum multiplicity 14 
Removed systematic 
absences 
0 Filtered off 
(Shel/OMIT) 
0 
Rint  0.0405  
Parameters  202  
Restraints  0  
Largest Peak  0.2678  
Deepest Hole  -0.2222  
GooF  1.0538  
wR2 (all data)  0.1074  
wR2  0.1030  
R1 (all data)  0.0418  
R1  0.0375  
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Table 2. Crystal data and structure refinement for 111a-Me. 
Compound  test_Kopie  
    
Formula  C14H13NO3  
Dcalc./ g cm
-3  1.362  
 /mm-1  0.793  
Formula Weight  243.25  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.20×0.17×0.10  
T/K  123.00(10)  
Crystal System  orthorhombic  
Flack Parameter  -0.04(5)  
Hooft Parameter  -0.02(5)  
Space Group  Pca21  
a/Å  6.15130(10)  
b/Å  7.10860(10)  
c/Å  27.1285(4)  
α/°  90  
β/°  90  
γ/°  90  
V/Å3  1186.25(3)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuK   
min/
°  3.258  
max/
°  73.385  
Measured Refl.  12129  
 194 
 
 
 
 
 
Reflection Statistics 
Total reflections (after 
filtering) 
13391 Unique reflections 2356 
Completeness 0.986 Mean I 39.98 
hklmax collected (7, 8, 33) hklmin collected (-7, -8, -33) 
hklmax used (7, 8, 33) hklmin used (0, 0, -33) 
Lim dmax collected 100.0 Lim dmin collected 0.77 
dmax used 13.56 dmin used 0.8 
Friedel pairs 3213 Friedel pairs merged 0 
Inconsistent equivalents 0 Rint 0.0225 
Rsigma 0.0141 Intensity transformed 0 
Omitted reflections 0 Omitted by user (OMIT 
hkl) 
0 
Multiplicity (3930, 2579, 978, 291, 
41) 
Maximum multiplicity 14 
Removed systematic 
absences 
1262 Filtered off 
(Shel/OMIT) 
0 
Independent Refl.  2356  
Reflections with I > 2(I)  2304  
Rint  0.0225  
Parameters  198  
Restraints  19  
Largest Peak  0.160  
Deepest Hole  -0.141  
GooF  1.055  
wR2 (all data)  0.0757  
wR2  0.0749  
R1 (all data)  0.0285  
R1  0.0278  
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Table 3. Crystal data and structure refinement for 119. 
Compound  Q138  
    
Formula  C18H23NO4  
Dcalc./ g cm
-3  1.266  
 /mm-1  0.726  
Formula Weight  317.37  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.15×0.09×0.04  
T/K  122.96(13)  
Crystal System  monoclinic  
Space Group  P21/n  
a/Å  5.7268(2)  
b/Å  18.8102(6)  
c/Å  15.4599(5)  
α/°  90  
β/°  91.124(3)  
γ/°  90  
V/Å3  1665.05(10)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuK   
min/
°  3.701  
max/
°  73.883  
Measured Refl.  9719  
Independent Refl.  3341  
Reflections Used  2817  
Rint  0.0341  
Parameters  212  
Restraints  0  
Largest Peak  0.192  
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Reflection Statistics 
 
Total reflections (after 
filtering) 
9908 Unique reflections 3341 
Completeness 0.989 Mean I 17.62 
hklmax collected (7, 21, 19) hklmin collected (-6, -23, -18) 
hklmax used (7, 23, 19) hklmin used (-7, 0, 0) 
Lim dmax collected 100.0 Lim dmin collected 0.77 
dmax used 11.94 dmin used 0.8 
Friedel pairs 1235 Friedel pairs merged 1 
Inconsistent equivalents 16 Rint 0.0341 
Rsigma 0.0326 Intensity transformed 0 
Omitted reflections 0 Omitted by user (OMIT 
hkl) 
0 
Multiplicity (4180, 1596, 628, 148, 
12) 
Maximum multiplicity 10 
Removed systematic 
absences 
189 Filtered off 
(Shel/OMIT) 
0 
Deepest Hole  -0.201  
GooF  1.054  
wR2 (all data)  0.0977  
wR2  0.0920  
R1 (all data)  0.0457  
R1  0.0375  
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Table 4. Crystal data and structure refinement for (+)-120. 
Compound  R110  
Formula  C31H37NO7  
Dcalc./ g cm
-3  1.235  
 /mm-1  0.710  
Formula Weight  535.61  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.28×0.20×0.15  
T/K  123.00(10)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  8.79163(14)  
b/Å  31.2432(5)  
c/Å  10.6264(2)  
 /°  90  
 /°  99.3024(17)  
 /°  90  
V/Å3  2880.47(9)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuK   
min/
°  4.447  
max/
°  74.206  
Measured Refl.  32161  
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Reflection Statistics 
 
Total reflections (after 
filtering) 
32516 Unique reflections 5795 
Completeness 0.99 Mean I 47.45 
hklmax collected (10, 39, 13) hklmin collected (-10, -38, -11) 
hklmax used (10, 38, 13) hklmin used (-10, 0, 0) 
Lim dmax collected 100.0 Lim dmin collected 0.77 
dmax used 10.49 dmin used 0.8 
Friedel pairs 7276 Friedel pairs merged 1 
Inconsistent equivalents 3 Rint 0.02 
Rsigma 0.0114 Intensity transformed 0 
Omitted reflections 0 Omitted by user (OMIT hkl) 0 
Multiplicity (9183, 6062, 2276, 915, 
131, 11) 
Maximum multiplicity 16 
Removed systematic 
absences 
355 Filtered off (Shel/OMIT) 0 
Independent Refl.  5795  
Reflections with I > 2(I)  5472  
Rint  0.0200  
Parameters  360  
Restraints  0  
Largest Peak  0.270  
Deepest Hole  -0.237  
GooF  1.039  
wR2 (all data)  0.0879  
wR2  0.0864  
R1 (all data)  0.0371  
R1  0.0353  
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Table 5. Crystal data and structure refinement for 145. 
Compound  JA-6 
CCDC  n/a 
Formula  C12H15NO5  
Dcalc./ g cm
-3  1.401  
 /mm-1  0.927  
Formula Weight  253.25  
Colour  clear colourless  
Shape  plate  
Max Size/mm  0.46  
Mid Size/mm  0.32  
Min Size/mm  0.09  
T/K  122.98(10)  
Crystal System  monoclinic  
Space Group  P21/m  
a/Å  12.2037(2)  
b/Å  6.76442(12)  
c/Å  15.3457(3)  
α/°  90  
β/°  108.595(2)  
γ/°  90  
V/Å3  1200.67(4)  
Z  4  
Z'  1  
min/
°  3.822  
max/
°  73.884  
Measured Refl.  23955  
Independent Refl.  2643  
Reflections Used  2460  
Rint  0.0259  
Parameters  215  
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Reflection Statistics 
 
Total reflections (after 
filtering) 
23978 Unique reflections 2643 
Completeness 0.995 Mean I 51.73 
hklsub>max</sub> 
collected 
(15, 8, 19) hklsub>min</sub> 
collected 
(-15, -8, -18) 
hklmax used (14, 8, 19) hklmin used (-15, 0, 0) 
Lim dmax collected 100.0 Lim dmin collected 0.77 
dmax used 11.57 dmin used 0.8 
Friedel pairs 3802 Friedel pairs merged 1 
Inconsistent equivalents 14 Rint 0.0259 
Rsigma 0.0096 Intensity transformed 0 
Omitted reflections 0 Omitted by user (OMIT 
hkl) 
0 
Multiplicity (1845, 2268, 2153, 
1213, 563, 297, 120, 
73, 25, 4) 
Maximum multiplicity 27 
Removed systematic 
absences 
23 Filtered off 
(Shel/OMIT) 
0 
 
Restraints  0  
Largest Peak  0.273  
Deepest Hole  -0.206  
GooF  1.032  
wR2 (all data)  0.1001  
wR2  0.0984  
R1 (all data)  0.0353  
R1  0.0336  
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